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The way malaria parasites are transmitted in space will have an influence on their 
genetic relationships.  It can be expected that parasites collected within close 
geographic distances of each other would be more closely related than those across 
large geographic distances.  Further to this, because malaria transmission is focal and 
heterogeneous in space, then the genetic relatedness between malaria parasites in 
these foci of malaria transmission would be greater within tightly clustered regions.  
Thus, using the level of genetic relatedness of these parasites would reveal how they 
are transmitted not only within these foci but at different geographic settings.  This 
knowledge would offer insight on how malaria control methods can be effectively 
disseminated. 
 
In field settings malaria infections are polyclonal and each of the clones represented 
within these infections occur at different proportions.  With the aid of genetic 
markers such as single nucleotide polymorphisms (SNPs) or microsatellites, parasite 
clonal genotypes can be identified.  In this study, the genetic markers of choice are 
SNPs.  Using a method that can quantify these SNPs representing the different clones 
occurring at different proportions in an isolate, then each of the clonal genotypes can 
be determined.  Microsatellites were also used as additional markers in the study. 
 
In this thesis, 1.Genetic markers (SNPs) across the P. falciparum genome were 
identified (Chapter 3); 2. Pyrosequencing
TM
 was validated as a technique that would 
enable the identification of each genetically distinct clone represented in an infection 
by assigning proportions to the SNPs representing each genetically distinct clone and 
enabling the identification of parasite clonal genotypes in every isolate analysed.  
This was validated using laboratory prepared clone mixtures of P. falciparum. In 
addition; the progeny from a cross derived from genetically characterised 3D7 and 
HB3 isolates was analysed in preparation for the analysis of the field isolates 
(Chapter 4).  , 4. In Chapter 5, field isolates were tested and clonal genotypes 
identified using both SNPs and microsatellites.  A detailed population genetic 
analysis was also performed and finally in Chapter 6, evidence for correlation 
between the genetic relationships of these parasites and geographic distance was 
investigated. 
 
The results from field isolates summarised in this thesis were from analysis of 54 
isolates; 7 samples collected from Cameroon, 13 from Kenya and 34 from Mali.  The 
data consists of 13 SNPs analysed by Pyrosequencing
TM
 and 8 microsatellites.  84 





Analysis of both SNPs and microsatellites revealed that microsatellites were more 
informative than the SNPs based on the observed allelic richness and heterozygosity 
(genetic diversity) across all loci analysed.  The overall FST value was 0.061 using 
SNPs and 0.043 by microsatellites analysis.  These values were low but consistent 
with what is typically observed in African P falciparum populations. 
Finally, analyses of the combined data set revealed that no statistically significant 
levels of spatial autocorrelation existed within the studied parasite populations. 
However, there was evidence of within host mixed parasite infections exhibiting a 






























I keep the subject of my inquiry constantly before me, and wait 
till the first dawning opens gradually, by little and little, into a 
full and clear light. 
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1. INTRODUCTION 
1.1. Chapter synopsis 
The chapter begins with a brief background on discovery and history of malaria, the 
debilitating effects of the disease, the different types of Plasmodium, and, the 
lifecycle of the parasite in the female Anopheles mosquito and in the human host. 
Next, important principles of malaria transmission developed using epidemiological 
concepts and mathematical modelling will be discussed including their implications 
in malaria control programs.  Further the spatial distribution of malaria parasites 
revealing the focal and heterogeneous aspects of the disease and how obtaining this 
information can improve malaria intervention programs will be outlined.  
Since the objective of this thesis is to use the genetic relationships of malaria 
parasites to define dispersal of these parasites in different geographic settings, the 
multiplicity of infection and how this confounds detection of genetically distinct 
clones will be discussed.  In addition, a review is provided detailing advances in 
technology for genome-wide exploration and subsequent ease in detection of parasite 
clones from multiclonal infections.  
Finally, the project concept which provided the impetus for this study and, the 
intended objectives in this thesis are given. 
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1.2. Background 
Charles Louis Alphonse Laveran, a French army doctor, identified malaria parasites 
in fresh blood in 1880.  He must have had remarkable eyesight as this was 10 years 
before Dimitri Romanowski developed the methylene blue staining method.  It was 
not until 17 years later in 1897 that Ronald Ross demonstrated that these parasites 
were transmitted by mosquitoes providing insight on the lifecycle of these parasites 
then known as Plasmodium (historical perspective obtained from Bruce-Chwatt LJ, 
1981; Capanna, 2006).   
130 years since Laveran’s discovery, malaria still remains a global burden with 
statistics according to the recent WHO report 2010 estimating that it affects 
approximately 300 million individuals and causes approximately 700,000 deaths 
annually. Its greatest impact is exerted in sub-Saharan Africa with most cases 
reported in children less than five years of age and pregnant women.  The disease is 
caused by protozoa of the genus Plasmodium and is transmitted by female Anopheles 
mosquitoes.   
Plasmodium falciparum is of great significance as it is highly pathogenic causing the 
most severe form of malaria with the highest number of reported cases 
predominantly in Africa.  The malaria disease caused by this parasite is characterized 
by cyclic patterns of fevers and chills, without a clear remission between peaks of 
fever.  P. falciparum malaria is highly prevalent in Africa due to the fact that 
Anopheles gambiae, the most important vector in Africa, has a strong preference to 
blood feeding on humans rather than other animals, with a penchant for feeding and 
resting indoors increasing its chances of human interaction.  It also has a long 
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lifespan, increasing such a mosquito’s chance of becoming infected with human 
malaria parasites and of transmitting it to another human being (Beier, 1998).  In 
addition, Africa has temperate and stable weather conditions enabling the Anopheles 
host to thrive and hence transmit the parasites to the human host.   
The other species of human malaria parasites are Plasmodium vivax, Plasmodium 
ovale, Plasmodium. malariae and Plasmodium. knowlesi (Singh et al., 2004). P. 
vivax and P. ovale cause periodic fevers recurring every 48 hours but P. malariae 
fevers recur every 72 hours. Recent findings indicate that P knowlesi is zoonotic 
being transmitted from macaque monkeys to humans by the vector Anopheles 
leucosphyrus (Coatney et al., 1971; Cox-Singh & Singh, 2008a).  This strain causes 
cyclic periodic fevers every 24 hours (Jongwutiwes et al., 2004; Cox-Singh et al., 
2008b). 
 
1.2.1. Lifecycle of malaria parasites 
The Plasmodium life cycle begins with a bite from an infected female Anopheles 
mosquito to the human host during a blood meal (Figure 1.1).  About 10-100 
sporozoites are injected and deposited into the skin of the human host (Doolan et al., 
2009; Nkhoma et al., 2012), locate a blood vessel and migrate to the liver.  This 
initiates asexual reproduction (schizogony), an asymptomatic phase.  
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Figure 1.1  Lifecycle of P. falciparum showing the asexual phase in the human host 
and the sexual stage in the female Anopheles mosquito (Wirth 2002).  
 
Each sporozoite invades a single hepatic cell developing and multiplying to 10,000-
30,000 merozoites (reviewed by Jones & Good 2006).  In P. vivax and P. ovale, 
some of the parasites can remain in the liver for years as hypnozoites and may cause 
recurrent episodes of malarial disease.  The schizogony stage in the liver takes 
approximately 6 days in P. falciparum, 8 days in P. vivax, 13 days in P. malariae and 
9 days in P. ovale and P. knowlesi respectively (Borrowed from the malaria site: 
www.malariasite.com).  
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The merozoites in the liver are released from ruptured hepatocytes into the blood 
stream and immediately invade red blood cells (RBCs) initiating the blood stage 
infection.  The merozoites in the RBC develop to a ‘ring’ stage and then to a 
trophozoite which replicates to form a multinucleated schizont containing an average 
of 10 merozoites (review by Greenwood et al., 2008).  When the schizont matures, 
the erythrocyte ruptures and releases merozoites that infect new erythrocytes. The 
characteristic periodic fevers that are the signature of malaria are precipitated by 
synchronous parasite development and erythrocyte rupture which releases new 
merozoites, malaria antigens and toxic metabolites. 
Rather than maturing into schizonts, some of the trophozoites develop to male and 
female sexual gametocytes.  The haploid gametocytes are ingested as part of the 
female mosquito’s blood meal and initiate sexual reproduction (sporogony) in the 
mosquito’s gut (Cycle in mosquito, Figure 1.1).  The male gametocyte nucleus 
undergoes 3 rounds of DNA replication producing eight nuclei with each forming a 
flagellum in a process known as exflagellation.  Thus, 8 motile male microgametes 
are produced.  The female gametocyte matures to a macrogamete. The male and 
female gametes fuse to form a diploid zygote.  At this stage, if a mosquito ingests 
two genetically distinct parasite clones, recombination takes place leading to 
emergence of novel genotypes.  The motile zygote (ookinete) migrates through, and 
encysts on, the outer surface of the gut wall (as an oocyst).  Asexual division within 
this oocyst produces numerous haploid sporozoites which migrate to the mosquito’s 
salivary gland ready to be transmitted to the human host in a blood meal.  The 
sporogonic phase lasts between 8-15 days in the mosquito (Carter & Graves, 1988; 
Eichner et al., 2001).  
 
  6 
 
1.2.2. Pathophysiology of malaria 
Malaria can be categorised as: 
1. Uncomplicated malaria: 
This presents in the form of fever which occurs following bursting (lysis) of 
schizonts in the blood (Figure 1.1) to release merozoites that invade RBCs.  This 
lysis of the infected RBCs (iRBCs) is usually accompanied by release of toxins 
which initiate a paroxysmal response in the human host.  These toxins have been 
observed to initiate a toxic shock response where monocytes activate the production 
of cytokines such as the pro-inflammatory TNF- or activate the production of 
reactive nitrogen intermediates necessary for killing of asexual and sexual parasites 
with the exception of ring stages which are relatively heat-resistant (Karunaweera et 
al., 2003; reviewed in Langhorne et al., 2008).  The fevers may also be accompanied 
by headaches, general malaise, body aches, sweating.  Excessive hemolysis may lead 
to severe anaemia and enlargement of the spleen.  If malaria is left untreated, this 
may lead to severe disease.   
2. Severe and complicated malaria: 
Two factors are associated with severe malaria:  
a. Reduced deformability of iRBCs - An infected RBC undergoes changes as 
the parasite grows within it. In P. falciparum infections, iRBCs have been 
observed to become rigid and spherical losing their fluidity unlike the normal 
RBCs that are biconcave enabling them to squeeze through microvasculature 
(Paulitschke & Nash, 1993). This mechanism enhances splenic clearance of 
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IRBCs but on the other hand causes blockage in microvasculature due to their 
inflexibility which manifests as severe malaria (review by Suwanarusk et al., 
2004).  
b. In P. falciparum malaria, mature forms of the parasite are not usually 
observed by microscopy as they adhere to the endothelium of 
microvasculature, a phenomenon known as cytoadherence (Berendt et al., 
1994).  In addition, uninfected RBCs and platelets have been observed to 
stick to iRBCs also known as rosetting which together with cytoadherence 
are believed to be involved in development of severe malaria (Wahlgren et al., 
1998 review).  Major organs such as the brain, lungs, liver and the placenta 
undergo obstruction due to the sequestration of non-infected and infected 
RBCs affecting their function (Miller et al., 1994).  Pathological 
examinations of individuals who have succumbed to severe malaria reveal 
this sequestration in major organs suggesting the association of severe 
malaria and cytoadherence (Fried & Duffy, 1996; Newbold et al., 1997).  In 
the brain this manifests as cerebral malaria while in pregnant mothers as 
placental malaria.  Cytoadherence and rosetting have been associated with 
presence of the surface molecules Plasmodium falciparum erythrocyte 
membrane protein 1 (PfEMP 1) that render the iRBCs ‘sticky’ causing them 
to form rosettes with non-infected RBCs and also, enabling them to sequester 
to capillaries or tissues (reviewed by Pasternak &, Dzikowski, 2009) 
Constant malaria attacks in the human host exert a social, psychological, physical 
and economic burden (Carter & Mendis, 2002).  The mental and physical capacities 
are affected reducing individuals’ viability.  These malaria attacks also expose the 
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individual to opportunistic infections and since in such a state the immunity is 
lowered, death ensues. 
 
1.2.3. Management of malaria 
Various tools and strategies have been developed or are still in the process of 
development to counter the debilitating effects of malaria.  These are covered in this 
section. 
(a) Anti-malarial drugs 
These drugs may be classified according to the parasite stages they act against and 
include: (i) the pre-erythrocytic forms of Plasmodium especially for eliminating 
hypnozoites associated with P. vivax and P. ovale that may remain dormant in the 
liver for extensive periods causing disease relapse.  Primaquine is the only drug 
known to act against these stages rendering it effective in eliminating hypnozoites 
(Wells et al., 2010).  Prophylactic drugs recommended for use by travellers 
(presumed non-immune) to malarious regions fall in these categories (Castelli et al., 
2010).  (ii) Blood stage parasites e.g. quinine, chloroquine, sulfadoxine, 
pyrimethamine, mefloquine, halofantrine etc.  Emergence of multi-drug resistant 
parasites has led to the use of different drug combinations including the discovery of 
the antimalarial properties of Artemisinin. Unfortunately reports of parasites resistant 
to ACTs have begun to emerge (Dondorp, 2009; Noedl, 2008).  (iii) The sexual 
forms of the parasites.  Primaquine is effective in eliminating gametocytes of all 
Plasmodium (White, 2008). Chloroquine and quinine have this activity against P. 
vivax and P. malariae but not P. falciparum.  
 
  9 
NB.  Although Primaquine is effective against most of the parasite stages, its use is 
limited when administered to individuals with the Glucose-6-Phosphate 
Dehydrogenase (G6PD) deficiency trait as it has been observed to trigger haemolytic 
crisis in these individuals. 
(b)  Vector control strategies 
These have been developed to reduce contact between the female Anopheles 
mosquito and humans and include (i) Insecticide treated nets (ITNs) infused with 
insecticide which repel or kill mosquitoes that come into contact with them.  One 
type of net is a conventionally treated net impregnated with insecticide that lasts 
temporarily, necessitating constant re-treatment every three months or at least once a 
year to ensure continued insecticide effect.  The other one is a factory made long 
lasting insecticide treated net (LLINs) incorporated with insecticide and can last for 
up to three to five years (WHO, 2007).  ITNs have been shown to reduce the malaria 
cases by up to 50% in comparison with untreated nets (Clarke et al., 2000; 
Greenwood et al., 2008).  ITNs have contributed to reductions of child mortality 
cases by about 44% (Fegan et al., 2007) and increase an in child survival by 27% in 
Tanzania (Schellenberg et al., 2001). (ii)  Indoor residual spraying (IRS) which acts 
by repelling or killing mosquitoes that enter and/or rest on the areas that the 
insecticide has been applied.  It is therefore considered to be most effective against 
endophilic vectors such as Anopheles gambiae (http://www.who.int/whopes/en/; 
Pluess et al., 2010 review).  (iii)  Larviciding (source reduction) to curtail the 
development of mosquito larvae to adulthood using larvivorous fish such as the 
minnow also known as mosquito fish (Gambusia affinis), or the common guppy 
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(Poecilia reticulata) or bacteria such as Bacillus sphaericus and B. thuringiensis var 
israelensis [National Vector Borne Disease Control Programme (NVBDCP)].  
(c)  Vaccines 
No malaria vaccine exists at the moment although the target set by vaccine 
developers is to reduce severe disease and death with a vaccine having 80% efficacy 
lasting more than four years by 2025 (MVTR, 2006). The current potential malaria 
vaccines are those that: (i) Target pre-erythrocytic stages to avoid the clinical 
manifestations of malaria in the human host.  A circumsporozoite surface protein 
(CSP) target antigen recombinant vaccine named RTS,S/AS01E is currently in the 
phase 3 trial and has been shown to offer 51% protection against all forms of clinical 
malaria episodes in a phase 2 trial (in children aged 5-17 months) conducted in Kilifi, 
Kenya (Olotu et al., 2011).  The RTS,S/AS01E is the most promising vaccine 
candidate on trial with preliminary phase 3 trial results revealing concordant results 
as the phase 2 trial with 55% reduction of clinical malaria episodes and 35% 
reduction of severe malaria cases in children of two age categories: 6-12 weeks and 
5-17 months (The RTS,S Clinical Trials Partnership, 2011; White, 2011). (ii) 
Targeting the erythrocytic stages for elimination of the asexual blood stages of 
malaria parasites thus reducing the clinical manifestation of the disease.  Potential 
vaccine molecules include those involved in the merozoite invasion of RBCs e.g. 
Apical Membrane Antigen 1 (AMA1), Merozoite Surface Proteins 1 & 2 (MSP1 & 
2) and Recombinant Rhoptry-associated Protein 2 (RAP2) (WHO, 2011). Others 
such as one form of the surface antigen PfEMP1 known as VAR2CSA which binds 
to the chondroitin surface antigen (CSA) in the placenta offer possible vaccine 
candidates for malaria protection of pregnant women (Duffy, 2007).  Of great 
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interest is MSP1 which has been implicated in eliciting a strain specific protective 
immune (SSPI) response i.e. protection achieved from the exposure of one 
genetically distinct strain does not ensure protection from another genetically distinct 
strain.  MSP1 has been associated with SSPI in studies conducted using animal 
models and the rodent malaria P. chabaudi chabaudi (Cheesman et al. 2009; 2010). 
Since MSP1 is highly polymorphic, the design of a hybrid vaccine encompassing all 
the variants present in natural P. falciparum infections has been proposed (Cowan et 
al., 2011).  (iii) Targeting the sexual and mosquito stages essential for reducing the 
chances of gametes being fertilised thus reducing transmission of the parasites, 
which is why they are known as transmission blocking vaccines (TBVs).  Surface 
antigens identified during the sexual stages of these parasites in the mosquito midgut 
are potential targets for these vaccines.  The antigens, Pfs48/45 and Pfs230 expressed 
on the surface of gametocytes while still in the human host and in male and female 
gametes in the mosquito midgut constitute prospective transmission blocking vaccine 
candidates (reviewed by Carter, 2001).  Antigens expressed on the surface of zygotes 
and mature ookinetes in the mosquito midgut following fertilization have also been 
identified namely Ps25 and Ps28 (reviewed by Carter, 2001).  These antigens are 
favoured vaccine candidates as they have not been exposed to the human host 
immune system enabling them to develop evasion mechanisms.  Animal vaccine 
trials using these antigens reveal strong transmission blocking activity (Miura et al., 
2007) whereas in humans similar findings were observed but trials were suspended 
due to reported adverse reactions (Wu et al., 2008)   
The current focus by the Malaria Eradication Research Agenda (malERA) is to 
eradicate the disease (Alonso et al., 2011).  MalERA’s goal is to develop a vaccine 
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targeting antigens in: (i) the sexual stages in the female Anopheles mosquito, (ii) the 
pre-erythrocytic stages with emphasis on P. vivax and P. ovale that are characterised 
by hypnozoites in the liver stages.  VMP001/AS01B, a circumsporozoite based 
vaccine, is the only P. vivax vaccine under clinical trial at the moment 
(http://clinicaltrials.gov/ct2/show/NCT01157897), (iii) the erythrocytic stages 
reducing the clinical manifestations of the disease.  This vaccine has been classified 
under the broad concept broad concept of Vaccines that Interrupt Malaria 
Transmission (VIMT) (The MalERA consultative group on vaccines, 2011). 
 
1.3. Principles of malaria transmission 
1.3.1. The basic malaria reproductive number (R0)  
The concept of R0 initially developed by Ross (1911) was further expounded by 
Macdonald (1957).  R0 is defined as the number of new cases generated from an 
existing case of malaria in a naïve population.  R0 is determined by efficiency of a 
vector in transmitting malaria i.e. the vectorial capacity, and the interaction of the 
parasites and the human host, leading to the parasites infecting the vectors i.e. the 
human capacity of transmission. R0 therefore defines the intrinsic capacity of an 
environment to support malaria transmission.   
Malaria transmission is sustained when: 
R0 > 1  
and, malaria transmission cannot be maintained when: 
R0 < 1.   
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Different places have different R0 values and these can fall between 0 (a region with 
no intrinsic capacity to support malaria transmission e.g. with no mosquitoes), to 
possibly 100 to 1000.  
R0 helps establish the amount of work that needs to be done to reduce R0 to < 1.  It 
follows that places with an intrinsic capacity for malaria transmission (R0) of less 
than 1 require no work at all in ensuring no malaria transmission. At the other end of 
the spectrum, places with R0 of 100 to 1000 would require massive work to reduce it 
to less than 1 and ensure no malaria transmission. 
The R0 equation is given as: 






m= the number of female Anopheles mosquitoes’ bites per person 
a = number of humans that are bitten by a single female Anopheles mosquito in a day 
p = the chance of the female Anopheles mosquito surviving for one day 
n = how long in days it takes from a female Anopheles mosquito’s blood meal 
containing gametocytes to the development of infective sporozoites in the mosquito’s 
salivary glands (extrinsic cycle)  
= the probability of human susceptibility to infection (In the lifecycle (Figure 1.1), 
between a mosquito bite with sporozoite injection to the liver stage) 
= how long in days potentially infectious gametocytes are in the blood of a malaria 
naïve person (This is equivalent to the reciprocal of the recovery rate, 1/r, in 
Macdonald, 1957). 
 = the probability that the gametocytes in the human host will infect mosquitoes 
 
The equation is composed of the vectorial capacity and the human capacity for 
malaria transmission. 
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1.  The vectorial capacity  
 The vectorial capacity defines how good local mosquitoes are in transmitting 







The reduction of vectorial capacity was the basis for the malaria eradication program 
recommended by WHO in the 1950s.   
2. The human capacity of transmission 
This is how effective humans are in maintaining the parasites and transmitting them 
to the vector.  From the R0 equation above, the human capacity of transmission is 
represented by: 

These are the targets of drugs and vaccines that reduce malaria transmission. 
The parameters supporting the transmission of malaria have a multiplicative effect as 
shown in the equation.  Therefore, using multiple malaria control methods would be 
highly effective as they would attack and reduce the different aspects necessary for 
sustaining malaria transmission leading to the reduction of R0 < 1.   
Sub-Saharan Africa is characterised by high malaria transmission intensity which 
offers a great challenge in the implementation of malaria control programs.  
Heightening this problem is poverty, bad governance, lack of proper health care 
services and lack of proper government structures.  It is against this background that 
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proper malaria interventions require to be established and sustained to reduce the 
malaria burden.   
Successful malaria control programs have been observed in the past to be evidence 
based.  A good example is the malaria eradication campaign by William Gorgas 
during the construction of the Panama Canal (Gorgas, 1918). Identifying the vectors 
responsible for spreading malaria in an area, their feeding, resting and breeding 
patterns and their interaction with the human host is important prior to the 
implementation of malaria control programs.   
 
1.3.2. Strategies ensuring effective malaria control 
Malaria eradication efforts have shied away from regions of intense malaria 
transmission, like Sub-Sahara Africa (WHO, 2008).  The strategies discussed below 
would ensure effective dissemination of the currently available malaria interventions. 
1.3.2.1. Integrating malaria interventions 
WHO has recommended integrating the previously discussed tools, hence ensuring 
an attack against all the parameters defined in the R0 equation responsible for 
sustained malaria transmission. It is logical and sensible to scale-up and integrate the 
existing malaria interventions to ensure that in areas of high malaria transmission 
(R0>>1), the value of R0 is reduced and maintained at less than 1. 
Although integrating malaria interventions is sensible, implementing it in areas of 
high malaria transmission intensity is costly.  A study conducted in Aneityum Island, 
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a low and unstable malaria transmission area in the South Pacific, achieved success 
in eliminating malaria (Kaneko, 2010).  However, this was feasible because the 
island has low malaria transmission intensity and only 718 inhabitants, making it 
possible to carry out effective malaria intervention through constant monitoring and 
surveillance. A study conducted in Bioko Island, Equatorial Guinea, an area of high 
malaria transmission, successfully achieved reduction over 2 to < 5 years in child 
mortality rates, mosquito abundance and infection prevalence (Kleinschmidt et al., 
2009).  In spite of the 4 year intensive effort in this project, which garnered support 
from the local government as well as from internal and external donors, malaria is 
yet to be eliminated from this island (Steketee, 2009).  The project can indeed be 
considered a success but achieving this in areas of stable malaria transmission such 
as sub-Saharan Africa requires massive scale-up.  Reduction in malaria risk has also 
been observed in Zanzibar (Bhattarai et al., 2007), Gambia (Ceesay et al., 2008), 
Kilifi, Kenya (O’Meara et al., 2008), Rwanda (Sievers et al., 2008; Otten et al., 
2009) and Ethiopia.  These reductions have been precipitated by massive scale up of 
interventions fuelled by improved international donor support enabling availability of 
long lasting impregnated bed nets (LLIN), artemisinin-based combination therapy 
(ACT), & rapid diagnostic tests (RDT).  Although the feasibility of achieving 
malaria elimination in high malaria transmission such as sub-Saharan Africa remains 
unknown, even so, effective malaria control in such areas is achievable as outlined in 
the next section. 
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1.3.2.2. Malaria interventions by targeted treatment 
In this thesis, transmission of malaria will be shown to be focal (Section 1.3.3); for 
example individuals closest to mosquito breeding grounds are at high malaria risk.  
In addition, within these high malaria risk areas, malaria transmission is 
heterogeneous as malaria incidences have been observed to cluster in certain 
households and not others as shown in Section 1.3.4.  In light of this discussion, 
applying malaria interventions by identifying and targeting these high malaria risk 
areas (malaria hotspots) is highly recommended (Woolhouse et al., 1997; Smith et al., 
2005; Bousema et al., 2010; Bousema et al., 2012).   
Integrating malaria interventions coupled with proper deployment of these 
interventions by targeting malaria hotspots would lead to marked reduction of 
malaria in Africa.  
 
1.3.3. Focal transmission of malaria  
One of the fundamental aspects of malaria transmission is that it is focal. The female 
Anopheles mosquito is haematophagous as it requires blood from a human host for 
egg formation, after which it identifies the nearest breeding site to lay its eggs 
(oviposition).  It is during this time that it might encounter a human host carrying 
Plasmodium parasites which it ingests as it takes its blood meal.  The interaction of 
the vector and the human host is therefore dependent on the presence of a suitable 
and productive breeding site.  It is on this basis that malaria transmission is focal.  It 
follows that, after oviposition, the vector secures its next blood meal from the human 
host residing within its limit of movement to and from the breeding site.   
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A focus of malaria transmission is therefore a geographic region with the capacity to 
sustain malaria transmission as it has suitable climatic conditions to support vectors, 
suitable breeding grounds and human habitation.  Such areas have a basic 
reproductive number (R0) >1 (discussed in Section 1.3.1).     
Malaria risk tends to decline with distance from a breeding site because it is 
dependent on mosquito density and the ratio of female vector Anopheles to the 
number of people at a particular location, as represented by m in the equation for R0 
(Section 1.3.1).  
 
 
Thus individuals residing in an area characterised by high mosquito abundance (high 
m value) are at high malaria risk compared to individuals in an area having fewer 
mosquitoes (low m value).   
In Africa, Anopheles mosquitoes have been observed to travel ~1km from a breeding 
site in search of a blood meal (Trape et al., 1992; Takken et al., 1998).  This may be 
attributed to the behavioural patterns of An. gambiae, the predominant vector in 
Africa, which preferentially breeds in transient sunlit water collections that are 



















Figure 1.2  Malaria prevalence reported as percentage spleen rates in children. This 
figure shows a focus of malaria transmission where the prevalence of malaria 
reduces with increasing distance from the breeding sites (darkened areas in black). In 
the locality given above, malaria is being transmitted to a distance of approximately 
1km (Ross, 1911). 
To reiterate, the observation made by Ross, 1911 (Figure 1.2) indicates that a focus 
of malaria transmission is within a radius of ~1km from a breeding site but beyond 
its border malaria transmission is not sustained i.e. 0% malaria risk with R0 < 1 
values.  Conversely, in regions where productive breeding grounds are isolated and 
located a great distance from human habitation such that mosquitoes have to travel 
far in search of a blood meal, defining a focus of malaria transmission is difficult.  In 
this case, mosquitoes are widely dispersed and foci of malaria transmission cover a 
greater distance and may overlap (Carter et al. 2000).  For instance, individuals at 
highest malaria risk were found to be located at a distance of 2km from a breeding 
site in Gambia  (Thomas & Lindsay, 2000), 3km away from breeding grounds 
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(microdams built as sources of water) in Ethiopia  (Ghebreyesus et al., 1999) and 
5km away in South America (Charlwood & Alecrim, 1989).   
 
1.3.4. Malaria heterogeneity within foci of transmission 
Malaria has also been observed to be clustered within certain households and not 
others (Figures 1.3).  The degree of contact between human hosts and the mosquito 
varies with some mosquitoes being attracted to certain houses.  Poorly constructed 
houses that are not properly sealed allowing entry of the vectors have been observed 
to report with higher malaria cases (Gamage-Mendis et al., 1991).  
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(each point represents 10 individuals in neighbouring households)
(after A.C. Gamage-Mendis et al. (1991) Am. J. trop. Med. Hyg. 45, 77-85)
Kataragama, southern Sri Lanka, Nov 1986 to March 1989
3 to 4 times greater than average
2 to 3 times greater than average
up to 2  times greater than average
up to 2  times lower than average
2 to 3  times lower than average
Malaria cases Clustered by Household
 
Figure 1.3  Study carried out in Sri Lanka showing heterogeneity of malaria transmission within a 1 km region.  Each coloured point 
represents a total of 10 individuals in neighbouring houses.  Red points represent the highest number of reported malaria cases while the 
black points represent the lowest as described above.  Note the black circled region above.  Households located within close distance of 
each other present with varying degrees of malaria reported cases ranging from 3-4 times higher than average (red dots) to lower than 
average cases (black dots). Malaria cases are therefore clustered within certain households and not others.  This is an indication of 
heterogeneity within a focus of malaria transmission (Figure adapted from Gamage-Mendis et al., 1991). 
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Certain individuals have also been observed to attract mosquitoes because of their 
body odours (Takken & Knols, 1999; Mukabana et al., 2002). Mosquitoes have also 
been observed to preferentially feed on individuals harbouring gametocytes (Lacroix 
et al., 2005).  Some studies have also suggested that people with certain blood groups 
are more prone to mosquito bites than others (cited by Mukabana et al., 2002). RBC 
polymorphisms that confer protection against malaria to certain individuals e.g. the 
sickle cell trait have also been observed to be responsible for the uneven distribution 
of malaria cases within foci of transmission (Kreuels et al., 2008).  Other factors that 
contribute to heterogeneity include use of mosquito repellents or bed nets (Srinivas et 
al., 2005) and even pregnancy (Ansell et al., 2002). 
Evidence of this clustering of malaria cases is given in different studies conducted in 
Africa and Sri Lanka (Gamage-Mendis et al., 1991; Lindsay et al., 1995; 
Gunawardena et al., 1998; Ghebreyesus et al., 2000).  A study conducted in a village 
at Dielmo, Senegal revealed that children between the ages of 0-2 years had differing 
malaria episodes.  Most children had 1-2 malaria attacks during the study period but 
two children reported with 20 and 40 clinical episodes respectively (Trape et al., 
2002).  In a study conducted in Kenya over a period of 3-5 years within a small 
geographical region (~2km), some children did not have any malaria episode 
whereas approximately 21% of children in the same age group experienced >2 
episodes of malaria over different seasons and were termed the ‘more susceptible’ 
group (Mwangi et al., 2008).  The more susceptible children were likely to be highly 
exposed to malaria in comparison to the children who were negative during the study 
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period and this evidence of spatial clustering was observed throughout the study 
period (Mwangi et al., 2008) 
The heterogeneity in transmission of infectious agents occurs in other host-vector 
interactions such as humans, black flies and onchocerciasis (Bockarie et al., 1990); 
cattle, tsetse flies and trypanasomiasis (Wacher et al., 1994); humans, snails and 
schistosomiasis (Wilkins et al., 1987; Chandiwana & Woolhouse, 1991).  This 
variation in transmission of pathogens was quantified from observations made on 
host-vector contact.  Mathematical simulations were made from the data revealing 
the consequences of heterogeneous host-vector interactions.  The results showed that 
typically 20% of the human host population has a net potential to transmit 
approximately 80% of the infectious agent (Woolhouse et al., 1997).  Further studies 
conducted on P. falciparum malaria transmission (Smith et al., 2005; Smith et al., 
2007) corroborate with the findings by Woolhouse et al., (1997) in Tanzania. 
So far, evidence for heterogeneity in malaria transmission has been shown.  Where 
only a few individuals may harbour malaria infections, they play a major role as they 
serve as reservoirs of infection in field settings.   
 
1.4. The spatial distribution of Plasmodium  
In the previous section, the principles of malaria transmission were discussed.  Since 
malaria transmission is non-uniform, prior to carrying out any intervention, it is 
important to map out areas at great malaria risk.  This way, malaria control efforts 
can be tailored to the needs of local settings to maximise their effectiveness.   
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Mapping malaria risk in Africa (MARAIARMA URL; http://www.mara.org.za) and 
Scientists for Health and Research for Development (SHARED URL; 
http://www.shared.de) are databases established to reveal the spatial heterogeneity of 
P. falciparum across Africa (le Sueur et al., 1997). The maps were generated from a 
meta-analysis conducted on available annual entomological inoculation rates (AEIR) 
data as measures of malaria transmission intensities across Africa.  The AEIR is 
calculated as previously described elsewhere (Drakeley et al., 2003; Shaukat et al., 
2010): 
EIR = mas (refer to R0 equation in Section 1.3.1) 
m = Number of Anopheles per person (density of human-biting Anopheles) 
a = Mean number of persons bitten by one female Anopheles per day (human blood 
index 
N.B.  ma = human biting rate 
s = Proportion of sporozoite infected Anopheles (Sporozoite rate) 
NB.  To obtain AEIR the above parameters are averaged over a year 
 
The malaria risk maps were generated with the aid of a Geographical Information 
System (GIS), a computer based programme that allows spatial data manipulation, 
interrogation, assemblage and visualisation (http://www.esri.com/).   
These maps were of great benefit to guiding malaria control efforts as they revealed 
the population at risk of malaria in sub-Saharan Africa. This data highlighted the 
relevance of incorporating the spatial aspects of malaria distribution for the targeting 
of malaria interventions (Hay et al. 2000a, Hay et al., 2000b).  In addition, the 
temporal aspect of malaria distribution was included in the map data, which 
recognised the changing patterns of malaria transmission during different seasons 
(Craig et al., 1999). For example, in the dry season, vector abundance is reduced 
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which leads to low malaria transmission.  Conversely, following the rainy season 
collection of water puddles constituting suitable vector breeding grounds leads to 
elevated mosquito numbers and enhanced malaria transmission.   
The MARA initiative led to the establishment of the Malaria Atlas Project (MAP), 
which contains global malaria risk maps (Hay & Snow, 2006) provided in the 
database: http://www.map.ox.ac.uk/.  In addition to AEIR data, these maps were 
refined to include the parameter parasite ratio (PR), which is defined as the 
proportion of individuals confirmed malaria positive by the examination of asexual 
blood stages (rings) of malaria parasites with the aid of a microscope (Gilles, 1993). 
This parameter was used to provide a more specific definition of malaria endemicity 
(Hay & Snow, 2006) as a global baseline of malaria risk.   
The determination of malaria distribution within small spatial settings has also been 
investigated.  A retrospective study conducted in Gambia utilised data from previous 
surveys that identified potential mosquito larval habitats.  Using this information 
together with GPS, a spatial autocorrelation extrapolation of EIRs and malaria risk 
over a 2km radii from these potential breeding sites was carried out (Thomas & 
Lindsay, 2000). In this study, high malaria transmission regions (closest to breeding 
sites) reported with low malaria clinical cases while low malaria transmission regions 
had more clinical cases.  This is in contrast with what has been typically observed in 
Africa; i.e. individuals at greatest malaria risk are found in high malaria transmission 
regions.  The reason given for this observation was that reduced exposure to malaria 
parasites in individuals residing in low malaria transmission regions caused a delayed 
development of acquired immunity to the disease (Thomas & Lindsay, 2000).  A 
study conducted in Kilifi, Kenya based on data obtained from longitudinal studies 
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conducted over a 12 year period identified high malaria risk areas (Bejon et al., 
2010). In this study, individuals reporting with more febrile episodes aggregated 
within regional clusters of about 1.3km.   
A study conducted in Korogwe, Tanzania (Bousema et al., 2010) used GPS/GIS to 
determine expected clusters of malaria exposure within a radius of 2km (predicted 
flight distance of the Anopheles).  Blood isolates collected from infants 8-16 weeks 
old were tested by enzyme-linked immunosorbent assay (ELISA) for IgG antibody 
levels against the antigens AMA-1 and MSP-1.  The results indicated that clusters of 
high mosquito exposure within the 2km region corresponded to the highest sero-
conversion rates (rate at which individuals develop antibodies against parasite 
antigens per year) and high malaria incidences (determined by AEIR).  This is in line 
with what was observed in Kilifi, Kenya, where high mosquito exposure is 
associated with high malaria risk but is in contrast with the study by Thomas & 
Lindsay, (2000) in Gambia. 
The above mentioned studies highlight the need to investigate the transmission of 
malaria within small spatial settings. Because of the heterogeneity of malaria 
transmission, different localities present with different transmission patterns.  Prior to 
dissemination of malaria interventions, the local patterns of malaria transmission 
need to be established. 
The prevalence of malaria parasites in different geographic settings in these studies 
were estimated by spleen rates (Ross, 1911), parasite ratios by microscopy (Gilles, 
1993; Hay & Snow, 2006), AEIRs (Hay et al., 2000 a & b; Thomas & Lindsay, 
2000) and using serological markers (Bousema et al., 2010).  These strategies have 
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provided important information of the dispersal of malaria parasites over large 
geographic areas. However, since malaria parasites exist as mixed clone infections 
genotyping methods have also been developed to enable the detection and 
discrimination of parasite clones present per individual blood sample (isolate).  This 
has facilitated the study of genetic variation in natural populations of malaria 
parasites at different geographic settings.  In this thesis, the dispersal of malaria 
parasites in small spatial settings will be estimated by genotyping methods.  These 
are favoured as genotyping platforms are fast, require small blood samples and are 
cheap. The next section reviews the generation of genetic variation in malaria 
parasites and implications for genotyping. 
 
1.4.1. The genetic events of Plasmodium during the sexual stage of infection 
 During a blood meal, the female Anopheles mosquito ingests one or several 
genetically distinct clones from the human host.  The only diploid phase in the life 
cycle is the zygote in the mosquito midgut.  To retain haploidy, meiosis occurs 
shortly after zygote formation, resulting in sporozoites (refer to Figure 1.1).   
Gametes arising from identical clones undergo self-fertilization to produce 
homozygous zygotes, containing identical alleles at all loci.  In this case, 
recombination during meiosis does not have major genetic consequences, as the 
resulting haploid products possess genotypes that are indistinguishable from the 
parental clones (Figure 1.4).  However, if gametocytes of two or more genetically 
distinct clones are taken up into the mosquito, genetic recombination as well as self-
fertilization events among the gametes are expected.  Genetic recombination during 
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meiosis of these forms will result in parasite progeny with novel gene combinations 
among the haploid progeny (Figure 1.4).  
 
 
Figure 1.4  The process of genetic recombination in malaria parasites when 2 clones 
undergo cross mating in mosquitoes.  A and a are alleles of one gene, and B and b 
are alleles of a second gene.  One parent clone has genotype AB and the other ab; 
both produce gametocytes capable of infecting mosquitoes, between which mating 
can occur.  Recombinants Ab and aB are produced following meiosis of diploid 
zygotes AaBb (Figure adapted from Babiker et al., 1999). 
As shown in Figure 1.4, sexual recombination occurs in Plasmodium during meiosis 
and is important for the generation of novel genetic combinations.  This occurs either 
by:  (i) the independent assortment of unlinked genes on different chromosomes, (ii) 
crossing over events between linked genes on homologous chromosomes and (iii) 
recombination events within genes (intragenic recombination) leading to the 
generation of new allelic combinations (Walliker et al., 1998).   
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The rate of genetic recombination in P. falciparum is high and has been estimated to 
be ~17kb per cM from an experiment conducted using the cross of the genetically 
distinct clones Dd2 & HB3 (Su et al., 1999).  It has recently been estimated to be 
~12.8 kb/cM using the progeny of the genetic cross between 7G8 and GB4 (Jiang et 
al., 2011).  This means that there is a 1% chance of genetic recombination occurring 
every 12.8-17kb in the genome.  Genetic recombination plays a key role in 
generating parasite variants that have major implications on the multiplicity of 
infection (MOI) in P. falciparum as discussed below. 
 
1.4.2.  The multiplicity of infection (MOI) in Plasmodium  
The probability of parasites with novel clonal genotypes being generated in natural 
malaria infections depends on how often the mosquito takes in a blood meal 
containing more than one genetically distinct clone and the number of clones present 
in the human host at the time of the blood meal (Hill & Babiker, 1995).  The question 
then arises as to how often multiple clonal genotype infections occur in nature.  This 
is represented under different transmission conditions (inoculation rates) in Table 1.1. 
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Table 1.1  Frequency of multiclonal infections of P. falciparum in areas of different 
malaria transmission intensity  
 
Parasite 










Proportion of positive 
samples with 
multiclonal infections References 
Plasmodium 
falciparum 
Nigeria   >100 3.9 (1-9) 0.94 6 
Papua New 
Guinea  >100 3.9 (1-9) 0.8 11 
Senegal 
(Dielmo) 100-200 3.7 (1-8) 0.92 3,4 
Ghana  300 3.4 (1-8) 0.84 10 
Tanzania >500 3.3 (1-6) 0.85 2 
Sao Tome     - 2.4 (1-6) 0.7 7 
The Gambia >40 2.3 (1-4) 0.5-0.6 1 
Kenya >30 2.1 (1-4) 0.7 8,9 
Senegal 
(Ndiop) 17 1.6 (1-4) 0.47 5 




Guinea  >100 3.8 (1-8) 0.65 12 
Thailand  0.1-5 1.2-1.3 (1-3) 0.21 13 
China  0.1-1 1 0.05-0.06 13 
Plamodium 
malariae 
Malawi  1-5 2.1 (1-4) 0.71 14 
Thailand  0.1-5 1.2 (1-2) 0.19 14 
Gambia  1-2 1.2 (1-2) 0.2 14 
* Mean (range in parentheses) 
# EIR values obtained from http://www.map.ox.ac.uk/ 
 References:  1. Conway et al., (1991); 2. Babiker et al. (1999); 3. Ntoumi et al. (1995); 4. 
Trape et al. (1994); 5. Konate et al. (1999); 6. Engelbrecht et al. (2000); 7. Muller et al. 
(2001); 8. Kyes et al. (1997); 9. Mbogo et al. (1995); 10. Owusu-Agyei et al., (2002); 11. 
Bruce et al., 2000a & b; 12.  Kolakovich et al., 1996; 13. Yang et al., 2006; 14. Bruce et al., 
2007. 
 
The results depicted in Table 1.1 indicate that there is a strong correlation between 
high malaria transmission intensity and the number of clones infecting individuals 
(MOI).  This is as discussed below. 
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1.4.2.1. MOI in high malaria transmission areas 
Individuals residing in regions of intense malaria transmission (EIRs > 100) are 
highly exposed to malaria parasites throughout the year.  As shown in Table 1.1, 
individuals residing in these regions have an average of 3-4 parasite clones.  A 
parasite infected blood isolate collected from a single individual can have as few as 
1-2 genetically distinct parasite clones to about 8-9 clones (Table 1.1) or even more 
(upto 16 clones) as observed by Juliano and colleagues (2010a).  Multi-clonal 
infections may arise from numerous mosquito bites with each bite injecting 
genetically distinct clones also known as ‘superinfection’ (Hill & Babiker, 1995; 
Nkhoma et al., 2012).  Alternatively, a single mosquito bite may also contain 
numerous genetically distinct clones (Druilhe et al., 1998). Nevertheless, high 
parasitaemia levels are usually observed in these regions and high MOI values are 
expected because the higher the parasitaemia, the higher the chance of detecting 
multiple parasite clones (Contamin et al., 1995; Färnert et al., 2001). 
The high parasite inoculation rates experienced in these regions lead to a pattern of 
development of clinical disease stratified by age.  Children younger than five years 
bear the main burden of morbidity and mortality while older children and adults may 
develop partial immunity (Doolan et al., 2009).  Protective immunity acts against 
blood stage malaria parasites and their products, reducing morbidity and mortality.  
Persistent inoculation of a human host with the parasites determines the rate of 
development of immunity (Baird et al., 1991).  Immunity has also been observed to 
be both parasite species specific and ‘strain’ specific (Mendis et al., 1991).  For 
every antigenically distinct strain, the human host must mount a specific immune 
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response.  Further to this, for the immunity to be maintained, persistent parasite 
inoculation needs to be maintained.   
Host immunity has an effect on the number of infecting parasite clones.  Young 
children (under 5 years of age) whose immunity is not yet developed experience the 
highest clinical malaria episodes with some studies showing that they have low MOI 
compared to older children and adults (asymptomatic) (Magesa et al., 2002; Färnert 
et al., 2009). It has been suggested that pre-existing clones are usually suppressed or 
eliminated by the pyrogenic and toxic effects experienced during a clinical attack 
such that only a few genetically distinct clones are present (Felger et al., 1999; Arnot, 
2002).  On the other hand, older children and adults have been observed to harbour a 
high number of parasite clones as they experience less clinical episodes with the 
existing immunity sustaining the infecting clones at low proportions (Magesa et al., 
2002; Färnert et al., 2009).  
 
1.4.2.2. MOI in Moderate to low malaria transmission regions 
Regions of moderate to low malaria transmission are characterised by EIRs of <50 to 
<1 and might occasionally experience peak malaria transmission during particular 
seasons e.g. during and after the rains.  The average number of clones detected 
within individuals fall within the range of 2-3.  Individuals residing in these regions 
have been observed to develop malaria immunity at a slower rate or not at all 
(Doolan et al., 2009).  The number of parasite strains present in the population is 
therefore maintained at a low proportion.  In addition, since immunity is slow to 
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develop, each infective bite to the human host may result in a malaria episode.  
Higher MOI values are usually observed during peak transmission periods (Vafa et 
al., 2008).   
 
1.4.2.3. Other confounding factors of MOI 
Human host polymorphisms that have arisen as a protective mechanism against 
severe malaria disease have also been implicated in the observed MOI in individuals.  
These include haemoglobinopathies such as the sickle cell trait (HbAS),  & 
thalassemia or the enzymopathy, G6PD deficiency.  Individuals having these 
polymorphisms rarely develop clinical malaria episodes and are therefore 
asymptomatic (Williams, 2006).  Studies conducted to determine MOI in individuals 
possessing these erythrocyte variations have been contradictory.  Ntoumi et al., 
(1997) in a study carried out in Gabon observed high MOI in HbAS individuals but 
in Senegal no such association was detected (Konate et al., 1999). So far no studies 
have been conducted to clearly affirm the assertion that the malaria associated human 
polymorphisms reduce MOI levels in individuals.  However, since humans bearing 
these traits are usually asymptomatic and rarely present with clinical malaria 
episodes, they harbour malaria parasites and act as reservoirs of infection as 
discussed by Gouagna et al., (2010).   
The number of clones present in an individual varies within the course of a clinical 
infection.  For example in low transmission areas, the same clonal genotypes have 
been detected over long periods of time: 5-7 months (Babiker et al., 1998) to about 9 
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months (272 days) (Hamad et al., 2000) whereas in high malaria transmission areas 
clones were observed to persist for a single day to about 50 days (Daubersies et al., 
1996), indicative of high recombination rate generating novel clonal genotypes.  In 
asymptomatic individuals sampled over consecutive days of infection, different 
clonal genotypes were detected (Farnert et al., 1997; Bruce et al., 2000a; Magesa et 
al., 2002). This could be due to sequestration of the parasite, clearance of some 
parasites by host immune responses (Färnert et al., 2008) or in the case of P. vivax 
and P. ovale presence of hypnozoites in the liver that appear in the bloodstream after 
a prolonged period from time of initial parasite inoculation.  Interestingly, similar 
parasite clones at the time of sampling were observed to be in synchrony i.e. either 
sequestered or in the blood circulation (Fänert et al., 1997; Bruce et al., 2000a).  It is 
therefore recommended that repeated sampling of the same individual be carried out 
over several months in order to detect the repertoire of infecting clones present 
(Cole-Tobian et al., 2005).  These studies give clear evidence that a single blood 
isolate collected at a single time point does not give the actual representation of the 
infecting parasite clones.  This has implications especially in population genetic 
studies where small sample sizes representing the whole population are used to make 
inferences on, for example, the population structure of these parasites.  Failure to 
have the correct sample representation may lead to poor interpretation and 
conclusions as far as these parameters are concerned. 
Finally, the intake of antimalarial drugs affects MOI (Fänert et al., 2008).  This has 
been demonstrated in a study carried out on individuals undergoing treatment for 
uncomplicated malaria in Uganda (Myrick et al., 2006).  A striking feature in this 
study was the reduction of malaria parasites to levels below detection of microscopy 
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or PCR analysis during therapy.  After several days following the clearance of the 
drug from the body (observed average 9.2 days), parasite recrudescence was 
observed i.e. the same parasite genotypes were observed before and after treatment 
(Myrick et al., 2006).  This in turn affects the number of clones that can be detected 
with parasites occurring at very low proportions being missed out altogether yet they 
also contribute to the MOI levels. 
 
1.4.3. Identification of P. falciparum clonal genotypes from mixed infections 
The fact that malaria parasites exist as mixed clone infections necessitates the need to 
develop strategies that can identify parasite clonal genotypes present in every 
infection.  This is important for the accurate representation of individual parasites 
when making inferences on parasite populations occurring in different geographic 
settings.  The genetic composition of parasites in malaria infections can be 
investigated using genetic markers such as variation in the electrophoretic mobility 
of proteins e.g. enzymes, single nucleotide polymorphisms (SNPs) and 
microsatellites.  These markers help identify parasites that are genetically related in a 
mixed clone infection by identifying parasites that carry the same gene allele 
combinations (genotypes).  The detection of parasite clones present per blood isolate 
depends on (i) The ability of the markers used to discriminate the clones present 
(how polymorphic the markers are in elucidating clonal diversity) (ii) The ability to 
detect clones that are present at low proportions (minor clones). 
Various molecular methods have been developed to identify these markers and have 
been used to quantify the proportions of genetically distinct P. falciparum parasites 
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occurring in mixed clone infections. As discussed below, these techniques have 
various detection limits. 
 
1.4.3.1. Pre-genomic methods of detection 
a) The electrophoretic forms of enzyme 
Initial studies to determine MOI in Plasmodium investigated the variant forms of 
enzymes and antigens.  Carter & McGregor in 1973 studied the electrophoretic forms 
of P. falciparum enzymes from field isolates collected in Gambia.  Since blood form 
P. falciparum are haploid and the fact that these enzymes occur as single copy genes, 
each genetically distinct clone occurred as a single enzyme form (allele).  Isolates 
containing more than one clone could be distinguished by the visualisation of the 
migratory patterns of these enzymes by starch gel electrophoresis.  This study 
revealed that in the human host, these genetically distinct clones are present at 
different proportions.  
Following the study by Carter & McGregor, (1973), other studies were conducted to 
determine the extent of P. falciparum genetic diversity in Africa (Carter & Voller, 
1975; Sanderson et al., 1981; Creasey et al., 1990), South America (Creasey et al., 
1990) and Asia (Thaithong et al., 1981; Creasey et al., 1990).  Some of the 
conclusions drawn from these studies include that similar enzyme forms were 
detected across different geographic regions but at varying frequencies within the 
blood isolates studied.  Secondly, some of the enzyme forms revealed extensive 
polymorphism compared to others which shows that some markers were more 
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informative than others.  Indeed multiclonality was observed in these studies, with 
the study by Creasey et al., (1990) observing the highest MOI levels in Africa 
compared to South America and Asia.  Carter & Voller, (1975) attempted to generate 
parasite clone genotypes from the observed enzyme combinations but this was only 
possible with two enzyme markers that occurred as two electrophoretic forms (a total 
of four possible enzyme clone combinations).  The enzyme clone combinations 
obtained from Gambia (West Africa) and Tanzania (East Africa) differed in 
frequency within their countries of origin. 
Although use of enzyme variants as genetic markers is cheap, easy and fast, few 
markers have been identified and can be visualised by electrophoresis (Shaw, 1970; 
de MeeÛs et al., 2007).  In P. falciparum, a total of six were used (Sanderson et al., 
1981; Thaithong et al., 1981; Creasey et al., 1990).   In addition, these markers 
display low polymorphism (MeeÛs et al., 2007) limiting their ability to identify and 
distinguish the repertoire of parasite clones especially in areas of high malaria 
intensity.  They also failed to reveal the degree of variation present between parasite 
clones as was observed by Creasey et al., 1990. 
 
b) Determination of antigenic variation using monoclonal antibodies 
Antigenic diversity was investigated using monoclonal antibodies (MAbs) to identify 
allelic serotypes of the P. falciparum surface antigens (MSP1, MSP2 & Exp-1) 
(Creasey et al., 1990; Conway & McBride, 1991).  These antigens are known to have 
extensive allelic polymorphism such that the MAbs identify distinct antigen epitopes 
each representing a parasite clone.  The MAbs were identified by staining using 
indirect immunofluorescence assay (IFA) (Mcbride et al., 1982).  In the study by 
 
  38 
Conway & Mcbride, (1991a & b) blood isolates obtained from an urban/periurban 
region in Gambia used MAb pairs to resolve the number of parasite clones present 
per blood isolates.  1-4 parasite clones could be identified.   
Antigenic variants as markers of clonal diversity give more accurate results than 
enzyme forms due to the degree of polymorphism exhibited in these antigens such 
that the probability of encountering shared alleles per locus is greatly reduced 
(Conway & Mcbride, 1991b). The major setback with this approach is that it requires 
the laborious adoption of ring stage blood forms to culture for maturation to 
schizonts.  This is because mature schizont forms were observed to react and stain 
intensely with IFA compared to the ring stage forms (Mcbride et al., 1982; Day et al., 
1992).  Another problem as highlighted in the study by Conway & Mcbride, (1991b) 
is the reduced ability to detect parasite clones at low parasite levels (1% of the total 
parasite number per isolate).  However, this setback is encountered irrespective of 
technique used and advances in technology are underway to find a solution.  
 
1.4.3.2. The genomic period 
a. Polymerase chain reaction 
The use of polymerase chain reaction (PCR) to genotype Plasmodium enabled the 
analysis of parasite DNA directly from blood samples without the need for DNA 
enrichment by culture establishment (Walliker, 1994).  PCR technology has been 
utilised with the markers outlined below: 
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i. P. falciparum surface antigen genetic markers 
The genetic markers encoding antigens on the surface of genes include: the most 
extensively studied: P. falciparum merozoite surface protein 1 (PfMSP1) & PfMSP2 
together with other genes such as: glutamate-rich protein (PfGLURP) & 
circumsporozoite protein (PfCSP) (Kimura et al., 1990; Marshall et al., 1994; Arnot 
et al., 1993).  These markers exhibit sequence repeat length variation and can be 
distinguished by size using gel electrophoresis following PCR analysis.  Allelic 
variation in the MSP1 gene is determined by the allelic families namely K1, MAD20 
& RO33 and in MSP2 by the allelic types IC3D7 & FC27. These markers have been 
used for the determination of MOI mostly in Africa (Babiker et al., 1994, Creasey et 
al., 1990) and in South East Asia (Paul et al., 1995, Felger et al., 1994), see also 
Table 1.1.  The findings revealed that there is a direct relationship between malaria 
transmission intensity, number of genetically distinct clones infecting individuals and, 
extensive clonal diversity observed between geographic regions at a continental level 
(Babiker & Walliker, 1997 and as outlined in Table 1.1). Further to this, in 
comparison to the previously used markers (enzyme forms and Mabs detection), by 
PCR, a higher number of genetically distinct parasite clones could be detected (see 
Table 1.1). 
However, these genetic markers occur on the parasite surface antigens of the human 
blood stages and are therefore under high selection pressure to evade the host 
immune response (Hughes, 1992; Hughes & Hughes, 1995).  They are therefore not 
ideal for studies of malaria parasites’ population genetic structure.  This is because 
the variation observed between the clonal genotypes could be due to frequency-
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dependent selection maintained on these loci as a result of host immune response 
selection pressure obscuring gene flow patterns at a geographical level. In addition, a 
nested PCR is normally used for the amplification of these loci and in MSP1, in vitro 
recombination has been observed to occur in samples containing mixed genotypes 
(Tanabe et al., 2002).  This may lead to an overestimation of the number of clonal 
genotypes identified and subsequently to the erroneous interpretation of parasite 
genetic diversity at a population level.   Finally, routine PCR is not quantitative thus 
the DNA product does not give a representation of the proportions of parasite clonal 
genotypes per blood isolate. 
  
ii. Microsatellites 
Microsatellites are repetitive sequences across the genome of various organisms 
(Selkoe & Toonen, 2006).  They comprise short tandem repeats of 2-6 nucleotides.  
They arise as a result of replication slippage where misalignment of the synthesized 
strand to the template strand leads to an insertion whereas a template strand – 
synthesized strand misalignment leads to a deletion (Levinson & Gutman, 1987).  
Microsatellites also arise due to the unequal crossing over events of homologous 
chromosomes during meiosis but this is common in alleles having large observable 
changes in their sizes compared to the small size changes between alleles arising 
from replication slippage (Jarne & Lagoda, 1996).  They are favoured in population 




 per locus 
per gamete per generation (Avise, 2004), resulting in extensive allelic diversity that 
renders them highly informative. In P. falciparum, the microsatellite mutation rate 
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( is higher than for SNPs and has been estimated to be 1.59x10
-4
 substitutions per 
microsatellite locus per generation (Su et al., 1999; Anderson et al., 2000a).    
Microsatellites derived from loci in which polymorphisms appear to be neutral have 
been validated for use in P. falciparum population genetic studies (Anderson et al., 
1999).  Due to their highly polymorphic nature, they are appropriate for identifying 
closely related parasites (Su et al., 2007). 
 
b. Sequencing technology 
Advances in DNA sequencing and genotyping platforms have led to increased 
interest in use of SNPs as genetic markers (Vignal et al., 2002). The current 
technology is geared toward development of an accurate, high throughput, robust and 
less costly genotyping platform  
A single nucleotide polymorphism (SNP) is a point mutation leading to the existence 
of an alternative form of a nucleotide at a genetic locus (unique position in a DNA 
sequence) between members of the same species or, in this context, between two 
genetically distinct P. falciparum clones.  For genetic analysis, a SNP present in the 
population at a minor allele frequency of >1% is typically used (Vignal et al., 2002).  
In P. falciparum, comparison of 5 different parasite clones revealed a genome wide 
average of one SNP every 5.9kb (Mu et al., 2007).  SNPs are highly conserved over 
many generations and in P. falciparum, the rate of mutation () in SNPs has been 
estimated to be 1.2-1.7x10
-9
 substitutions per site per generation (Hughes & Vierra, 
2001).   
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SNPs have recently gained favour in P. falciparum studies over microsatellites or the 
PCR analysis of antigenic genes due to their abundance enabling multilocus 
genotyping for the identification of parasite clones.  Further, in population genetic 
studies, neutral markers are pertinent for the detection of population structure and 
gene flow patterns.  The existence of numerous SNPs enhances the identification and 
analysis of neutral loci.  The various technological advances for SNP identification 
and analysis in Plasmodium studies are discussed below: 
 
i. The Sanger method of sequencing 
The Sanger sequencing method also known as the ‘dideoxy’ or chain termination 
method (Sanger et al., 1977) formed the foundation of genome sequencing 
technology.  This method involved a radioisotope (
32
P) labelled primer 
complementary to the DNA being sequenced initiating the process.  DNA 
polymerase sequentially added nucleotides to the growing strand until a terminator 
nucleotide was incorporated.   Each of the reactions was performed in four different 
tubes containing the terminators A, C, G & T or ddNTPs.  The numerous copies of 
DNA obtained were resolved by polyacrylamide gel electrophoresis and 
autoradiography (reviewed by Franḉa et al., 2002).  This method was time 
consuming, expensive and laborious but major improvements were made such as 
addition of a PCR step for DNA amplification, radiolabelling the ddNTPs or 
fluorescently labelling the primers and replacement of polyacrylamide gels with 
capillaries housed in sequencing machines (also known as automated Sanger 
sequencing) (Hall, 2007).  
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The Sanger sequencing technology was used to analyse worldwide P. falciparum 
isolates (Mu et al., 2005).  SNPs located in chromosome 3 of P. falciparum that had 
been previously identified from comparison of 5 worldwide isolates (Mu et al., 2002) 
were used in this study. In this study, a single clone was obtained and used for 
subsequent analysis.  Haplotypes (allelic combinations) generated from the analysis 
of P. falciparum blood isolates collected from Africa, Southeast (SE) Asia, South & 
Central America and Papua New Guinea (PNG) revealed that these parasites possess 
unique haplotypes within their geographic regions indicative of population structure 
(Mu et al., 2005).  These findings are similar to observations made by Anderson et 
al., (2000) using microsatellites.  The Sanger sequencing technology although of 
great significance in genome wide studies is laborious, of limited throughput and 
time consuming necessitating the need to develop advanced sequencing technologies. 
 
ii. Pyrosequencing 
Pyrosequencing is a non-Sanger method for SNP detection within short sequence 
reads (about 20bp) developed by Ronaghi et al., 1996.  Pyrosequencing was 
validated for genotyping and allele quantitation in mixtures of malaria parasites 
(Cheesman et al., 2007) and was used in this study. It facilitated the identification of 
P. falciparum mixed clone infections from 6 SNPs located in the MSP119 antigen in 
blood isolates collected from Mali (Takala et al., 2006).  In most of the isolates, 1-2 
haplotypes (1-2 parasite clones) were obtained.  However, clear deciphering of 
individual haplotypes in isolates containing high MOI (>2 clones) was difficult 
(Takala et al., 2006).  Further discussion on the use of this method in this study is in 
Chapters 3 & 4.   
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1.4.3.1. Advances in genomics – Next generation sequencing technologies  
The Sanger method of sequencing is known as the first generation sequencing 
technology and its improved versions together with other recently developed 
sequencing technologies are known as next generation sequencing (NGS) 
technologies.  The NGS strategies used so far in P. falciparum studies are reviewed 
below. 
a. 454 Pyrosequencing technology 
This is an advanced form of Pyrosequencing and is also known as the massively 
parallel pyrosequencing (MPP) (Zhou et al., 2010).  It involves the fragmentation of 
DNA followed by the ligation of linkers at both ends of the fragments.  The linkers 
are attached to a streptavidin bead and serve as primers for the PCR reaction.  This is 
carried out in a picotiter plate where each cell contains a single bead (Hall, 2007).   
Following the PCR, each cell contains numerous copies of the DNA template. In the 
sequencing step, nucleotides are allowed to flow into the picotiter plate sequentially, 
whereby nucleotide incorporation leads to the production of light (photons) as occurs 
with the conventional Pyrosequencing strategy.  This method is an improvement 
from Ronaghi’s (1996) in that sequence reads of approximately 250bp can be 
obtained compared to 100bp.  In addition, a large number of PCR amplified unique 
DNA templates are captured on beads (about 300,000 per picotiter plate) (Leamon et 
al., 2003) for subsequent sequencing in contrast to the single DNA sequence per 
bead obtained by the conventional Pyrosequencing method (Metzker, 2009).   
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The 454 sequencing technology was used for the massive parallel sequencing of P. 
falciparum MSP1 and MSP2 genes for the detection of infecting clones present in 
blood isolates collected from Malawi, a high malaria transmission region and 
Cambodia, a low malaria transmission region (Juliano et al., 2010).  This method 
was compared to the conventional nested PCR approach for detection of allelic 
variation in these loci.  There was a marked improvement in the number of parasite 
clones detected by the 454 sequencing method.  In Malawi, there was a 5 fold 
increment in the number of clones detected by this method compared to the nested 
PCR method.  In Cambodia, where parasite clones occurring at low proportions have 
a high probability of being undectected, there was a 6 fold icrease in the number of 
infecting clones detected per isolate (Juliano et al., 2010).  Unlike the conventional 
Pyrosequencing technology, in this method, longer sequence reads can be obtained 
(upto 250bp).  The sequences obtained can then be investigated for sequence 
diversity among the different observed parasite clones.  This is a significant 
improvement from the nested PCR and fragment electrophoresis approach which has 
limited information as polymorphism is defined by size and not by exact sequences 
(Juliano et al., 2007; Liu et al., 2008).   
b. Illumina technology 
This technology is an advanced form of NGS currently in use at the Sanger institute 
(http://www.sanger.ac.uk/) and constitutes genotyping platforms such as Solexa.  
This involves the random cleaving of DNA into small fragments which are then 
ligated with adapters for attachment on a slide with flow cell channels.  
Amplification of each fragment generates clusters in each channel of the flow cell.  
The sequences are obtained by adding four fluorescently labelled reversible 
 
  46 
terminators, DNA polymerase and sequencing primers.  The clusters are then 
sequenced, with a camera capturing images of fluorescence emitted from each cluster.  
The obtained sequences are then aligned to a reference genome and assessed for 
quality.  The setback with this technology is that the P. falciparum genome is AT 
rich such that the PCR is biased to amplifying regions with adequate GC content or 
regions with high sequence similarity misalign to the reference genome.  Efforts have 
been made to eliminate the PCR step whereby the template DNA is attached to 
adapters that are partially double stranded together with the sequencing primer such 
that each strand is sequenced directly minus the cluster formation step (Kozarewa et 
al., 2009).  This technology has recently been used by Manske et al., (2012) to 
develop a library of SNPs relevant for delineation of worldwide P. falciparum clones 
from field isolates.  These SNPs are now available for population genetics studies in 
Africa as they are available in the open access website:  
http://www.malariagen.net/resource/10. 
The Illumina GoldenGate technology has recently been used to detect and distinguish 
P. falciparum clones present in mixed infections (Campino et al., 2011; Nkhoma et 
al., 2012).  The difference between this technology and Solexa sequencing is that 
instead of a solid flow cell, biotinylated DNA is immobilised on streptavidin beads 
like in Pyrosequencing
TM
 technology then amplification and sequencing are 
performed in a 96 well plate.   
 
  47 
 
1.5.  The population genetics of P. falciparum  
In this section, a brief review on the worldwide patterns of P. falciparum population 
structure is given.  In addition, the basic concepts and underlying assumptions 
applied in population genetic studies that will be used in the analyses sections 
(Chapters 5 & 6) of this thesis will be introduced.  Population genetic studies 
involve understanding how the distribution of genetic variation can explain 
interaction of individuals in space e.g. their mating systems or gene flow patterns.   
One of the most extensive studies to define the population structure of malaria 
parasites was conducted using microsatellite loci that are assumed to be neutral 
(Anderson et al., 2000).  This study was conducted in 3 African countries (known to 
have high malaria transmission intensity), 3 South American countries (moderate to 
low malaria transmission) and 3 sites from the Asian/Pacific region (one from 
Thailand (moderate malaria transmission) and two villages known to be malaria 
endemic in Papua New Guinea). The results showed that parasites clustered to their 
geographic region of origin at a continental level.  Secondly, the degree of parasite 
genetic variation within Africa and Papua New Guinea was found to be high and 
little genetic differentiation was observed among localities in these regions.  On the 
other hand, isolates obtained from localities in the Asian/Pacific region exhibited less 
genetic diversity and were highly genetically differentiated among the localities.  
Lastly, there was a correlation between the degree of genetic diversity and the 
transmission intensities of a region thus Africa and Papua New Guinea had the 
highest parasite genetic diversity, followed by South American and then Asia/Pacific 
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region.  Mu et al., (2005) in another study using SNPs to determine P. falciparum 
population structure at a global scale mirrored the findings by Anderson et al., (2000).   
Recently, Manske et al., (2012) also observed that at a global scale, malaria parasites 
clustered within their continents of origin.  Also, parasite isolates obtained from 
within Africa were not genetically differentiated compared with those from 
Southeast Asia.  Similar observations were made by Mobegi et al., (2012) in West 
Africa. 
The above mentioned studies reveal that the level of parasite genetic variation across 
Africa is high.  Since malaria transmission in Africa is heterogeneous, the genetic 
relationships of parasites in different localities are expected to vary.  This is due to 
the focal nature of malaria transmission as discussed earlier.  It can be assumed that 
each focus of malaria transmission represents a cluster of genetically interacting 
parasites that are highly related or, it comprises highly overlapping clusters whose 
boundaries cannot be clearly established.  It is on this basis that this study was 
devised in an attempt to determine how malaria parasites are transmitted within 
different foci.   
 
1.5.1. Population genetics concepts applied in this thesis 
The interaction of malaria parasites in space is influenced by various underlying 
forces such as mutations, natural selection, genetic drift or gene flow.  This leads to 
changes in their allelic frequencies.  An attempt to capture the influences of these 
forces from genotypes is achieved by the generation of mathematical models.  This is 
discussed below. 
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Referring to the genotypes in Figure 1.4, for simplicity, let us assume that in the first 
generation denoted by t, the genotypic frequency of parasites with the genotype A 
(represented by the A allele) is p, whereas the genotype frequency of a  is 1-p.  If the 
two parasites mate to form a diploid, under random mating expectations, the 




 Aa & aA = p (1-p) + p (1-p) or 2p (1-p) 




Following meiosis to restore haploidy, the expected frequencies of the alleles in the 
next generation t + 1, will be: 
A = p
2
 + 1/2 X 2p (1-p) = p
2
 +p (1-p) = p
2
 + p – p
2
 = p 
a = (1-p) 
2
 + ½ X 2p (1-p) = (1-p) 
2
 + p (1-p) = (1-p) [(1-p) + p] = 1-p 
Thus if the allele frequencies in generation t are p and the frequencies in generation 
t+1 are p´, p = p´ whereby the genotypic frequencies remain the same from their 
initial values.  Thus, the genotypic frequencies from one generation can predict the 
allele frequencies in the next generation and those allele frequencies can also be used 
to predict genotypic frequencies for the next generation, and so forth (adapted from 
Felsenstein, 2007). 
 
1.5.2. Hardy-Weinberg equilibrium 
The scenario described in the previous section reveals that the genotypic frequencies 
and the allele frequencies remain constant from one generation to another.  This 
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forms the theoretical basis for the most commonly used model in population genetics 
known as the Hardy-Weinberg equilibrium (HWE).  This model was generated using 
diploid organisms but since in this thesis the organism is haploid (with a brief diploid 
phase); the mathematical derivations have been adjusted accordingly.   
This model was generated based on the following assumptions: 
 The population in question comprises an infinite number of individuals 
 No mutation  
 The population is isolated with no migration  
 There is no natural selection 
 Sexual reproduction occurs and a zygote is formed by the random association 
of gametes. 
This model forms the null hypothesis of population genetics studies such that 
departures from it i.e. deviations in genotypic or allelic frequencies across 
generations denotes that one of its underlying assumptions no longer hold. 
 
1.5.3. Deviations of HWE expectations in natural populations 
a) Genetic drift 
In natural populations, the individuals that mate and contribute alleles to the next 
generation are of finite size.  The result is that genotype and allele frequencies 
fluctuate from one generation to another due to sampling error.  This stochastic event 
leading to changes in allele frequencies between generations is known as genetic 
drift (Ridley, 2004).  For example, malaria parasites have been observed to cluster 
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around mosquito breeding sites (e.g. Midega et al., 2012), a situation implicating that 
they constitute a single subpopulation.  In an area with numerous breeding sites and 
subsequently numerous subpopulations, genetic drift is expected to act on each of the 
isolated subpopulations (highly inbred) driving their alleles either to loss or fixation.  
The effects of genetic drift are higher in small population sizes than in larger such 
that fixation of these alleles occurs faster in the former than in the latter. 
b) Mutations 
Mutations are hereditary changes that occur in DNA sequences of organisms as a 
result of errors during replication and are the only source of genetic variation 
(Hamilton, 2009).  Mutation is a slow acting process which barely alters the allele 
frequencies between generations.   
In many parts of genomes it is speculated that, most mutations are non-lethal or 
neutral. The per site neutral mutation rate per generation () in P. falciparum has 
been estimated to be approximately 4.91x10
-9
 substitutions per site per year or 6.88 
x10
-9
 substitutions per site per year assuming divergence from P. reichenowi  ( a 
parasite of chimpanzees) either of 5 or 7 million years ago (mya) (Ayala et al., 1998; 
Deirdre et al., 2003).  
Point mutations play a significant role as they lead to either a single base substitution 
or to an insertion/deletion (indel) event in the genome.  Single base substitutions 
constitute SNPs which will be used for analysis in this thesis (see Chapter 3).  Indels 
lead to the addition or deletion of two or more nucleotides as a result of replication 
slippage, which sometimes disrupts the 3 codon amino acid reading frame.  They 
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mostly affect repetitive loci such as microsatellites discussed further in this thesis in 
Chapters 5 & 6.   
c) Migration  
In natural populations malaria parasite populations are not isolated but they exchange 
genetic material with one another.  The probability that two parasites will mate 
depends on their location within the population.  It follows that parasites located 
within close distance of each other have a higher chance of mating than those farther 
away.  This leads to population structure i.e. partitioning of a large population into 
sub-populations comprising closely mating individuals by virtue of their location in 
space.   
Population structure leads to changes in genotypic and allelic frequencies by the 
partitioning of large populations into small genetically isolated subpopulations that 
are acted upon independently by evolutionary forces such as genetic drift or 
mutations.  Deviations of HWE in this case occur due to non-random mating at a 
subpopulation level and genetic structuring at a population level.   Further discussion 
of this is in Chapters 5 & 6. 
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(d) Natural selection 
This is a force that affects genotypic and subsequently allelic frequencies.  Natural 
selection acts on genotypes that have different viable phenotypes leading to their 
survival or loss across generations.  The changes arising on the genotypic frequencies 
following natural selection lead to changes in allele frequencies. 
In population genetic studies, loci under selection are not ideal in the interpretation 
of overall genetic structure of parasite subpopulations as the observed allele 
frequencies could be as a result of selection on these loci thus obscuring the neutral 
effects on allele frequencies due to genetic drift and gene flow patterns at a 
geographical level.   
d) Non-random association of alleles (linkage disequilibrium) 
LD is defined as the non-random association of alleles (Hamilton, 2009).  To explain 
this, it is better to first define linkage equilibrium.  When alleles located in loci of the 
same chromosome (unlinked) or in different chromosomes are genotyped and their 
allele frequencies calculated, due to genetic recombination and independent 
assortment of genes, it is expected that those alleles will occur at different allele 
frequencies.  The occurrence of one allele is independent of the occurrence of the 
other, they are therefore randomly associated.  These alleles are said to be in linkage 
equilibrium as expected under the classical Mendelian expectations.  However, if 
these alleles keep occurring at the same allele frequencies than is expected by chance, 
due to linkage or due to their conferring a phenotypic advantage such that they are 
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inherited together, the occurrence of one allele is dependent on the occurrence of the 
other one in a non-randomly associated manner.  They are therefore said to be in LD.  
In P. falciparum the rate of recombination is high (as discussed in Section 1.4.1) 
such that LD is seldom observed. This is evidenced by a study of parasite isolates 
collected across Africa where linkage disequilibrium (LD) along the MSP1 gene was 
observed to rapidly decline with increasing nucleotide distance between the 
polymorphic loci analyzed.  In fact, minimal LD was detected in regions located 
>1kb away from the MSP1 gene (Conway et al., 1999). 
 
1.6. Project concept 
The intended objective of this study is to trace the dispersal of malaria parasites in 
space based on their genetic relatedness.  By using genetic markers, parasite 
genotypes representing the clones occurring within infections can be identified.  The 
genetic relatedness (GR) of malaria parasites can then be calculated by pairwise 
comparison of the identified parasite genotypes using the equation: 
GR = 1-n´/n 
Where: n´ = Number of SNPs not shared between the parasites 
  n = Total number of SNPs analyzed 
 
The GR values can then be compared to the geographic distance of the parasite 
genotypes which is expected to be related to the distance the mosquito travelled to 
transmit the parasites (see Figure 1.5). 
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Figure 1.5  Schematic diagram showing the genetic relatedness of malaria parasites 
across different generations.  The letters a-j represent different parasite clonal 
genotypes, n is the total number of SNPs analysed, n´ is the number of SNPs not 
shared between.  The numbers 1-5 represent the generation number.  Assuming 
random mating in the population, a & b are considered to be the ancestral pair 
(Generation 0) with no alleles shared between them thus GR = 0.  When a mosquito 
picks the ancestral pair from one individual and they recombine after which they are 
transmitted to another individual, their immediate progeny (c & d) will have half of 
their alleles identical by descent to the ancestral pair as shown above.  They will 
therefore have GR = 0.5 and the proportion of alleles not shared between them (n´) 
will be 0.5 of the total SNPs analysed (n). When this 1
st
 generation progeny mate 
back into the population, their progeny i.e. e & f (2
nd
 generation) will have a quarter 
of their alleles identical by descent to the ancestral pair (GR = 0.25), 0.75 of their 
total alleles not shared (n´), and they will share ½ of their alleles with the 1
st
 
generation (c & d).  The 3
rd
 generation (g & h) will have 1/8 of their alleles identical 
by descent to the ancestral pair, will share ¼ of their alleles with the first generation 
(c &d) and ½ of their alleles with the second generation (e & f), and so forth.  Each 
generation represents the number of inoculations or transmission cycles from one 
individual to another by the mosquito.  Thus from 0-1 generation that is one 
inoculation, from 0-2 generations, 2 inoculations and so forth.  Parasites that are 
closely related to the ancestral pair will have high GR values.  This means that there 
are fewer transmission cycles (inoculations) between them relative to the ancestral 
pair. However, parasites with low GR values define genetically distant clones 
relative to the ancestral pair representative of more transmission cycles between them 
(Figure developed by Carter, R). 
 
  56 
In the representation depicted in Figure 1.5, the identified GRs of parasite clones can 
be used to determine the number of inoculations or transmission cycles between 
them relative to the ancestral parasites.  If the geographic distance between the 
parasite clones is known, the distance the mosquito travels to transmit malaria 
parasites per transmission cycle can be predicted.  For example, if two parasite 
clones having GR = 0.25 which is equivalent to 2 inoculations are collected 100m 
apart, that means for each inoculation, the mosquito has travelled 50m. 
This information can then be used to trace malaria parasites in space as it will reveal 
the distance the mosquito travels between inoculations.  The spatial patterns of 
malaria parasite distribution can then be resolved.  Although attempts have been 
made to determine high malaria risk areas within small geographic settings, no study 
has so far used the genetic relationship of malaria parasites to reveal the distance of 
parasite dispersal between inoculations or per transmission cycle (as proposed in this 
section).  If parasites are observed to be dispersed within a certain mean distance per 
transmission cycle, then the boundaries of malaria transmission can be established 
enabling the targeting of interventions to maximise their effectiveness.  On the other 
hand, if the mean distance varies between transmission cycles with no established 
pattern of transmission, then different intervention strategies can be envisaged. 
The concept described above forms the basis of the project design for this thesis.  
However, the work described in this thesis constitutes a feasibility study conducted 
prior to the actual testing of the above mentioned concept in natural parasite 
populations.  The aims of the thesis are therefore outlined in the next section. 
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1.7. Aims of thesis 
The study outlined in this thesis was devised to: 
1. Identify suitable genetic markers (SNPs) across the P. falciparum genome for 
the identification of parasite clonal genotypes represented within a single blood 
isolate (Chapter 3). 
2. Validate PyrosequencingTM, a technique which identifies and quantifies SNPs 
representing different parasite clones occurring in mixed clone infections (Chapter 
4).  This was done by analysis of laboratory prepared P. falciparum mixtures of 
clones represented at different proportions.  In addition, the validated method and the 
identified SNPs were used in an analysis to determine the GR values in the 
recombinant progeny of a P. falciparum genetic cross of 3D7 and HB3. 
3. Identify P. falciparum parasite genotypes in isolates collected from different 
geographic regions using the identified SNPs and microsatellites.  This was done by 
the analysis of malaria positive isolates collected from individuals residing in 
Rusinga Island in Kenya, Kolle region in Mali and the South Western province of 
Cameroon.  These isolates were collected in places separated by distances of <1km 
to >2000km.  The obtained parasite genotypes were used in population genetic 
analyses such as: informativeness of the genetic markers as explained by levels of 
detected genetic diversity in the clonal genotypes, neutrality of the markers and the 
detection of population structure (Chapter 5). 
4. Determine how widespread these parasites are in space by performing spatial 
autocorrelation tests (Chapter 6). 
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1.7.1. Hypothesis   
In this study, the degree of genetic relatedness between identified parasite genotypes 
was determined.  The hypothesis stating that closely-related malaria parasites are 
located within short geographic distances of each other will be tested. Based on the 
project concept described in Section 1.6, it is expected that closely-grouped parasites 
have fewer transmission cycles between them.  The level of genetic relatedness is 
therefore expected to decrease with increase in geographic distance as this translates 
to more transmission cycles between the parasites by the mosquito from one 
individual to another. 
The phenomenon that parasites at close geographic distance have a high chance of 
mating compared to those that are far apart, has been observed widely in other 
organisms and Wright, 1943 described it as isolation by distance.  Its existence in 
natural populations governs the way individuals interact at a population level.   
The fact that closely related parasites have a high chance of mating leads to non-
random mating events, presenting as either inbreeding or partitioning of parasites 
into distinct subpopulations with limited gene flow between them (population 
structuring).  In the case of malaria parasites, since mosquitoes cluster around 
breeding sites, transmission of malaria parasites by these mosquitoes would be 
confined around these sites.  It is therefore expected that parasites closest to the 
breeding sites would represent a genetically distinct parasite population.  However, 
since the transmission of malaria parasites is heterogeneous within small spatial 
settings i.e. between individuals residing in a single hut or individuals residing in 
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separate huts, further inbreeding, population structuring and limited gene flow is 
expected between the parasites.  
On this basis it was hypothesised that closely-related malaria parasites collected from 
individuals residing within short distances of each other (~1km) exhibit high genetic 
relatedness and will therefore represent the shortest distance the mosquito travels per 
single inoculation compared to malaria parasites collected from individuals who are 
far apart (>1km and beyond). 
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2. MATERIALS AND METHODS 
 
This study was devised to determine the genetic relationships of P. falciparum wild 
isolates and how this information can be used to define their interactions in space. 
Since these isolates exist in the form of mixed clones, prior to their analysis, it was 
pertinent to validate a technique that could enable the identification of the individual 
clones represented in each isolate.  Pyrosequencing
TM
 was the technique of choice 
for this study and this section describes the standardization of the technique.   
 
2.1. Validation of PyrosequencingTM  
2.1.1. Laboratory preparation of genetically distinct P. falciparum pure clones 
The marker assays generated in Chapter 3 were used to analyse P. falciparum field 
isolates that contain mixed clone infections for the identification of parasite 
genotypes represented within them and reveal the parasites’ genetic relatedness.  
Before this was done, the technique and the selected markers were tested to ensure 
that the intended objective was achieved.  This was done using laboratory prepared 
P. falciparum clones grown in vitro in RBC culture medium and harvested as pure 
clones.   
The laboratory prepared samples (Parasitaemia 1-4%) containing different P. 
falciparum pure clones (3D7, CAMP, FCR3 or HB3) were used to determine which 
of the primer sets selected for analysis (see Chapter 3) gave the most accurate 
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allele (SNP) quantification scores (95-100%) using Pyrosequencing™. They were 
also used to confirm if the SNPs identified by the Pyrosequencing™ corresponded 
to the SNPs provided in the PLASMODB database in each locus  The pure clones 
were prepared using uninfected whole blood at 5% hematocrit (packed cell volume 
of RBC present in whole blood), infected blood from culture at 5% hematocrit and 
5% parasitaemia.  These were grown for several days and then the parasite cultures 
were then serially diluted with uninfected whole blood at the same hematocrit in 
order to achieve 1-4% parasitaemias respectively.  
The parasites were collected at such high parasitaemias to ensure good DNA yield 
for PCR analysis and subsequent analysis by Pyrosequencing
TM
. These blood 
samples were then blotted on Whatman FTA® cards and left to dry.  These cards 
are impregnated with a patented chemical formula that lyses cell membranes and 
denatures proteins on contact.  Nucleic acids are physically entrapped in the 
cellulose fibres and can be recovered by washing away all cell debris and inhibitors 
of downstream analysis using standard wash protocols.   
 
2.1.2. Laboratory preparation of P. falciparum samples containing genetically 
distinct clone mixtures  
Having identified the allele specific primers that would amplify regions containing 
genetic markers for the identification of clones in mixed infections (see Chapter 3), 
the next step was to analyse samples containing a mixture of clones.  Since P. 
falciparum mixed infections are common in nature, laboratory prepared clone 
mixtures were prepared to simulate what occurs in field isolates. This was done to 
test if the Pyrosequencing
TM
 can identify and assign proportions to the clones 
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represented in the mixture enabling the identification of parasite genotypes 
represented in each mixture.   
To accomplish this, P. falciparum laboratory prepared mixtures at different 
parasitaemia ranging from percentages of 0.1, 0.01, and 0.001 were analysed.    The 
mixtures were prepared in proportions of 100:0, 98:2, 95:5, 90:10, 80:20, 50:50, 
20:80, 10:90, 5:95, 2:98 and 0:100. The mixtures comprised P. falciparum cloned 
isolates of 3D7 and HB3, 3D7 and DD2, or 3D7 and 7G8 clones.  The mixtures were 
prepared using uninfected whole blood at 5% hematocrit (packed cell volume of 
RBC present in whole blood), infected blood from culture at 5% hematocrit and 5% 
parasitaemia.  The parasite cultures were then serially diluted with uninfected whole 
blood at the same hematocrit.  A 20 l sample was taken from each serial dilution 
and blotted on FTA
®
 filter paper for subsequent analysis. 
 
2.1.3. DNA extraction 
(a) From samples derived from parasite cultures 
To extract DNA, the malaria parasite culture suspension was spun down and the 
eluate discarded.  It was then re-suspended to 10ml with PBS.  DNA was extracted 
following the protocol provided in the Qiamp® DNA blood midi/maxi (Qiagen®).  
500l Protease K enzyme was pipetted into an empty 50ml centrifuge tube.  The 
blood re-suspended in PBS was added into the 50ml tube together with 12ml buffer 
AL or the lysis buffer.  This was thoroughly mixed and placed in a pre-heated 70°c 
water bath for 10 minutes to ensure maximum lysis of the cells for parasite DNA 
release.  10ml of ethanol was added thereafter and this was thoroughly mixed to 
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ensure maximum homogeneity of the solution for successful DNA precipitation.  The 
mixture was then placed in a Qiamp® column provided in the kit.  The column 
consists of a silica membrane that traps the precipitated DNA allowing protein and 
other contaminants that may contaminate the DNA to pass through.  The column is 
then washed twice with buffer AW1 and AW2 provided in the kit.  This ensures 
complete removal of contaminants from the bound DNA in the column.  The DNA 
was then eluted with buffer AE (elution buffer).  The DNA was finally collected and 
stored at -20°c for analysis by Pyrosequencing
TM
. 
(b) From samples blotted on Whatman FTA® cards 
To prepare a sample for analysis, a disc was taken from the dried blood spot using 
either a 1.2 mm or 2.00 mm Harris micro punch and placed in a 0.2 ml PCR 
amplification tube.  It was taken through three washes using 150l FTA® 
purification reagent with vortexing for 10 seconds in between the washes to ensure 
complete removal of blood which may contain nucleases or proteases that may 
compromise the subsequent analysis of the DNA blot by PCR.  It was finally washed 
off with Milli-Q pure water (Millipore) then air dried.  It was then transferred to a 0.2 
ml PCR tube ready for analysis under standard PCR conditions. 
 
2.1.4. PCR analysis for Pyrosequencing™ assay 
Each locus was amplified in a 50 l volume using the following reagents and 
reaction conditions: 1x immoBuffer, 1.5 mM MgCl2, 150 M dNTPs, 1 unit 
Immolase™ DNA polymerase (Bioline) and 0.4 M for the forward and reverse 
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primer respectively.  The previously prepared disc in a 0.2 ml PCR amplification 
tube with immobilised DNA was used for the PCR reaction.   
The reactions were performed in a DNA thermocycler (Biometra, T3000.), and 
programmed as follows: First denaturation step at 95C for 7 min, first annealing at 
42C for 1 min, first extension at 72C for 2 min, second denaturation at 95C for 3 
min, second annealing at 44C for 1 min, followed by a total of 38 amplification 
cycles comprising: denaturation at 95C for 1 min, annealing at 49C for 1 min and 
extension at 72C for 2 min.   The reaction was ended by a final extension time of 5 
min at 72C. PCR products were visualised on 1 % agarose gels and samples that 
produced single amplicons of the predicted length were used for subsequent 
Pyrosequencing™ analysis.  
Negative and positive controls were included to ensure no contamination of the PCR 
as well as to validate the results.  The PCR protocol is shown in Appendix A.  
Results indicated that some of the 1.2 mm discs containing DNA failed to yield a 
PCR product hence the 2.0 mm discs were ideal. 
 
2.1.5. Pyrosequencing™ assays 
These were carried out on a PSQ™ HS-96A instrument.  The single stranded PCR 
products served as the template for the Pyrosequencing™ analysis. One of the 
primers was biotin tagged; therefore the PCR products are biotinylated.  The biotin 
tag renders the DNA ability to bind to streptavidin beads and remain immobilised on 
them.  The unbound DNA strands are washed off.  The sequencing primer is allowed 
 
  65 
to hybridise to the template DNA and the sequencing reaction proceeds in the PSQ™ 
HS-96A instrument. 
To start the Pyrosequencing™ analysis, two plates were set up (Plate 1 and Plate 2).  
Each well in Plate 1, a clear and round-bottomed 96 well plate, was loaded with 40 
l high purity Milli-Q water (Millipore), 38 l of binding buffer (Biotage), 2 l of 
Streptavidin Sepharose high performance beads (Amersham Biosciences, Sweden) 
and 2-4 l of DNA (dependent on band intensity of gel photo). Some wells were set 
up as negative controls devoid of DNA to check for contamination.  Plate 2 (PSQ™ 
HS-96-well, Biotage), an opaque flat bottomed 96 well plate was loaded with 11.5 l 
annealing buffer and 0.5 l sequencing primer (10 M final concentration).  Plate 1 
was placed on a shaker to allow binding of the biotinylated single stranded PCR 
product to the streptavidin beads.   
Using a Pyrosequencing™ vacuum prep tool (Biotage) containing probes to fit into 
each well of Plate 1, the DNA immobilised onto streptavidin beads was sucked and 
suspended onto the probes.  The probes were then immersed in 70% ethanol wash 
buffer for 5s and then onto 0.2M Sodium hydroxide for 5s to remove the non-
biotinylated unbound DNA strands.  The final wash was done in a wash buffer 
(10mM Tris acetate, PH 7.6) for another 5s.  The vacuum was then switched off to 
release the DNA into Plate 2.  The plate was incubated at 80 °C for 2 min to allow 
the sequencing primer to hybridise to the DNA and then allowed to cool before 
transfer to the PSQ™ HS-96A instrument.  Analysis was then performed in the 
PSQ™ HS-96A instrument using enzyme, substrate and nucleotides from Biotage. 
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2.2. Preparation of P. falciparum genetic cross of 3D7 and HB3 
Sexual recombination in P. falciparum was investigated in the laboratory following 
the generation of a genetic cross containing the genetically distinct clones 3D7 and 
HB3 (Walliker et al., 1987). The progeny of this cross was tested using various 
genetic markers characteristic of each of the parental clones.  These tests confirmed 
that sexual recombination had indeed taken place as the various recombinants 
recovered contained both parental genomes represented in them (Walliker et al., 
1987). Material from this original 3D7 and HB3 cross progeny was grown in culture 
containing complete RPMI at 5% hematocrit.   
In natural P. falciparum infections, an individual is typically infected by 1-3 
genetically distinct clones. Using the assumption that the progeny distribution in the 
RBCs follows a Poisson expectation (Appendix B), the calculations outlined below 
were carried out to reduce the number of recombinants in the culture to a level that 
mimics the number of clones infecting individuals in natural P. falciparum malaria 
infections i.e. 1-3 recombinants per diluent.  This process of reducing the number of 
recombinants by limiting dilution is referred to here as semi-cloning.   
 
2.2.1. Thawing of cryopreserved cross progeny material 
The culturing process was begun by thawing the cross progeny material in liquid 
Nitrogen storage.  Solutions for use in this process prepared under sterile conditions 
comprise:  A. 12% Sodium chloride, B. 1.6% Sodium Chloride & C. 0.9% Sodium 
chloride + 0.2% dextrose).  The cryopreserved vial was removed from the storage 
and placed in a 37C water bath until fully thawed.  The blood sample was then 
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transferred to a sterile 50ml falcon tube after its volume was estimated its volume.  
Using 0.2ml of solution A per 1m of the thawed blood sample the solution A was 
added slowly drop by drop with constant mixing but gently.  The tube was allowed to 
stand for 3 minutes.  This was done to ensure that the frozen parasites were 
recovered with minimal loss due to lysis of the RBCs.  10ml Solution B for every 
1ml of the original thawed sample was then added drop by drop with gentle continual 
mixing.  Thereafter, Solution C was added drop by drop using 10ml for every 1ml of 
original blood sample.  Centrifugation was then performed at 2000rpm for 5 minutes.  
The supernatant was removed.  
The cells recovered were then re-suspended slowly in complete medium at 5% 
haematocrit then cultured.  The complete medium was prepared using 62.25ml RPMI 
1640 (containing 20mM Sodium Bicarbonate and 25mM HEPES buffer.  Addition of 
5m glutamine (2mM concentration), 5ml of 20% glucose solution, 25g/ml 
gentamicin, 1ml of Sodium Hydroxide at 7.2-7.4 PH, and 40ml human serum 
followed thereafter.  Since the complete medium was stored at 4C, if added directly 
to the parasite culture at this temperature, parasites would die of cold shock.  It was 
therefore warmed in a water bath at 37C before use.  10ml of the suspension was 
transferred to a 25cm
2
 flask.  Gas mixture containing 1% oxygen, 3% Carbon 
Dioxide and 96% Nitrogen was added for 60 seconds and the flask cap screwed 
tightly to avoid gas loss.  The flask was then placed in an incubator maintained at 
37C.   
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2.2.2. Parasite growth in culture 
Daily monitoring of the culture is recommended by preparation of blood smears to 
ensure that the parasites are thriving.  In addition, gassing is also performed to ensure 
optimal parasite growth conditions.  Parasite smears were prepared by taking a small 
drop from the flask and placing in a 500l eppendorf tube then spun down by quick 
spin centrifugation.  The supernatant was removed and the pellet resuspended to 50% 
haematocrit using complete medium.  This was then smeared onto a clean glass slide, 
fixed with methanol to ensure the cells do not slough off when stained with 10% 
Giemsa.  The Giemsa was prepared using Phosphate buffered saline (PBS) at PH 7.2.  
This was then viewed under a microscope with immersion oil at objective X100.  
Parasitaemia was estimated by counts of approximately 500 cells.  A drop of blood 
was added on the 2
nd
 day of culture coinciding with the bursting and reinvasion of 
ring stages to fresh RBCs.  
The blood for culture maintenance was obtained from the Scottish National Blood 
Transfusion Service.  The blood is drawn into packs containing the anticoagulant 
Acid Citrate Dextrose (ACD) or Citrate Phosphate Dextrose (CPD) but not heparin 
as it hampers parasite growth.  The blood was spun down by centrifuging at 2000rpm 
for 5 minutes.  The serum was aspirated off followed by 3 washes with centrifuging 
and re-suspension using incomplete RPMI 1640 incomplete medium (lacking the 
human serum).  100% of the incomplete medium or more of the volume of cells was 
used in the washes.  The RBCs were then re-suspended at 50% haematocrit in 
complete medium.    
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To ensure efficient growth of the parasites, blood and culture need to be added.  To 
know the amount of blood needed, the parasitaemia was first estimated.  Since most 
parasites give approximately a 5 fold reinvasion each cycle, the amount of blood 
added depended on the needed parasitaemia.  For example, starting with a 200l 
packed cell volume (PCV) at 10% parasitaemia, a 1:5 dilution was achieved by 
adding 800l PCV fresh RBC which reduced the parasitaemia to approximately 2%.  
Thus the next reinvasion cycle should take the parasitaemia back to about 10%.   
The equation used to estimate the amount of complete medium to add when changing 
the medium during the culturing process was: 
Medium (ml) = 5 X % parasitaemia X PCV (ml) 
The culture was first transferred to a 15ml falcon tube for a 4 minute centrifugation 
at 2000rpm.  The supernatant was then removed comprising of the old culture.  Fresh 
medium was then added with gentle mixing.  The culture with the fresh medium was 
then transferred to 25cm
2
 sterile flasks gassed and incubated at 37C.   
 
2.2.3. Parasite synchronization  
The parasite culture was synchronized to ensure that the parasites were at the same 
growth stage (rings) for the limiting dilution assay.  Synchronization of the cultures 
was achieved by growing the parasites to ~1% with a high percentage of ring forms 
and re-suspending to original volume using sorbitol (made up of 5% sorbitol in PBS). 
This was allowed to stand at room temperature for 5 minutes and then centrifuged.  
The sorbitol solution was removed and the culture was re-suspended in complete 
RPMI medium and washed twice.  After washing, the culture was re-suspended in 
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complete medium and a smear taken after 24 hours to ensure that synchronization 
was successful.  This was grown for a week and at a parasitaemia of ~7.7%, the 
number of parasitized red blood cells (RBC) was determined by performing an RBC 
count using a haemocytometer to estimate the total RBC count in the culture which 
was found to be 4.9x10
8
 RBC per millilitre (ml).   
 
2.2.4. Semi-cloning the 3D7 and HB3 cross progeny  





That means there is 3.8x10
5
 pRBC per 0.01ml (10l)  
10l of culture was made up to 3.8ml of complete RPMI medium containing fresh 
washed blood at 5% hematocrit.   More RPMI complete medium containing freshly 
washed blood at 5% hematocrit was prepared to make up the suspensions shown 
below. 
There is now 1x10
5
 pRBC in 1ml 
1. 1x103 pRBC in 10l.  This was called Suspension A 
2. 100l of Suspension A was made up to 1ml; 100l of this suspension 
contained 10
2
 PRBC………Suspension B 
3. 200l of Suspension B was made up to 2ml thus 100l of this suspension 
contained 10 pRBCs.......Suspension C 
4. 100l of Suspension C was made up to 2ml; 100l of this suspension had 
5pRBC……..Suspension D 
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5. 40l of Suspension D was made up to 2ml therefore there were ~2.5pRBC in 
100l……..Suspension E 
6. 140l of Suspension E was made up to 2ml and this had ~0.7pRBC in 
100l……. Suspension F 
7. 40l of Suspension F was made up to 2ml giving ~0.375PRBC in 100l…….. 
Suspension G 
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(b) 
Suspension 
Calculated number of  
pRBCs 








C 10 7 
D 5 10 
E 2.5 10 
F 0.7 15 
G 0.375 12 
 
Figure 2.1  Schematic diagram showing the plate set-up for the 3D7 and HB3 cross 
progeny semi-cloning by limiting dilution.  (a) Shows how each of the diluents were 
set up in the plate to culture.  Each of the colours indicates the suspension contained 
in each well. The outer wells were loaded with complete RPMI to ensure that the 
cultures do not get dehydrated. Note that the number of wells increases as the 
number of pRBC per suspension decreases to increase the chances of detecting 
parasites per well. (b)  Table showing a summary of the suspension, the estimated 
number of pRBC in each suspension and the number of wells containing each 
suspension.   
 
The cultures in the plate were grown for 2 weeks and smears taken every day to 
monitor parasite growth.  All wells in A, B, C were found to be positive, 8 out of the 
10 wells in D containing estimated 5 pRBCs per well were positive, while all wells 
in E, F and G remained negative.  From the Poisson distribution, 80% positive wells 
are expected to occur in wells estimated to contain 1.6 pRBCs and 99-100% 
positive wells in those estimated at 5 pRBCS (Appendix B) 
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The fact that 8 out of 10 (80%) of wells were positive in row D, (estimated to have 5 
pRBC per well) indicates an average of ~1.6 clones per well. This suggests, 
according to the Poisson distribution curve (see Appendix B), that there was either 
an over-estimation in the calculations or a loss of parasites during the culturing 
process. All the cultures in the D wells were taken and transferred into bigger flasks 
to grow them and increase parasitaemia for higher DNA yield.  The parasites were 
harvested at parasitaemias of between 6-15% and DNA extracted from them. 
 
2.3. Analysis of field isolates 
Isolates were collected from Cameroon lying approximately 2,300km from Mali and 
approximately 2,800km from Kenya, and, Mali lying approximately 5,100 km from 
Kenya (Figure 2.2).  
 
















Figure 2.2  Map of Africa drawn to scale and showing the countries from which the 
isolates were collected.   
 
2.3.1. Sample collection in Kenya 
2.3.1.1. Study site 
Blood samples were collected from Rusinga Island which has an area of 42 km
2 
and 
is located in Suba District, Nyanza Province, Western Kenya, within Lake Victoria, 
on the southern shores of the Winam gulf of the lake.  Due to its close proximity to 
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Mbita Township, the major trading and administrative centre of Suba district (Figure 
2.1). 
 
Figure 2.3  Map of Rusinga Island showing part of Mbita that is in the mainland (in 
white) connected to Rusinga Island by the 200m causeway (grey arrow).  The island 
is demarcated into large locations as shown in this map. Malaria positive samples 
collected from each location are shown.   During the time of the sample collection, 
there was no clear demarcation of the Island thus Kamasengre East and West were 
merged (the area was known as Kamasengre). Kaswanga and Waware South were 
also merged (the area was known as Kaswanga) (ESRI ArcView version 3.2 - 
http://www.esri.com/) 
 
Two rainy seasons are typical for the area, the ‘long rains’ between March and June 
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unreliable with some years characterised by prolonged dry periods and others by 
prolonged wet seasons.  Malaria transmission fluctuates seasonally but is sustained 
all year round by three primary malaria vectors Anopheles gambiae, An. arabiensis 
and An. funestus; (Chen et al., 2004 and Minakawa et al., 1999)  Mosquito breeding 
sites in this area include:  man-made water collection points such as open cemented 
tanks, pools made from animal hoof prints, ponds, marshes (Fillinger, 2004).  In 
addition, the water levels of the lake have been receding leaving a patch of land that 
has been identified as a potential breeding site (Minakawa et al., 2008).   
A census implemented by the end of 2006 during the establishment of a 
Demographic Surveillance System (DSS) indicated that Rusinga island had 24,078 
inhabitants which formed 5,425 households and 21 % of the population were 
children below the age of five (Satoshi Kaneko, Nagasaki University, unpublished 
data).   
 
2.3.1.2. Study Population  
120 malaria positive samples were collected (Table 2.1).  The sample size was 
chosen on the basis of adequacy in estimating allele frequencies.  Since most of the 
population genetic studies are pegged on allele frequency numbers, a sample size 
giving good representation of allele frequencies for the whole P. falciparum 
population is favoured.  Inclusion criteria were: 
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a) Malaria positive individuals of all ages 
b) Presenting with fever and other symptoms consistent with malaria e.g. 
vomiting, lack of appetite, convulsions.  
c) Blood smears showing P. falciparum 
d) Inhabitants of Rusinga Island.  At the time of sample collection the actual 
geographic distances of separation for the sample collection were not taken 
into consideration.  Thus for this study site the geographic coordinates 
specifying the actual residence of the inhabitants is missing. 
 
2.3.1.3. Ethical Clearance 
The institutional ethical clearance was granted by the joint University of Nairobi - 
Kenyatta National Hospital ethical review committee (protocol approval number 
P156/9/2005) (Appendix C). In addition, permission was obtained from the district 
authorities.   Blood samples were collected only after individual or parental consent. 
 
2.3.1.4. Study design  
Rusinga Island has been reported to have a high prevalence (50%) of malaria (GoK 
reports, 2001). However, this has reduced conceivably due to intervention strategies 
such as usage of nets as well as availability of drugs in the health centre.  Further, 
there have been changes in weather patterns with extended wet periods that may lead 
to washing away of mosquito larvae hence low malaria transmission by the vectors.  
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In addition, over the counter drugs are readily available so individuals are recorded 
to have taken them prior to visiting a health centre making it difficult to detect 
malaria parasites by microscopy. 
Initially, blood samples were collected from individuals reporting for treatment and 
falling within the inclusion criteria irrespective of whether they were malaria positive 
or negative, by a single prick using a lancet about 2 mm behind the nail bed.  The 
flowing blood was then blotted onto the Whatman FTA
®
 cards and allowed to dry 
completely before storage in a desiccant (silica) ready for shipping to the University 
of Edinburgh.  Some blood was also placed on a glass slide and thin and thick smears 
prepared on the same slide and left to dry.  The thin smear was fixed with 99 % 
methanol and left to dry completely.  The smears were then stained using Giemsa’s 
stain and stored for later analysis by light microscopy. 
However, since few malaria positive cases were reported and due to time constraints, 
the sample collection process was reviewed and extended to individuals over 5 years 
and malaria positive cases confirmed by microscopy.  This involved making a prick 
first to determine whether the patient was malaria positive or negative by light 
microscopy. Once identified as malaria positive, then a second prick was made and 
blood was blotted onto the Whatman FTA
®
 cards.   
Because of insufficient numbers of samples collected from the villagers attending the 
clinic, there was also need to visit the nearby schools and perform mass free malaria 
screening and medical campaigns in order to increase the probability of detecting 
malaria positive cases. 
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2.3.1.5. Data collection 
Samples were collected between May and October, 2007 the ‘long rains’ period.  
Blood samples were collected from:   
1. Mbita Sub-district Hospital located in Mbita Township which is the major 
trading and administrative centre of Suba district.  Malaria positive samples 
were obtained from individuals attending the medical facility for treatment.   
2. Tom Mboya Memorial Health Centre (TMMHC) situated on the North-
Eastern part of Rusinga Island.  Malaria positive samples were collected 
from individuals attending the medical facility for treatment.   
3. Schools located in Rusinga Island namely: 
a) Kibisom Nursery School located approximately 100m from the 
TMMHC in Kaswanga Location, Rusinga Island.  20 children aged 3-
6 years old were chaperoned to the health centre and screened for 
malaria.  No malaria positive cases were reported from this school. 
b) Agiro Primary School situated approximately 1 km north from the 
TMMHC in Kaswanga location, Rusinga Island.  Screening was 
conducted within the school premises.  209 children aged 1-15 years 
were screened; of these 13 were positive for malaria. These were 
taken to the TMMHC for medication.   
c) Kaswanga Primary School Located approximately 1 km south from 
the TMMHC.  Screening was conducted within the school premises. 
116 children aged 1-15 years were screened; of these 4 were positive 
for malaria and were treated at TMMC. 
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d) Island of Hope Humanist Centre situated approximately 5 km from 
the TMMHC in Kamasengre location, Rusinga Island.  Screening was 
conducted within the school premises. 145 children aged 1-15 years 
were screened; of these 6 were positive for malaria and were 
transported to TMMC for treatment. 
 
2.3.1.6. Determination of Parasitaemia 
Thin and thick blood smears were prepared on one glass slide and left to dry.  The 
thin films were fixed with methanol and both stained with Giemsa’s stain.   These 
were later analysed by light microscopy.  Parasite density was assessed by counting 
the number of parasites per 200 leukocytes in an oil immersed thick film (using a 
microscope with X100 objective and X10 eyepiece).   
A sample was considered negative after 20 high powered fields had been read 
without parasites. Although the protocol demands reading of 200 high powered fields, 
only a maximum of 20 fields could be read due to time constraints.  Parasite counts 
were converted to parasites per 1 l blood assuming an average of 8000 leukocytes 
per l of blood for thick films.  For the thin films, the number of RBC present in the 
average microscopic field was determined as it varies depending on anaemia 





 RBC/l (females) is generally assumed (Shute, 1988).  The 
number of asexual parasites per 25 microscopic fields was counted and the total 
parasite count per l of blood calculated.  The parasitaemia ranged from forty to 
three hundred and fifty six thousand parasites per microliter of blood (Thick smear).   
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Table 2.1  Summary of P. falciparum infected blood samples collected from Rusinga 
Island, Kenya  
 
Location Male Female Total 
Kamasengre East and West 10 6 16 
Kaswanga & Waware South 16 12 19 
Wanyama & Ngodhe 14 8 22 
Waware North 25 29 54 
Total 65 55 120 
 
Of the 120 samples collected from this region, only 15 samples were analysed in this 
study.  These samples were selected on the basis of high parasitaemia levels.  The 
rest of the samples were not included in this feasibility study which serves as a proof 
of method and whose preliminary data will inform a larger planned future study with 
the remaining isolates.  In addition this study had budgetary constraints plus the 
missing geographic co-ordinates hence the analysis of the few samples.  These 
samples were collected from patients attending health clinics and information on 
their place of residence was not collected.  Nevertheless the geographic co-ordinates 
of the locations (given in Table 2.1) were used in the analysis in this study. 
 
2.3.2. Sample collection in Mali 
2.3.2.1. Study site 
P. falciparum malaria positive samples were collected from Mali in a region 60 
kilometres south of Bamako (Mali’s capital) known as Kolle. In this region, P. 
falciparum malaria has a prevalence of 40-50% during the low peak season (October 
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–May) and 70-85% in the high peak season (June-September). The major malaria 
vectors in Mali are:  Anopheles funestus, An. brohieri, An. gambiae, An. flavicosta, 
An. coustani, An. pharoensis, An. arabiensis, An. nili, An. hancocki, and An. paludis 
(WHO report, 2006). Kolle has about 2,500 inhabitants with 69 families living within 
a radius of 600 metres from the nearest female Anopheles mosquito breeding site 



















Figure 2.4  Maps showing (a)  Mali with study site (Kolle) indicated in red and (b) 
Kolle region divided into 5 aureoles increasing in radii by 200 metres and the 
location of the households with household numbers outlined in green, blue, pink, 
purple and dark green .  Demarcating by aureoles was established by the group in 
charge of this project for easy sampling and identification of households represented 
in this area.  The River Kolle, which is the main mosquito breeding site in this region 
transverses across the study site (maroon line). 
 
2.3.2.2. Study population 
P. falciparum malaria positive blood samples were collected from 51 individuals of 
all ages (Table 2.2).  This sample collection was done between September – 
December2010. The lack of geographic coordinates in the Rusinga Island sample 
collection necessitated additional sample collection from this study site.  Thus the 
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actual residences of individuals from which the samples were collected are known. 
Further to this, the study site is <1km enabling determination of P. falciparum spatial 
patterns in a region with short geographic separation distances.  In addition, 





4. Household identification number (ID) 
5. Head of household name 
6. Village and any additional information that can assist in tracing the house if 
the household ID gives problems 
7. List of symptoms:  
a. fever  
b. anaemia 
c. Other signs of severe disease 
8. Last reported malaria attack 
a. Date or month of malaria attack 
b. Whether it was diagnosed at the clinic or elsewhere 
c. What treatment was taken 
 
2.3.2.3. Ethical clearance 
This was granted by the ethical review Board of the Faculty of Medicine, Pharmacy 
and Dentistry, Bamako, Mali (ethical review number 0940/FMPOS).  Blood samples 
were collected following individual or parental consent. 
 
2.3.2.4. Study design 
Blood samples were collected from individuals reporting to the clinic (located in 
aureole 3, Figure 2.2b).  Following a needle prick in the finger, blood was collected 
on a slide for a thick smear for malaria parasite detection.  The slide containing the 
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thick smear was stained with Giemsa’s stain and parasitaemia determined by 
microscopy as previously described.  Thus, 51 malaria positive blood samples with 
parasitaemia between 1075 - 74,550 parasites/l were collected and blotted onto 
Whatman FTA
®
 cards.  These were left to dry then stored in pouches containing 
desiccant ready for shipping to the University of Edinburgh.   
Table 2.2  Summary of P. falciparum infected blood samples collected from Kolle, 
Mali 
Aureole Male Female 
1 3 8 
2 13 10 
3 5 10 
5 1 1 
Total 22 29 
 
2.3.3. Sample collection in Cameroon 
2.3.3.1. Study site 
Cameroon is located in the Central West Africa region.  The study site, Buea is 
located in the South West province of Cameroon on the lower slopes of Mount 
Cameroon (Figure 2.3).  
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Figure 2.5  Map of Cameroon’s South Western province showing the locations 
where the blood isolates were collected i.e. Buea, Molyko and Muea. (Map provided 
by Anong D, collaborator in Cameroon). 
 
P. falciparum malaria transmission is perennial in this region and is mainly 
transmitted by Anopheles gambiae sensu stricto. The high malaria peak transmission 
season is during the rainy season between March and October and the low peak 
season is during the dry season between November and February.  The main 
mosquito breeding sites include:  fish ponds, man-made cemented tanks, hoof prints, 
roadside ditches (Wanji et al., 2009). 
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2.3.3.2. Ethical clearance 
The study was approved by both the University of Buea’s ethical review committee 
and the Cameroonian South West Regional Delegation of health (ethical review 
number R11/MPH/SWP/PDPH/FP-Research/5077/84).  Blood samples were 
collected only after individual or parental consent. 
 
2.3.3.3. Study Design 
13 P. falciparum malaria positive blood samples were collected from individuals 
residing in Buea region who reported to the local health post (Table 2.3).  The 
inclusion criteria was individuals of all ages with parasitaemias >20,000 parasites/l 
and who resided in close proximity to each other (within a radius of 5km).  The 
samples were collected within the month of September.  The reason for this sample 
collection was to analyse them by Illumina Solexa sequencing.  However, 
preliminary analyses of the 3D7/HB3 cross progeny by Solexa sequencing yielded 
numerous non-specific sequence reads following alignment with the reference 
sequence, 3D7.  This may be caused by either human DNA contamination or the 
misalignment of non-unique sequences. This is a major setback especially when 
dealing with multiclonal infections.  The strategy was discarded but the samples were 
analysed using Pyrosequencing
TM
.  The geographic coordinates for the residences of 
individuals from which these samples were collected are also missing for this study 
 
  88 
site. However, geographic coordinates for Molyko, Buea and Muea were used in the 
final analysis outlined in this thesis. 
2-4 ml of blood was collected into a labelled tube containing the anticoagulant Acid 
Citrate Dextrose (ACD). The tube was inverted several times to allow mixing with 
the anticoagulant.  The blood was then spun down by a bench top centrifuge at 2500 
revolutions per minute (rpm) and the plasma and buffy coat layer were removed.   
The red blood cells (RBCs) were then washed twice with 10ml Phosphate buffered 
saline (PBS) buffer with centrifugation and supernatant removal per wash. The RBCs 
were then resuspended in 10ml PBS solution and transferred to a sterile 50ml tube.  
The RBCs were spun down and the supernatant removed.  The packed cell volume 
(PCV) was estimated.  Glycerolyte was then added at a ratio: 3 volumes of PCV to 5 
volumes of glycerolyte.  The glycerolyte was added to the RBC pellet slowly and 
drop wise with continual gentle swirling of tube to ensure even mixing with minimal 
RBC lysis.  The RBC/glycerolyte mixture was then transferred to Nunc
TM
 cryotube 
freezing vials and stored at -70C then to liquid nitrogen the next day.  The samples 
were then stored in liquid nitrogen ready for shipping to the University of Edinburgh. 
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2.3.3.4. Thawing of frozen blood samples and culturing 
The frozen P. falciparum malaria positive samples were stored at -70C at the 
University of Edinburgh.  8 of the blood samples were thawed by removing the 
Nunc
TM
 cryotube freezing vials from the -70C freezer and transferring to a 37C 
water bath.  Each thawed blood sample was transferred to a 50ml tube. Sterile 12% 
NaCl was added dropwise and slowly with gentle shaking to minimise RBC lysis at a 
ratio of 200l NaCl to 1ml thawed blood suspension.  
This suspension was allowed to stand for 5 minutes then 10ml of 1.8% NaCl solution 
was added slowly and drop by drop.  Finally, 10ml of 0.9% NaCl plus 0.2% glucose 
was added.  The suspension was then spun down by centrifugation for 4 minutes at 
Region Male Female Total 
Buea Town 0 2 2 
Molyko 2 3 5 
Great Soppo 1 0 1 
Mutengene 0 1 1 
Bomaka 1 0 1 
Bolifamba 0 1 1 
Bova 0 1 1 
Sosse 1 0 1 
Total 5 8 13 
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2000 rpm.  The supernatant was aspirated and the RBCs resuspended in 20ml 
incomplete RPMI.  This was spun again as previously described and the supernatant 
removed.   
The PCV was determined and the RBC pellet resuspend in complete RPMI at 2% 
hematocrit. A small aliquot was taken and was used to prepare a thin smear for 
parasitaemia determination by microscopy.  The suspension was transferred to a 
culture flask then gassed with a mixture of 94% Nitrogen, 5% Carbon dioxide and 
1% Oxygen for 30-60 seconds. The culture was incubated at 37C for 24 hours until 
the ring stage parasites matured to schizonts or reinvaded new RBCs for enrichment 
of DNA required for subsequent analysis. The parasitaemia prior to culture was 
determined and recorded. 
 
2.3.3.5. Extraction of DNA 
After 24 hours of culture, an aliquot of the blood sample was taken for parasitaemia 
determination by microscopy.  Once the ring stage parasites were observed to have 
matured to trophozoites or reinvaded new RBCs, the culture was taken and DNA 
extracted using the Qiagen® kit as previously described.   
 
2.4. Computer packages and software  
Pyrosequencing
TM
 assays were designed using the PSQ
TM
 assay design software 
(Chapter 3).  The data presented in Chapters 4, 5 & 6 was processed and stored in 
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Microsoft office Excel 2003 for easy management.  Figures and tables were 
generated by the Microsoft office Excel 2007.  Analysis of SNPs and microsatellites 
was carried out using the software FSTAT vs 2.9.3 (Goudet, 2001) (Chapter 5).  
The spatial autocorrelation analyses of the combined data set in Chapter 6 were 
perfomed using the Microsoft Excel, add-in software GenAlEx 6.5 (Peakall and 
Smouse 2006; 2012).   
The map of Rusinga Island, Kenya was generated using the mapping software 
distributed by the Economic and Social Research Institute (ESRI ArcView version 
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3. GENERATION OF MARKERS AND PYROSEQUENCINGTM 
TECHNIQUE VALIDATION FOR INVESTIGATION OF 




The genetic composition of parasites in malaria infections can be investigated using 
genetic markers such as allozymes, single nucleotide polymorphisms (SNPs) and 
microsatellites (see Chapter 1). These markers help identify parasites that are 
genetically related in a mixed clone infection by identifying parasites that carry the 
same gene allele combinations (genotypes).  Various molecular methods have been 
developed to identify these markers and have been used to quantify the proportions 
of genetically distinct P. falciparum parasites occurring in mixed clone infections.  
These methods have already been reviewed in Chapter 1.   
With the rapid technological advances, novel molecular techniques have been 
developed that are less costly, are more rapid and have higher throughput. 
Pyrosequencing
TM
, a method developed by Ronaghi et al., 1996 was used in this 
study.  Following Pyrosequencing
TM
 technique validation for genotyping and allele 
quantitation in mixtures of P. chabaudi chabaudi rodent malaria parasites (Cheesman 
et al., 2006) the work outlined in this chapter adopted a similar strategy for analysis 
of P. falciparum. 
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3.1.1. Chapter synopsis 
This chapter entails the SNP selection process from the available P. falciparum 
genomic databases.  The Pyrosequencing
TM
 technology for use in SNP analysis will 
also be clearly outlined.  Finally, validation assays will be carried out using 
artificially prepared laboratory clones.  
 
3.1.2. Aims of chapter 
This chapter represents the technical aspects involved in assay design and the initial 
analysis using the selected SNPs and Pyrosequencing
TM
.  It therefore aims to: 
1. Describe the PyrosequencingTM technique in detail and justify its use in this 
study 
2. Explain the process involved in SNP identification  
3. Test the identified SNPs by PyrosequencingTM using laboratory prepared pure 
P. falciparum clones. 
 
3.1.3. Hypothesis 
The testable hypothesis in this chapter states that the Pyrosequencing
TM
 technique is 
capable of identifying and quantifying the SNPs obtained from the P. falciparum 
genome following the analysis of laboratory prepared pure clones of P. falciparum. 
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3.1.4. Materials and methods 
The experiments performed in this chapter have been elaborately described in 
Chapter 2.  The first step was to identify SNPs as detailed in the section below. 
 
3.1.4.1. The SNP selection process 
a) Selection of a chromosome arbitrarily from the P. falciparum genome and 
scanning it for conserved genes e.g. hypothetical genes.  This is important to 
ensure that the selected SNPs were specific for the P. falciparum genome.  
This data was derived from the NCBI database 
(http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?chr=pfalciparum.inf).  
b) The gene of interest was then retrieved from the PlasmoDB database 
(http://www.plasmodb.org/plasmo/home.jsp) and scanned for available SNPs.  
These SNPs were selected based on their ability to differentiate between the 
world wide P. falciparum field isolates whose sequences are available in the 
database and can be compared with the 3D7 reference genome. These SNPs 
were selected from loci that are:  
i. believed to be under no selection pressure.  This is because alleles 
found in loci under high selection pressure may confound population 
genetic data interpretation as they will be highly represented in natural 
P. falciparum isolates 
ii. not highly polymorphic as these cause technical difficulties when 
designing primers for Pyrosequencing
TM
 analysis  
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iii. not highly repetitive within the genome due to redundancy that may 
affect assay design and final analysis of results. 
c) The genes containing SNPs of interest were retrieved from the databases and 
saved in a separate file.  Bearing in mind that these genes were obtained from 
the 3D7 reference strain in the database, they were then aligned against the 
other available strains in the databases (HB3, Dd2 and 7G8 strains) using a 
sequence alignment tool derived from the website      
http://bioinformatics.unl.edu/emboss/.  This was done for SNP verification 
with all the P. falciparum strains available in the databases. 
d) Once the SNPs were verified, the sequences were saved in an MS Word file 
and stored for assay design. 
 
Next, assay design was performed using the PSQ™ HS-96A assay design 
software as described in Section 3.2.4.  The identified SNPs were then tested 
using laboratory prepared pure clones of P. falciparum.  This was done to ensure 
that the developed assays and the technique used could provide the genetic 
identity of the tested parasite clones as well as quantitatively score them with 
accuracy giving the expected values of 100%. 
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3.2. Results 




 is a high throughput genotyping technique that involves the 
sequential incorporation of nucleotides on a growing strand of DNA hybridized on 
PCR pre-amplified template DNA. Its principle involves a series of enzyme-coupled 
reactions culminating in a light signal that is proportional to the number of 
nucleotides added to the sequence of DNA being synthesised. The enzyme cascade 
begins with the hybridisation of the sequencing primer onto the template DNA. 
Nucleotides are released sequentially and the nucleotide complementary to the 
template is added onto the synthesised DNA with the aid of DNA polymerase.  
Incorporation of the nucleotide produces inorganic pyrophosphate (PPi) which with 
the aid of the substrate adenosine 5΄ phosphosulfate and the enzyme ATP sulfurylase 
produces ATP.  The ATP is then converted to light in the presence of the substrate 
luciferin in a reaction catalysed by luciferase.  The signal produced is detected by a 
charge-coupled device (CCD) camera and is visualised as a series of graphical 
presentations known as pyrograms (Figure 3.1).  The unincorporated nucleotides and 
the excess ATP are degraded by the enzyme apyrase.   
 
  97 
 
Figure 3.1  Diagrammatic presentation of Pyrosequencing
TM
.  The reaction is 
initiated by addition of an enzyme mixture containing DNA polymerase, ATP 
sulfurylase, luciferase and apyrase.  The substrate mixture containing luciferin and 
adenosine 5΄ phosphosulfate follows.  The PCR product in the reaction consists of a 
single stranded DNA immobilised on a bead as described previously and serves as 
the template for the reaction.  The sequencing primer anneals to the template and the 
reaction proceeds.  In this example the template is the 3-CGTCCGGA…..-5΄ strand 
shown above and the synthesised strand following nucleotide incorporation is 5΄-
GCAGGCCT…..-3΄.  The DNA polymerase binds to the region where the incoming 
nucleotide will hybridise as shown above. The incoming nucleotide (T) is 
complementary to the nucleotide on the template and is thus added to the growing 
strand with the aid of DNA polymerase.  Once the T is added, inorganic 
pyrophosphate (PPi) is produced which in the presence of the substrate adenosine 5΄ 
phosphosulfate and the enzyme sulfurylase leads to ATP production.  The unused 
nucleotides (Ts) are degraded by the enzyme apyrase.  The ATP is converted to light 
in the presence of the enzyme luciferase as shown above.  This light is captured by a 
camera and is visualised in a computer as peaks known as pyrograms depicted on the 
right hand side of the figure above.  The intensity of light produced and subsequently 
the height of the peak is dependent on the number of nucleotides added.  For instance, 
as each nucleotide is sequentially added onto the strand being synthesised, a single 
peak is registered.  When two nucleotides are added, this is registered as a double 
peak as shown above in the double peaks representing GG and CC Note that when 
the first T is added above, no peak is registered as it is not part of the analysed 
sequence.  This is included in the reaction for quality control (Figure adapted from 
England & Pettersson, 2005).     
This technique is most suited for this study as it genotypes and assigns quantitation 
values to parasites occurring in different proportions in a mixed clone infection as 
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shown in Figure 3.2 a & b. In addition, this method allows for programmed 
nucleotide dispensation order.  If the sequence is known, only the nucleotides 
corresponding to the sequence under study are dispensed.  The program therefore 
provides an instruction ensuring that unnecessary nucleotides are not dispensed 
unless they have been incorporated in the program for quality control or unless the 
nucleotides at the polymorphic region are unknown.  This ensures high quality 
sequence reads (Figure 3.2 a) enabled by the high internal quality control in the 
instrumentation and subsequently in the final output. 
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(a) 
TEMPLATE               3’     AT(T/C)CAGAT 
NUCLEOTIDE SEQUENCE    5’     TA(A/G)GTCTA 
NUCLEOTIDE DISPENSATION ORDER - GTACTGATCTA 
(b) 
            
 
Figure 3.2  SNP analysis by Pyrosequencing
TM
.  This example is derived from 
analysis of a laboratory prepared artificial mixture of 3D7 and HB3 clones. (a) At the 
third (polymorphic) position in the sequence represented, 3D7 has the nucleotide T, 
and HB3 the nucleotide C, on the 3’ (template) strand corresponding to A and G 
respectively on the read-out 5’ strand. The Pyrosequencing
TM
 pre-programmed 
nucleotide dispensation order is also shown. (b) The output of the Pyrosequencing
TM
 
analysis (pyrogram).  
Pyrosequencing
TM
 uses a pre-programmed nucleotide dispensation order following 
the complementary 5’ sequence with the addition of the two nucleotides marked in 
red, G and A, in (a) above, as nucleotides included for quality control. The peaks in 
the pyrogram (b) above correspond to the nucleotides added onto the growing DNA 
strand. The E indicates addition of the enzyme mixture and S addition of the 
substrate mixture previously described in Figure 3.1.   
The first G, as already stated, is included for (negative) quality control so no peak is 
registered.  When a single T is then added (corresponding to the first A of the 3’ 
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because the template has two successive T’s (the complement of A) present in one of 
the strains as shown in the underlined region of the template (a) above. The C and T 
nucleotides are included in the dispensation order to cater for all the possible SNP 
combinations when analysing wild P. falciparum isolates.  Since C and T are not 
represented in this example, no peak registers when they are released onto the 
growing strand.  G is then added and a larger peak is again observed because two 
successive Cs are present in the template of one of the strains as underlined in (a) 
above. A negative control A is added, to which there is no signal, followed by four 
successive nucleotides - T,C,T and A - for four successive positions in which the 
sequence in both parasite strains is the same, each yielding a smaller sized peak 
corresponding to a single shared nucleotide.  
The box highlighted in blue above the pyrogram in (b) gives the values assigned by 
the Pyrosequencing
TM
 for the proportions of each nucleotide at the polymorphic 
(SNP) position and consequently of each clone in the mixture. Thus G, representing 
HB3, is calculated at 66.3% and A, representing 3D7, at 33.7%.  
  
3.2.2. SNP identification  
A single nucleotide polymorphism (SNP) is an alternative form of a nucleotide at a 
genetic locus (unique position in a DNA sequence) between members of the same 
species or, in this context, between two genetically distinct P. falciparum clones.  
SNPs can, therefore, be used as genetic markers to identify the various genetically 
distinct P. falciparum clones present in an infection.  As earlier stated, P. falciparum 
mixed infections are common in nature and for this reason, SNPs as genetic markers 
allow the identification of parasite clones of different genotypes to be identified and 
distinguished in an infection. 
 
3.2.3. Identifying SNP locations 
The P. falciparum nuclear genome is ~23 Mb in size and is distributed into 14 
chromosomes ranging in physical size from 640kb to 3290kb. It also contains a 
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separate plastid genome of approximately 35kb and a mitochondrial genome of 6kb 
(Gardner et al., 2002).  The complete P. falciparum strain 3D7 genome sequence 
facilitated the sequencing and development of other databases containing the 
different P. falciparum clones (HB3, Dd2, 7G8, and so on).  Various efforts have 
been made to develop a malaria haplotype map (Carlton, 2007).  Of great 
significance and relevance to this study was the genome-wide SNP identification 
depicted in Figure 3.3 by Mu et al., 2007.  They re-sequenced Dd2, HB3, D10 and 
7G8 clones and compared them with the 3D7 clone reference genome.  This study 
revealed numerous genetic markers for use in genetic studies showing an average of 
one genetic marker per 3.6kb in the genome.  A recent exploratory study to detect 
polymorphisms using a high-density microarray chip detected an average of one 
genetic marker per approximately 500bp in 3D7, DD2, 7G8, HB3 and FCR3 (Jiang 
et al., 2008).  All the above studies highlight the abundance of SNPs across the P. 
falciparum genome available for use in this project. 
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Figure 3.3  Distribution of SNPs across genome of P. falciparum derived from 
aligning cloned isolates, Dd2, HB3, D10 and 7G8 with the 3D7 genome sequence. 
The map details an average of one polymorphic marker per approximately 3.6 kb of 
the P. falciparum genome.  Vertical bars represent SNPs (black, non-synonymous 
substitutions; red, synonymous substitutions) or microsatellites (blue, under the 
horizontal lines). Only one non-synonymous SNP and one synonymous SNP are 
presented if there was more than one SNP in a gene (non-coding SNPs are grouped 
with synonymous SNPs). Most of the chromosomal ends (green vertical bars) are 
excluded because of repetitive gene families such as var, rifin and stevor (From Mu 
et al., 2007). 
 
The SNPs data can be accessed from the P. falciparum genome resource, PlasmoDB 
(http://www.plasmodb.org/plasmo/home.jsp) which provides information on 
polymorphisms occurring across the different cloned lines (3D7, HB3, Dd2 and so 
on) that have been sequenced and placed in the genome as representatives of 
worldwide isolates. Complete genomic data is usually first submitted to the 
PlasmoDB database then to the National Centre for Biotechnology Information 
(NCBI) database.  Genomic data can be accessed with ease from both databases.  
These databases facilitated the selection of about 50 SNPs distributed in various 
chromosomes for use in this project. 
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3.2.4. PyrosequencingTM assay design 
Once genes of interest containing the SNPs best suited for identification of parasite 
clonal genotypes had been identified for Pyrosequencing
TM 
analysis (as desbribed in 
Section 3.1.4.1), the next step was to design the specific assays for each of the SNPs.  
The Pyrosequencing
TM
 instrumentation is furnished with assay design computer 
software.  The assay design software allows for the uploading of files containing the 
genes of interest as long as the polymorphic regions are clearly highlighted.  It then 
designs forward and reverse PCR primers for the amplification of DNA and an 
additional sequencing primer for the subsequent Pyrosequencing
TM
 analysis.  It then 
assigns scores for each of the assays it designs depending on how well-suited the 
gene region is for PCR and Pyrosequencing
TM
 analysis.  Bearing in mind that the P. 
falciparum genome is highly AT rich (>80%), (Gardner et al., 2002), good primer 
design can be difficult.  Optimal primers must have a melting temperature (Tm) of 
58-65°C which is usually determined by the GC content of the region you are 
designing primers from. The AT richness of the P. falciparum genome therefore 
renders primer design difficult.  This computer software is highly pertinent as it 
designs assays around the polymorphic region and assigns assay scores giving 
warnings where: 
i. The primer melting temperature (Tm) is too low which depends on GC 
content of the SNP region 
ii. There is possibility of mis-priming due to non-specific binding of primer 
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iii. The template may generate secondary structures such as a hair pin loop 
structure, which compromise DNA polymerase progression along the 
template impeding further sequencing 
 
Most of the SNPs residing in the pre-selected gene regions are, therefore, discarded 
at this point due to low assay scores (<70%) assigned by the computer software.  It is 
on this basis that, of the 50 SNPs selected for use in this project from the PlasmoDB 
website, only 15 SNPs from four different chromosomes namely: Chromosome I, III, 
X & XIV (Figure 3.4) passed the Pyrosequencing
TM 
assay design software ‘quality 
control’ (see Table 3.1).  The fact that these genetic markers were obtained from 
different chromosomes across the genome provided a good representation of sites for 
genotyping purposes. 
 













Figure 3.4  Diagram depicting the SNPs selected for genotype analysis shown by 
stars, and the genes in which they reside shown as red stars and the numbers 1-5. The 
genes are located in chromosomes I, III, X and XIV. The chromosomes are indicated 
by the coloured bars and the chromosome sizes in kilobases (kb) are given on the 
side of each bar.  The total number of genes present in each chromosome is shown 
inside the chromosome bars.  The genes are located in the approximate position they 
occupy in each chromosome. Note that the nomenclature varies in the PlasmoDB or 
NCBI website; the variant names are therefore provided. 
Gene annotation:  
Chromosome I:  Gene 1. Ring infected erythrocyte surface antigen (PFA 0110w, PLASMODB or 
Mal1P1.13, NCBI); Gene 2. Hypothetical protein (PFA0230c, PLASMODB or Mal1P1.36, NCBI); 
Gene 3.  Selenocysteine-specific elongation factor selB homologue, putative (MAL1P2.28); Gene 4.  
Phosphatidylinositol-4-phosphate-5-kinase, putative (MAL1P2.32). 
Chromosome III: Gene 1. ABC transporter, putative (MAL 3P1.7); Gene 2. DNA polymerase δ small 
subunit, putative (MAL3P3.4); Gene 3. CTRP (PFC0640w); Gene 4. T-complex protein 1 ε subunit, 
putative (MAL3P7.9); Gene 5. Hypothetical protein (MAL3P7.37).  
                                        237 GENES III






1 2 3 4 
404 GENES X 1,690 
2 3 1 
   771 GENES 3,290 XIV 
1 2 3 
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Chromosome X:  Gene 1.  Hypothetical protein (PF10_0031); Gene 2. 3.8 protein (Serine/Threonine 
protein kinase, FIKK family) (PF10_160); Gene 3. Hypothetical protein (PF10_230). 
Chromosome XIV:  Gene 1. Hypothetical protein (PF14_0074); Gene 2.  Hypothetical protein, 
conserved (PF14_0400); Gene 3.  Hypothetical protein (PF14_0485). 
 
The assays designed for each of the SNPs by the Pyrosequencing
TM
 assay design 
software and the assigned assay scores by the Pyrosequencing
TM
 assay design 
software are shown in Table 3.1.  
 
Table 3.1  The assays generated by the Pyrosequencing
TM
 assay design software. The 
genes from where the SNPs occur and their sizes are given.   The gene IDs derived 
from NCBI and PlasmoDB (in brackets) databases are given in the first column. The 
nomenclature of the allele specific primer sets given in the second column is: pf – 
Plasmodium falciparum; 01, 03, 10, and 14 denoting the chromosome from which 
they were derived; while the remaining digits indicate the physical position of the 
SNP in the genome.  Since the genome was re-annotated, the SNP positions in some 
of the chromosomes changed; the new ones are given in brackets. The third column 
has the primer sets with the biotinylated ones given in bold while the fourth column 
shows the expected primer sizes following amplification. The last column shows the 
*quality control score (a ‘quality index’ (maximum 100) is allocated by the 
Pyrosequencing™ assay design software to each individual assay which is designed 
to reflect the quality of the assay).    
 







Pyrosequencing Primer sets (5′ – 3′).  
























F - GGATATTCAAACATGTCGCTAAAA 
R – TGGTTTCCGTTATCAACATTGG 













F - TTATTTCCATTGTTTCGACTGTTG 
R – AAGCAGTTTGATGAAAAGAACAA 














F – GGTGTTTTAGGACACGTTGATTCT 
R – TTATGTTTATCTAGGGCGCATGT 













F – TTTTCATCCATTGTGGAGATACAT 
R – CTCCCAATTGACCACATCTTTAGA 











F – AGAACGATCATTTCGTCTGTCATA 
R – TTATTGTTGCGCATATTGTCCT 
















F - TGGGGATACATATTTATCAGAAAA 
R – CTTTATCACCAGGCATTAAATCAA 









F – CAACACATTGCCAAGGTGAT 
R – TTTCCTGCTCATAACCTATATCCG 
S - AACTACATCTTTCTTCCATT 222 80 
 
 







Pyrosequencing Primer sets (5′ – 3′).  

























F – ATATTGTTGTCGATGCCGTTTT 
R – TTTAGGTGGTTCAAATGGACATG 













F – AGTGACACGGAATTATATGAGAAG 
R – TTTGAAAACCTCCTTCAGAAAAA 









F – TGAAAAAGAAGTCATCGAAAGTAA 
R – CTTTTGATTCTATTTTCGGTAGCA 












F – TGTGTAAACACGCTCCAATTAAAT 
R – AATCGATGCTTAGCCGAGTTT 









F – TTGCCTATCATTAATGGAAAAT 
R – TAATATAAATTCCGTACGGTCCTC 








F – ATTCTGAACAACGCCTTCCATTA 
R – ACAGCAACAAAATCCTTCAGAGA 









F – GGGAGCAAGTTTTTCTTCACTTTT 
R – AAGTGATCATACCATTTTTGAAGC 











F – GCTCAAACAATAGTAACAAAACCA 
R – ATGTTGTGATGGTACATTCATGTC 
S - AAAAACAAATGTTGAAAATT 222 78 
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The identified SNPs were then tested by Pyrosequencing
TM
 using laboratory 
prepared pure clones of 3D7, HB3, CAMP and FCR3 to test the technique for SNP 
identification.  The results shown in Table 3.2 reveal that the technique does indeed 
identify each SNP representing the pure clones tested and corresponds with 
information provided in the PlasmoDB database.  The proportions assigned by the 
Pyrosequencing
TM
 are also shown with all the SNPs occurring at a proportion >95% 
out of the expected 100%. 
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Table 3.2  Basic operational information on the SNPs used for genotyping.  The 
primer names, SNP positions in the genes where the assays are derived from are 
given and the genotypes for the sequenced P. falciparum clones available in the 
PLASMODB database. The table shows that the SNP determined by 
Pyrosequencing
TM
 analysis in each locus corresponds to that provided in the database 
as shown in the observed P. falciparum strain and SNP type column.  This data was 
obtained from pure clones of 3D7, HB3, FCR3 and CAMP.  The expected 
proportions assigned by the Pyrosequencing
TM
 should be 100%.  As shown below, 
the observed mean allele quantification values obtained from Pyrosequencing
TM
 are 




SNP position in gene and 
genotype of sequenced 















from the analysis 




3D7/RO33 - G 
7G8/D10/D6/DD2/FCR3/K1/HB





3D7   -    G 
HB3  –    T  















3D7    -  G    









  3D7   –   C 
CAMP –  C 
 FCR3 –  C 




 DD2/IT - G 





3D7    -    T  
CAMP   – T 
FCR3  –   G 




3D7/ HB3 – G 
DD2/D10/7G8 - T 
 
Synonymous 
  3D7    -    G 
CAMP   -  T  
FCR3   –  G 
 HB3   -    G 97.3 
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Primer 
name 
SNP position in gene and 
genotype of sequenced 















from the analysis 





3D7 – C 
DD2/7G8/D10/HB3 - T 
 
Synonymous 
3D7     -    C 
CAMP   -   T  
FCR3   –   C 




3D7 – G 




 3D7     –    G 
CAMP   -   G 
FCR3    –   A 




HB3 – C 




3D7     -    A 
CAMP    -  A 
FCR3    –  A 








3D7 – C 




3D7     -    C 
CAMP   -   A 
FCR3   –   A 










3D7    -     C 
CAMP   -   C 
FCR3   –   C 




3D7 - C 
7G8/FCR3/D6/HB3/SANTA 




3D7    -   C   













3D7    -   A  




3D7/RO33/SENEGAL3404 – A 
HB3/7G8/D6/DD2/FCB/K1/FCC-





3D7    -   A    







   
 










SNP position in gene and 
genotype of sequenced 















from the analysis 





3D7/7G8 – A 
HB3/D10/D6/DD2/K1/RO33/SE
NEGAL3404/V1_S/K1 - T 
 
Synonymous 
3D7    -  A   




3D7/7G8 – A 
HB3/D10/D6/DD2/K1/RO33/SE




3D7    -  A   





34.04/HB3/D10/3D7 – T 




3D7   -      T  
CAMP   -   T 
FCR3   –   T  
HB3    -     T 95.7 
 
3.3. Discussion 
In this chapter, (i) the SNPs of interest have been identified, (ii) assays for SNP 
analysis have been designed and (iii) the assays have been tested using pure clones of 
P. falciparum with the results ascertaining their use by Pyrosequencing
TM
.  The 
results obtained in this thesis conform to the hypothesis that indeed the technique 
identified and assigned the expected quantitation values (100%) to the analysed pure 
P. falciparum clones.   
At the writing of this thesis, tremendous advances had been made on the 
identification and use of genome wide SNPs for P. falciparum clonal identification 
as discussed in Chapter 1.  In addition, the PlasmoDB website has been constantly 
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updated with studies conducted on worldwide isolates increasing the SNP data.  For 
example Nkhoma et al., 2012 used a panel of 384 SNPs obtained from the 
PlasmoDB database.  These SNPs were selected on the basis of being highly 
polymorphic in Africa enabling detection of the extensive mixed clone parasite 
repertoire typically observed in this high malaria transmission region.   
The availability of SNP data as described by Nkhoma et al., 2012 and with more 
SNPs being identified and tested at the Sanger Institute such as by Campino et al., 
2011 or Manske et al., 2012 eases the burden of scouring through the PlasmoDB or 
NCBI websites as was done in this study.  Pyrosequencing
TM
 assays can therefore be 
designed around these SNPs.  Furthermore, as observed in this chapter, the 
Pyrosequencing
TM
 assay design software is highly stringent such that of the 50 
identified genes of interest for SNP detection only 15 were retained.  Thus with the 
resource of a large number of SNPs more assays can be designed for use with this 
technique.   
A major setback observed so far with this technique is the rigorous and time-
consuming process of assay design and testing.  However, the advantage of this 
technique is that once an assay has been ascertained for use, the interpretation of data 
obtained from the pyrogram reads is straightforward and does not need extensive 
downstream proofreading as is required with other genome wide sequencing 
techniques.  For example the deep sequencing analysis performed using Illumina 
platforms such as Solexa requires extensive sequence filtering in silico to ensure only 
quality and genuine reads are retained. 
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Further to this, Pyrosequencing
TM
 does not require the removal of human DNA by a 
leukocyte depletion step as is recommended when analysing P. falciparum field 
isolates using the Illumina platforms (Auburn et al., 2011).  This is because in the 
PCR step, primers specific for the amplification of parasite DNA are used. 
 
3.3.1. Conclusion 
In this chapter, 15 SNPs have been selected and their assays developed for analysis 
by Pyrosequencing
TM
.  More SNPs can indeed be identified for use especially with 
the ever increasing SNP data from worldwide P. falciparum isolates in the 
PlasmoDB database.  Since the work outlined in this thesis constitutes a feasibility 
study, the identified SNPs should suffice in this preliminary analysis.  The SNPs will 
then be validated for use in the next chapter using laboratory prepared mixed clone 
infections as well as material from the cross progeny obtained from the 3D7 and 
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4. STANDARDIZATION OF PYROSEQUENCING™ 
ASSAYS  
4.1. Introduction 
P. falciparum mixed clone infections are common in nature and parasites in such 
infections are usually present at different proportions.  This is a situation that can be 
exploited and, with a technique that can identify SNPs representing the individual 
parasite lines in a mixed infection and assigning proportions to them, it is possible to 
classify individual alleles existing at similar proportions as belonging to the same 
genotype.  These sets of alleles representing individual parasite clones in an infection, 
can be used to trace genetic relatedness of parasites where, the more closely related 
the parasites are, the larger the proportion of alleles they share.  
 
4.1.1. Synopsis of chapter 
Pyrosequencing™ has been tested using laboratory prepared pure clones of P. 
falciparum and is validated for use in this study (see Chapter 3).  The next objective 
was to determine if Pyrosequencing™ is able to quantify proportions of parasites 
carrying individual SNPs in a mixed clone infection with sufficient accuracy to 
identify parasite genotypes represented in laboratory prepared parasite mixtures.  
This is in line with work previously outlined by Cheesman et al., (2007).   
Also in this chapter, prior to analysis of P. falciparum field isolates, the genetic 
relatedness in a cross comprising known parental clones (3D7 and HB3) will be 
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determined.  Unlike the previous analysis involving laboratory prepared clones at 
known proportions, the cross progeny comprises genetically distinct clones, 3D7 and 
HB3 at unknown proportions as is commonly observed in field isolates.  In this 
chapter, the accurate detection and delineation of the 3D7 or HB3 clonal genotypes 
occurring within the cross will be tested in preparation for analysis of field isolates. 
 
4.1.2. Aims of chapter 
The experiments in this Chapter were, therefore, conducted to  
1. Determine if Pyrosequencing™ is able to accurately determine the genetic 
identity of parasites in mixtures of P. falciparum blood stage parasites of 
different genotypes.  
2. Identify the technique’s limits of detection in isolates occurring at different 
parasitaemia levels and how this may confound detection of parasite clones. 
3. Identify clonal genotypes represented in the cross progeny obtained from the 
genetically distinct clones, 3D7 and HB3. 
4. Test the genetic relatedness observed from analysis of the cross progeny. 
 
4.1.3. Hypothesis 
The testable hypotheses in this chapter are that: 
1.  Clonal genotypes can be accurately discriminated from the laboratory 
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2. The P. falciparum parental clones, 3D7 and HB3 are expected to mate 
randomly such that the progeny comprises 50% parental genotypes and 50% 
recombinants. 
 
4.1.4. Materials and methods 
4.1.4.1. P. falciparum clonal mixtures 
Laboratory prepared P. falciparum parasite mixtures containing two different 
genetically distinct clones, namely 3D7 & HB3, 3D7 & DD2 or 3D7 & 7G8 were 
made in various proportions to test this (See Chapter 2).  These mixtures were 
prepared thus to mimic mixed parasite genotype infections that, as already stated, are 
commonly found in natural P. falciparum infections.  
The mixed clone combinations were prepared at 0.1, 0.01 & 0.001% final 
parasitaemias and in calculated proportions of 100:0, 98:2, 95:5, 90:10, 80:20, 50:50, 
20:80, 10:90, 5:95, 2:98 and 0:100 (made by Richard Carter).  All the 
Pyrosequencing™ SNP assays previously generated for use in this study (Chapter 3) 
were tested.  For each of these SNP assays, Pyrosequencing™ was tested for its 
ability to assign the proportions of the parasites of each genotype in a mixture.  
Duplicate samples of each combination of calculated parasite proportions were PCR 
amplified and triplicate Pyrosequencing
TM
 measurements of each were taken. 
 
  118 
 
4.1.4.2. Analysis of cross progeny 
Information on how the P. falciparum cross progeny was cultured and semi-cloned is 
given in Chapter 2.  Following identification of the clonal genotypes, estimates of 
genetic distances (GDs) and genetic relatedness (GR) were determined from overall 
pair-wise allelic comparisons for all loci analysed in all the recombinants (from 
Figure 5.2) using the formula: 
 
             No. of alleles shared 
GD = 1 -   _______________________ 
              Total alleles analysed 
 
 




4.2.1. Analysis of mixtures of genetically distinct clone by Pyrosequencing™ 
to determine the genotypes of each of the clones represented in the mixtures 
The mean values derived from the medians of each triplicate measurement of SNP 
proportions representing each of the genetically distinct parasites in a mixture are 
summarised in Table 4.1 a, b & c.   
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Table 4.1  Summary of results obtained from Pyrosequencing™ analysis of 
laboratory prepared parasite mixtures at 0.1% parasitaemia of different proportions 
of (a) 3D7 & HB3, (b) 3D7 & DD2 and, (c) 3D7 & 7G8. Calculated values for the 
proportions in which the parasite mixtures were prepared are shown in the left hand 
column.  The measured proportions of SNPs at each marker locus are those assigned 
by Pyrosequencing™ for each SNP assay, as indicated, e.g. pf-01-101502 etc.  
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(a) 
 
   Measured proportions of SNPS at each marker locus 
Calculated 
values for 

















3D7 (100) 89.6 99.1 99.1 100 93.1 96.7 99.3 100 
HB3 (0) 10.4 0.9 0.9 0 6.9 3.3 0.7 0 
                 
3D7 (98) 90.6 96 96.1 95 90.5 95.3 96.4 94.8 
HB3 (2) 9.4 4 3.9 5 9.5 4.7 3.6 5.2 
                 
3D7 (95) 88.1 95.5 87.8 92.6 86.2 94.5 92.7 92.3 
HB3 (5) 11.9 4.5 12.2 7.4 13.8 5.5 7.3 7.7 
                 
3D7 (90) 78.4 87.6 80.4 82.7 80.1 90.6 88.7 85.2 
HB3 (10) 21.6 12.4 19.6 17.3 19.9 9.4 11.3 14.8 
                 
3D7 (80) 73.9 77.9 73.5 74.9 69.5 84 76.4 75.5 
HB3 (20) 26.1 22.1 26.5 25.1 30.5 16 23.6 24.5 
                 
3D7 (50) 57.3 66.7 61.8 63 62.9 65.5 67.4 61.1 
HB3 (50) 42.7 33.3 38.2 37 37.1 34.5 32.6 38.9 
                 
3D7 (20) 45.5 46.4 51.2 59.2 48.9 47.4 48.1 49.4 
HB3 (80) 54.4 53.6 48.8 40.8 51.1 52.6 51.9 50.6 
                 
3D7 (10) 26.5 34.6 33.2 35.7 33.2 39.6 33.9 31.4 
HB3 (90) 73.5 65.4 66.8 64.3 66.8 60.4 66.1 68.6 
                 
3D7 (5) 8.9 18.6 18.5 21.5 19.5 31.9 22.8 16.1 
HB3 (95) 91.1 81.4 81.5 78.5 80.5 68.1 77.2 82.9 
                 
3D7 (2) 12 12.9 17 19.7 14.9 20.6 16.2 11.2 
HB3 (98) 88 87.1 83 80.3 85.1 79.4 83.8 88.8 
                 
3D7 (0) 0.4 7.4 7.4 11.2 15.1 17.3 6.8 0.9 
HB3 (100) 99.6 92.6 92.6 88.8 84.9 82.7 93.2 99.1 
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(b) 
    Measured Proportions of SNPs at each marker locus 
Calculated 
values for 













3D7 (100) 100 100 94.7 95.6 85.5 88.7 85.8 
DD2 (0) 0 0 5.3 4.4 14.5 11.3 14.2 
               
3D7 (98) 98.1 95.6 91.4 94.6 87.7 91 85.6 
DD2 (2) 1.9 4.4 8.6 5.4 12.3 9 14.4 
               
3D7 (95) 95.3 95.4 89.5 90.4 88.9 89.2 83.8 
DD2 (5) 4.7 4.6 10.5 9.6 11.1 10.8 16.2 
               
3D7 (90) 93.1 88.5 86.0 87.2 82.7 82.6 83 
DD2 (10) 6.9 11.5 14.0 12.8 17.3 17.4 17 
               
3D7 (80) 83.1 79.8 72.1 84.2 75.1 72.9 78 
DD2 (20) 16.9 20.2 27.9 15.8 24.9 27.1 22 
               
3D7 (50) 56.5 48.9 46.9 47.7 53.5 54.5 55.5 
DD2 (50) 43.5 51.1 53.1 52.3 46.5 45.5 44.5 
               
3D7 (20) 29.6 25.2 17.9 22.3 22.6 21.9 36.6 
DD2 (80) 70.4 74.8 82.1 77.7 77.4 78.1 63.4 
               
3D7 (10) 19.5 14.7 7.8 13.8 17.5 16.4 23 
DD2(90) 80.5 85.3 92.2 86.2 82.5 83.6 77 
               
3D7 (5) 16.2 14.2 2.2 10.7 0 11 28.1 
DD2 (95) 83.8 86.8 97.8 89.3 100 89 71.9 
               
3D7 (2) 14.4 13.2 2.7 8.3 0 14 24.8 
DD2 (98) 85.6 86.8 97.3 91.7 100 86 75.2 
               
3D7 (0) 12.5 8.3 1.8 2.5 0 6.5 25.7 
DD2 (100) 87.5 91.7 98.2 97.5 100 93.5 74.3 
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(c) 
   Measured proportions of SNPs at each marker locus 
Calculated 
values for 













3D7 (100) 98.9 94 96.7 89.5 92.6 98.7 
7G8 (0) 1.1 6 3.3 10.5 7.4 1.3 
              
3D7 (98) 96.8 93.7 93.3 93.2 92 97.3 
7G8 (2) 3.2 6.3 6.7 16.8 8 2.7 
              
3D7 (95) 96.9 94.9 94 89.2 89.3 96.3 
7G8 (5) 3.1 5.1 6 10.8 10.7 3.7 
              
3D7 (90) 93.6 91.6 93.8 92 91.3 96.8 
7G8 (10) 6.4 8.4 6.2 8 8.7 3.2 
              
3D7 (80) 91.4 89 88.5 86.7 89.1 94.4 
7G8 (20) 8.6 11 11.5 13.3 10.9 5.6 
              
3D7 (50) 70.3 70.1 69.9 67.1 60.3 75.6 
7G8 (50) 29.7 29.9 30.1 32.9 39.7 24.4 
              
3D7 (20) 46.6 40.4 40.5 48.2 49.3 54.1 
7G8 (80) 53.4 59.6 59.5 51.8 50.7 45.9 
              
3D7 (10) 44.1 21 36.4 17.9 19.9 25.3 
7G8(90) 55.9 79 63.6 82.1 80.1 74.7 
              
3D7 (5) 23.2 14.7 22.4 4.8 9.8 20.0 
7G8 (95) 76.8 85.3 77.6 95.2 90.2 80.0 
              
3D7 (2) 18.9 4.8 15.1 0.1 0.7 10.0 
7G8 (98) 81.1 95.2 84.9 99.9 99.3 90.0 
              
3D7 (0) 18.4 12 8.7 1.3 0.4 1.0 
7G8 (100) 81.6 88 91.3 98.7 99.6 99.0 
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For each marker locus, Pyrosequencing™ quantifies the SNP for each parasite strain 
in a mixture. This, therefore, indicates the proportion of parasites represented by that 
SNP in the mixture (Table 4.1 a, b & c). In principle, all SNPs which are 
represented in the same proportion must belong to parasites of the same genotype.  
The results in Table 4.1 a, b & c showed that, when a clone was represented in high 
proportion in a mixture (the major clone), its SNPs were measured at the same high 
proportion and there was usually no difficulty in identifying its genotype.  In this 
way, for most parasite strain combinations, correct strain genotypes could be 
determined at least for the major clone in the mixture.  
However, Pyrosequencing™ has limited accuracy to assign SNP proportions for 
clones occurring in low proportions (Table 4.1 a, b & c). In general 
Pyrosequencing™ is inaccurate in assigning measurements for SNP proportions for 
clones occurring in proportions of <25%. Parasites and their SNPs that were 
represented in apparent proportions of less than 25% could not be confidently 
differentiated from total absence, i.e. from 0%. It is also not possible to clearly 
distinguish SNP proportions for clones occurring at proportions between 40% and 
60%.  Conversely, for major clones represented at proportions >60% or with minor 
clones represented between 25-40%, a SNP genotype could normally be confidently 
given. On this basis, it can be concluded that Pyrosequencing™ quantifies, within 
certain limits of accuracy, the proportion of a SNP at each marker locus for each 
parasite genotype in a mixture.  
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4.3. Accuracy and precision of Pyrosequencing™ in assigning 
proportions relative to the calculated values of the 
laboratory prepared genetically distinct clones 
 
To test the reliability of Pyrosequencing™ in assigning SNP proportions relative to 
the calculated values of the clones represented in the laboratory prepared mixtures, 
the results in Table 4.1 a, b & c were plotted in a graph (see, Figure 4.1 a, b & c).   
(a)
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(b)
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Figure 4.1  Diagrammatic presentation of the data in Table 4.1 a, b & c. The 
Pyrosequencing™ measurements of SNPs at all the analysed marker loci were 
plotted against calculated proportions of the parasites of each genotype in the 
laboratory prepared parasite mixtures of 3D7 & HB3, 3D7 & DD2 and, 3D7 & 7G8.  
The results in Figure 4.1 a, b & c reveal a nonlinear relationship between the 
calculated values and the Pyrosequencing™ measurements.  For each combination of 
parasite genotypes, the SNP proportions assigned by Pyrosequencing™ all showed 
closely similar deviations from the calculated proportions of parasite genotypes in 
the mixture (see, Figure 4.1 a, b & c).  The patterns, or directions, of these 
deviations were unique to each parasite mixture analysed (Figure 4.1 a, b & c). It is 
highly probable that these results are accounted for by inaccuracies in the calculated 
proportions of the parasites in the preparation of the laboratory mixtures. This is 
indicated by the fact that the discrepancies were unique to each mixture but closely 
consistent among the measurements of the different Pyrosequencing
TM 
assays for the 
same mixture. To test the degree of internal consistency among the measurements 
assigned by the different Pyrosequencing™ assays for the same parasite preparation, 
the SNP proportions measured by Pyrosequencing™ at all loci were plotted against 
the SNP proportions measured at the locus Pf-03-350224. This was done for each of 
the laboratory prepared parasite mixtures (Figure 4.2 a, b & c). 
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(c) 
     












0 10 20 30 40 50 60 70 80 90 100




































Figure 4.2  SNP proportions measured by Pyrosequencing™ at all the marker loci 
plotted against measured SNP proportions at the locus Pf-03-350224 for each of the 
parasite mixtures derived from analysis of 3D7 & HB3, 3D7 & DD2, and, 3D7 & 
7G8 at 0.1 % parasitaemia  
 
The results in Figure 4.2 a, b & c demonstrate relative consistency among all the 
Pyrosequencing™ assays in the SNP proportions assigned for each parasite mixture. 
This shows that, indeed, the deviations observed in Figure 4.1 a, b & c might have 
arisen due to relative inconsistencies during preparation of the laboratory prepared 
mixtures thus the proportions assigned by Pyrosequencing™ are accurate.   
These results, therefore, indicate that Pyrosequencing™ can, within the limits 
identified, be reliably used to measure the proportions of  SNPs representing 
parasites of different genotypes in many, but not all, mixtures containing genetically 
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distinct parasites.  From this information it is usually possible to assign at least one 
and often two of the parasite genotypes present in a mixture.  On this basis it should 
be possible to apply this method to assign genotypes in P. falciparum field isolates 
containing mixtures of genetically distinct parasites.   
 
4.4. Testing the limit of detection of Pyrosequencing™ from P. 
falciparum genetically distinct clone mixtures prepared at 
0.01% and 0.001% parasitaemias 
 
To validate the use of Pyrosequencing™ for analysis of field isolates whose 
parasitaemias vary, it was pertinent to test samples with reduced parasitaemias to 
determine the technique’s limit of detection i.e. at what level of parasitaemia it would 
still be possible to identify parasite genotypes from mixtures.  P. falciparum 
laboratory prepared clone mixtures containing 3D7 & HB3, 3D7 & DD2 or 3D7 & 
7G8 at proportions previously described and at parasitaemias of 0.01% and 0.001% 
were also tested by Pyrosequencing™. The markers summarised in Table 4.2 were 
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Table 4.2 Summary of results obtained from Pyrosequencing™ analysis of laboratory prepared parasite mixtures at 0.1%, 0.01% 
and 0.001% parasitaemia of different proportions of (a) 3D7 & HB3, (b) 3D7 & DD2 and, (c) 3D7 & 7G8. Calculated 
values for the proportions in which the parasite mixtures were prepared are shown in the left hand column.  The measured 
proportions of SNPs at each marker locus are those assigned by Pyrosequencing™ for each SNP assay, as indicated, e.g. 
pf-01-205304 etc.  
 
(a) 
  Measured Proportions of SNPs at each marker locus  
Calculated 
values for 
each clone  pf-01-205304 pf-03-350224 pf-03-842383 pf-10-658467 pf-10-992433 
  0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 
3D7 (100) 99.1 100.0 92.5 99.1 89.8 81.1 100 100.0 81.2 96.7 94.0 77.0 99.3 88.9 78.1 
HB3 (0) 0.9 0.0 7.5 0.9 10.2 18.9 0 0.0 18.8 3.3 6.0 23.0 0.7 11.1 21.9 
3D7 (98) 96 98.8 83.9 96.1 81.5 78 95 96.1 71.5 95.3 85.7 78.3 96.4 91.6 75.1 
HB3 (2) 4 1.2 16.1 3.9 18.5 22 5 3.9 28.5 4.7 14.3 21.7 3.6 8.4 24.9 
3D7 (95) 95.5 90.4 82.8 87.8 73.1 62.2 92.6 94.1 60.9 94.5 72.2 77.2 92.7 90.8 76.4 
HB3 (5) 4.5 9.6 17.2 12.2 26.9 37.8 7.4 5.9 39.1 5.5 27.8 22.8 7.3 9.2 23.6 
3D7 (90) 87.6 88.0 82.3 80.4 66.0 71.7 82.7 86.4 73.3 90.6 76.4 72.5 88.7 83.8 60.7 
HB3 (10) 12.4 12.0 17.7 19.6 34.0 28.9 17.3 13.6 26.7 9.4 23.6 27.5 11.3 16.2 39.3 
3D7 (80) 77.9 77.7 81.8 73.5 68.9 66.9 74.9 73.7 64.4 84 67.9 67.2 76.4 70.5 59.4 
HB3 (20) 22.1 22.3 18.2 26.5 31.1 33.1 25.1 26.3 35.6 16 32.1 32.8 23.6 29.5 40.6 
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Measured Proportions of SNPs at each marker locus 
Calculated 
values for 
each clone  pf-01-205304 pf-03-350224 pf-03-842383 pf-10-658467 pf-10-992433 
  0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 
3D7 (20) 46.4 60.0 48.4 51.2 57.8 38.7 59.2 41.7 58.0 47.4 48.2 38.4 48.1 36.0 51.7 
HB3 (80) 53.6 40.0 51.6 48.8 42.2 61.3 40.8 58.3 42.0 52.6 51.8 61.6 51.9 64.0 48.3 
3D7 (10) 34.6 30.7 37.3 33.2 44.3 31.6 35.7 36.8 37.0 39.6 36.8 35.6 33.9 36.4 50.6 
HB3 (90) 65.4 69.3 62.7 66.8 55.7 68.4 64.3 63.2 63.0 60.4 63.2 64.4 66.1 63.6 49.4 
3D7 (5) 18.6 27.5 39.1 18.5 41.0 33.2 21.5 34.0 41.6 31.9 27.1 54.5 22.8 20.4 41.4 
HB3 (95) 81.4 72.5 60.9 81.5 59.0 66.8 78.5 66.0 58.4 68.1 72.9 45.5 77.2 79.6 58.6 
3D7 (2) 12.9 18.1 33.4 17 40.8 39.9 19.7 26.2 38.3 20.6 23.7 30.4 16.2 20.4 38.5 
HB3 (98) 87.1 81.9 66.6 83 59.2 60.1 80.3 73.8 61.7 79.4 76.3 69.6 83.8 79.6 61.5 
3D7 (0) 7.4 5.2 22.9 7.4 39.4 42 11.2 11.8 31.7 17.3 22.9 28.5 6.8 15.2 32.5 
HB3 (100) 92.6 94.8 77.1 92.6 60.6 58 88.8 88.2 68.3 82.7 77.1 71.5 93.2 84.8 67.5 
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(b) 
 Measured Proportions of SNPs at each marker locus  
Calculated 
values for 
each clone pf-01-393153  pf-01-411796 pf-03-138-7 pf-03-350224 
  0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 
3D7 (100) 100 81.2 70.6 100 80.6 84.0 95.6 83.4 66.2 94.7 88.2 70.1 
DD2 (0) 0 18.8 29.4 0 19.4 16.0 4.4 16.6 33.8 5.3 11.8 29.9 
3D7 (98) 98.1 79.7 63.6 95.6 76.4 61.2 94.6 80.4 71.7 91.4 80.5 50.4 
DD2 (2) 1.9 20.3 36.4 4.4 23.6 38.8 5.4 19.6 28.3 8.6 19.5 49.6 
3D7 (95) 95.3 74.6 60.9 95.4 73.8 67.7 90.4 83.4 63.9 89.5 74.7 55 
DD2 (5) 4.7 25.4 39.1 4.6 26.2 32.3 9.6 16.6 36.1 10.5 25.3 45 
3D7 (90) 93.1 71.5 63.4 88.5 55.8 78.1 87.2 80.1 55.2 86 68.6 76.3 
DD2 (10) 6.9 28.5 36.6 11.5 44.2 21.9 12.8 19.9 44.8 14 31.4 23.7 
3D7 (80) 83.1 63.9 51.7 79.8 50.3 64.0 84.2 65.5 61.9 72.1 62.9 61.5 
DD2 (20) 16.9 36.1 48.3 20.2 49.7 36.0 15.8 34.5 38.1 27.9 37.1 38.5 
3D7 (50) 56.5 52.0 44.8 48.9 45.0 42.7 47.7 49.3 55.8 46.9 61.8 53.4 
DD2 (50) 43.5 48.0 55.2 51.1 55.0 57.3 52.3 50.7 44.2 53.1 38.2 46.6 
3D7 (20) 29.6 38.9 36.0 25.2 38.1 28.6 22.3 43.1 30.5 17.9 58.3 29.4 
DD2 (80) 70.4 61.1 64.0 74.8 61.9 71.4 77.7 56.9 69.5 82.1 41.7 70.6 
3D7 (10) 19.5 40.2 37.6 14.7 36.8 20.8 13.8 46.4 48.5 7.8 45.7 48.9 
DD2 (90) 80.5 59.8 62.4 85.3 63.2 79.2 86.2 53.6 51.5 92.2 54.3 51.1 
3D7 (5) 16.2 39.1 39.8 14.2 26.4 37.7 10.7 37.8 43.8 2.2 40.8 37.6 
DD2 (95) 83.8 60.9 60.2 86.8 73.6 62.3 89.3 62.2 56.2 97.8 59.2 62.4 
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Measured Proportions of SNPs at each marker locus 
Calculated 
values for 
each clone pf-01-393153 pf-01-411796 pf-03-138-7 pf-03-350224 
  0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 
3D7 (0) 12.5 19.3 40.5 8.3 29.2 5.6 2.5 21.1 40.3 1.8 26.7 20.5 
DD2 (100) 87.5 80.7 59.5 91.7 70.8 94.4 97.5 78.9 59.7 98.2 73.3 79.5 
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(c) 
  Measured Proportions of SNPs at each marker locus  
Calculated 
values for 
each clone  pf-03-138-7 pf-03-350224 pf-10-658467 
  0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 
3D7 (100) 98.9 90.2 83.4 96.7 93.0 82.2 92.6 90.6 82.3 
7G8 (0) 1.1 9.8 16.6 3.3 7.0 17.8 7.4 9.4 17.7 
3D7 (98) 96.8 92.0 83.6 93.3 89.4 90.2 92 85.5 82.5 
7G8 (2) 3.2 8.0 16.4 6.7 10.6 9.8 8 14.5 17.5 
3D7 (95) 96.9 92.2 90.7 94 76.5 85.6 89.3 82.8 76.9 
7G8 (5) 3.1 7.8 9.3 6 23.5 14.4 10.7 17.2 23.1 
3D7 (90) 93.6 89.7 80.1 93.8 72.3 78.5 91.3 78.4 83.8 
7G8 (10) 6.4 10.3 19.9 6.2 27.7 21.5 8.7 21.6 16.2 
3D7 (80) 91.4 72.2 65.5 88.5 68.6 68.8 89.1 77.8 77.4 
7G8 (20) 8.6 27.8 34.5 11.5 31.4 31.2 10.9 22.2 22.6 
3D7 (50) 70.3 65.5 49.3 69.9 65.3 69 60.3 68.1 70.6 
7G8 (50) 29.7 34.5 50.7 30.1 34.7 31 39.7 31.9 29.4 
3D7 (20) 46.6 51.9 36.4 40.5 58.6 44.4 49.3 42.5 32.7 
7G8 (80) 53.4 48.1 63.6 59.5 41.4 55.6 50.7 57.5 67.3 
3D7 (10) 44.1 31.9 20.1 36.4 55.7 46 19.9 33.1 42.4 
7G8 (90) 55.9 68.1 79.9 63.6 44.3 54 80.1 66.9 57.6 
3D7 (5) 23.2 46.0 19.8 22.4 48.1 22.4 9.8 17.7 17.7 
7G8 (95) 76.8 54.0 80.2 77.6 51.9 77.6 90.2 82.3 82.3 
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Measured Proportions of SNPs at each marker locus 
Calculated 
values for 
each clone  pf-03-138-7 pf-03-350224 pf-10-658467 
  0.10 0.010 0.001 0.10 0.010 0.001 0.10 0.010 0.001 
3D7 (0) 18.4 18.8 48.5 8.7 32.3 20.4 0.4 7.0 25.7 
7G8 (100) 81.6 81.2 51.5 91.3 67.7 79.6 99.6 93.0 74.3 
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The results in Table 4.3 a, b & c indicate that it is possible in most cases to identify 
the major clone within the limits previously described in Section 4.2.  This was 
demonstrated clearly at 0.1% parasitaemias, however, at 0.01% and 0.001% 
parasitaemias, only the major clone could be identified in most cases (see Table 4.3b 
& Table 4.3c).  Thus parasite genotypes can more often than not be clearly deduced 
from the major clone 
As already observed in Table 4.1 a, b & c, Pyrosequencing™ has limits in detecting 
clones occurring at low proportions (minor clones) accurately. The ability of the 
technique to accurately assign proportions to the minor clones was further 
compromised by reduced parasitaemias. The results in Table 4.3 a, b & c show that 
the minor clones could be identified in most cases within the limits of detection 
previously described at parasitaemias of 0.1% but at 0.01% and 0.001% parasitaemia 
tested in this stud but, it was almost impossible to identify the minor clone.  From 
this results it can be concluded that Pyrosequencing™, is in most cases able to 
accurately assign proportions to samples having parasitaemias of approximately 
0.1% or higher and, parasite genotypes present in these mixtures can be obtained, but 
within the limits of detection already described in Section 4.2. 
 
4.5. Identification of the parasite genotypes derived from the 
semi-cloned 3D7 and HB3 cross progeny 
The 3D7 and HB3 cross progeny, semi-cloned as described in Chapter 2, were 
analysed by Pyrosequencing
TM
 using the marker assays identified in Chapter 3 and 
known to distinguish the genetically distinct clones 3D7 and HB3.  The results are 
shown below in Figure 4.3. 
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The results in Figure 4.3 comprise 10 marker assays that have already been 
identified in Table 3.2, Chapter 3 to contain SNPs that distinguish the genetically 
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Figure 4.3  Schematic representation of the 8 samples of the 3D7 and HB3 semi-cloned cross progeny analysed by PyrosequencingTM. The coloured bars represent chromosomes I, 
III, X and XIV with their sizes given in kilo base pairs (Kbp) on the far right.  The stars with the numbers 1, 2…etc. above them represent the SNPs (marker loci) on the approximate 
region they occupy in the chromosomes.  These are given as follows: 
 Chromosome     I –   1. Pf-01-101502, 2. Pf-01-205304 
 Chromosome    III –  1. Pf-03-305204, 2. Pf-03-613146, 3. Pf-03-842383, 4. Pf-03-967838 
 Chromosome     X –  1. Pf-10-658467, 2. Pf-10-992433 
 Chromosome XIV-    1. Pf-14-279668, 2. Pf-14-1710196 
The tables on the right show the samples analysed (Samples 1-8), the marker loci in each chromosome, the quantitation values assigned by PyrosequencingTM at each SNP (marker 
locus) and the resulting genotypes.  The 3D7 parental clone genotypes are given in red and the HB3 parental clone genotypes are given in black.  The resulting genotypes are visually 
represented in the figures.  The locus defined by the parental clone 3D7 is represented by a red star and the locus defined by the parental clone HB3 by a black star.  
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Following analysis by Pyrosequencing
TM
, the SNPs identified at each marker locus 
for 3D7 (red) and HB3 (black) and their proportions are given in the tables within 
Figure 4.3.  The parasite genotypes of each sample analysed are also shown in the 
tables and in cases where two clones are represented each is defined as the clone 
occurring at a high proportion (the major clone or clone 1) and the one occurring at a 
lower proportion (minor clone or clone 2). The marker loci are mapped at the 
approximate positions they occupy in the chromosomes as shown in the figures on 
the left of Figure 4.3.  The SNP identified by Pyrosequencing
TM
 representing either 
of the two clones (3D7 or HB3) at each marker locus in the figures is represented by 
3D7 (red star) or HB3 (black star). 
The results in Figure 4.3 show that following semi-cloning (described in Figure 2.1), 
either one or two genetically distinct clones were recovered from the 8 wells 
(Samples 1-8).  Samples 1, 2, 4, 5 and 8 each contained one parasite genotype and 
samples 3, 6 and 7 contained two parasite genotypes.  The criterion for identifying 
the genotypes is as described in Chapter 4.  For the samples having one parasite 
genotype identified, the low proportions (indictive of a minor clone) assigned by 
Pyrosequencing
TM
 machine were ignored as they did not conform to the limits set in 
the identification of minor clones (Section 4.2.1).  This is based on the premise that, 
parasite genotypes are derived from the estimated SNP proportions and that, in a two 
genotype infection, SNPs occurring at a higher proportion constitute one parasite 
genotype, while those occurring at a lower proportion constitute the other. This was 
demonstrated in samples 3, 6 and 7 which revealed major clones represented at 
70% and minor clones at 30%.  Interestingly, Samples 4 & 5 and Samples 1 & 7 
(Clone 1) consisted of indistinguishable genotypes according to the markers used. 
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It is also noteworthy that all of the genotypes identified from the cross progeny 
(Figure 4.3) were recombinants except Sample 6 that had one parental genotype 
(3D7) as a minor clone.  These results are analogous to what was observed by 
Walliker et al., 1987 where, a high proportion of recombinants was also observed in 
the original analysis of this cross progeny. 
 
4.6. Estimating the genetic relatedness of the 3D7 and HB3 
cross progeny 
From the formula in Section 4.1.3, a GR value of 1 represents “total genetic 
relatedness”, while 0 represents “no genetic relatedness”.  It is noteworthy that most 
of the population genetic software use the parameter GD and not GR for analyses.  
Either GD or GR can be used to define levels of genetic diversity in P. falciparum.  
The results of the typical genetic relatedness matrix (or genetic distance obtained by 
subtracting the values in the given matrix with 1) obtained from pairwise 
comparisons of genotypes in the estimation of genetic diversity for subsequent 
population genetics analyses are summarised in Table 4.3. 
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Table 4.3  A matrix containing a summary of pair-wise allele comparisons across all 
loci analysed for the 3D7 and HB3 cross progeny.  All the parental clones and the 
cross progeny are given below.  Where there is either (a) or (b) signifies the major 
and minor clones for example 3a and 3b.  The average GRs between the parental and 
cross progeny genotypes and, among the cross progeny genotypes are also given. 
 
Samples 3D7 HB3 1 2 3a 3b 4 5 6a 6b 7a 7b 8 
1 0.2 0.8            
2 0.6 0.4 0.6           
3a 0.5 0.5 0.7 0.7          
3b 0.3 0.7 0.5 0.7 0.6         
4 0.3 0.7 0.5 0.3 0.6 0.6        
5 0.3 0.7 0.5 0.3 0.6 0.6 1       
6a 0.5 0.5 0.3 0.7 0.6 0.6 0.8 0.8      
6b 1 0 0.2 0.6 0.5 0.3 0.3 0.3 0.5     
7a 0.2 0.8 1 0.6 0.7 0.5 0.5 0.5 0.3 0.2    
7b 0.3 0.7 0.9 0.7 0.6 0.6 0.4 0.4 0.2 0.3 0.9   
8 0.2 0.8 0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.3 0.5 0.4  
Average GR 0.4 0.6  0.53 
 
Assuming random fertilization of gametes and no bias in survival, the resulting first 
generation progeny would be expected to comprise 50% of parental types and 50% 
of recombinants. The expected average GR would therefore be 0.5.  The results in 
Table 4.3 show that the average GR between the cross progeny genotypes and each 
of the parental genotypes was found to be 0.4 and 0.6 for 3D7 and HB3 respectively 
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and, the average GR among the cross progeny was 0.53.  These observed GR values 
are close to the expected GR of 0.5 in conformity to the null hypothesis.   
 
4.7. Discussion 
The aim of this chapter was to test the reliability of Pyrosequencing™ in accurately 
detecting and quantifying SNPs representing genetically distinct clones from 
laboratory prepared parasite mixtures and subsequently identifying the parasite 
genotypes represented therein.   It has been shown that the technique is indeed able 
to accurately assign proportions to the SNPs and parasite genotypes could be 
identified from the parasite mixtures on the premise that SNPs occurring at similar 
proportions belong to the same genotype.   
In Table 4.1 results, the median values were used as opposed to the mean of the 
overall measurements, to accommodate the outlier values observed in the triplicate 
measurements. The lack of replicability in the observed proportions was due to 
pipetting errors when preparing the Pyrosequencing
TM
 assays.  This method is prone 
to pipetting errors as with most DNA analysis methods so care should be taken when 
carrying out the analysis.   
It is also noteworthy that inconsistencies were observed in the values assigned by the 
Pyrosequencing
TM
 vis-à-vis the calculated proportions of the laboratory prepared 
clone mixtures (Figure 4.1 a, b & c).  It is plausible that the discrepancy arose in the 
preparation of the tested parasite clones.  To ascertain this, it is recommended that 
fresh parasite clone mixtures with the same proportions should be prepared and the 
experiment repeated.  
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The experiments in this Chapter were conducted to validate Pyrosequencing™ for 
use in analysis of P. falciparum field isolates which have unknown parasite 
genotypes and at varying proportions. The technique has been shown to have a limit 
of detection for clones occurring in low proportions (minor clones) but in most cases 
it should be possible to identify at least one parasite genotype (derived from the 
major clone) in mixed clone infections.  These results are in concordance with 
another study investigating the different types of Toxoplasma gondii wild isolates by 
Pyrosequencing
TM
.  The analysis revealed that at least two genotypes could be 
identified and discriminated in a mixed genotype infection but the technique was 
limited in identifying more than two genotypes (Sreekumar et al., 2005; Edvinsson et 
al., 2007). 
This is a major setback in using this technique especially when analysing African P. 
falciparum isolates where as many as 8 clones have been found in individual 
infections (Table 1.1, Chapter 1).  This is however an overall problem when using 
molecular genotyping technology in the detection of clonal genotypes occurring in 
wild isolates.  To circumvent it, Nkhoma et al., (2012) for example cultured parasites 
from field collections and cloned them by limiting dilution.  This has two main 
purposes; first of all it is a DNA enrichment process for sequencing purposes.  
Secondly it increases the chances of clone detection by ensuring that only one 
parasite per well is recovered for genotyping.  It is highly effective and in this study a 
maximum of 6 genetically distinct clones per infection were detected in Malawi but 
using the Illumina genotyping platform.   
The detection of the major clone in most cases might be due to the PCR technique 
selectively amplifying the most abundant clones leading to the minority clones being 
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missed out.  This is a common problem in PCR based genotyping technologies.  
However, the parasite biology of P. falciparum further exacerbates the situation as in 
most cases the major clones are fast growers and out-compete the minor clones 
rendering them undetectable.  This has been observed in the rodent malaria parasite 
P. chabaudi adami where the DS strain is fast growing while the DK strain is slow 
growing (Gadsby & Carter, 2008).  
This Chapter also outlined that Pyrosequencing™ not only has  limited accuracy 
when assigning proportions in clones occurring at low proportions but also when 
dealing with isolates present at parasitaemias less than 0.01%. P. falciparum field 
isolates usually occur at parasitaemias greater than 0.1% in most of the malaria 
positive symptomatic cases. It is also possible to encounter malaria positive 
asymptomatic cases at less than 0.01% parasitaemias.  Thus, when analysing P. 
falciparum field isolates by Pyrosequencing™, the technique’s limit of detection is 
parasitaemias >0.1% as it is possible in most cases to identify parasite genotypes 
from samples occurring at these parasitaemias.  This is a major setback as it means 
that when dealing with asymptomatic cases, many parasite clones might remain 
undetected. 
Attempts to genotype P. falciparum wild isolates can be further hampered by the 
existence of these parasites at low parasitaemia levels in peripheral blood.  This is 
because they sequester reducing them to undetectable levels.  Sequestration has been 
observed to occur during the 48hours cyclic asexual cycle in the peripheral blood and 
lasts for approximately 24 – 28 hours (Koepfli et al., 2011). To enhance the 
probability of developing accurate genotypic profiles in multiclonal infections, 
repeated sampling every 24 hours coinciding with emergence of sequestered 
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parasites to the blood has been recommended (Koepfli et al., 2011).  This sampling 
strategy is however impractical when working with human subjects. 
In this chapter, a genetic cross between the known genetically characterised clones 
3D7 and HB3 was analysed.  The results showed that both parental genotypes were 
represented in the cross progeny and interestingly one parental genotype was also 
identified in the cross progeny (Figure 4.3).  The level of genetic relatedness 
between the parental genotypes and the cross progeny genotypes as well as among 
the cross progeny genotypes was investigated and was found to be close to 0.5 as 
expected (Table 4.3).  
The strategy outlined in this section, whereby the genetic diversity of the malaria 
parasites is summarised in a genetic distance, will be utilised in later chapters of this 
thesis for the subsequent analysis using genetic distance based analysis.   
 
4.7.1. Conclusion 
In this chapter the identified SNPs in Chapter 3 have been used in the identification 
and quantification of parasite clones represented in laboratory prepared mixtures of 
parasite clones at known proportions.  In addition, the SNPs have also been tested 
using progeny from a cross between the genetically distinct clones 3D7 & HB3 with 
each of the clones present at unknown proportions.  These tests have been performed 
to validate use of these SNPs in analysis of P. falciparum field isolates.  They have 
facilitated the understanding of the technique’s limits of detection which will be 










The existence of P. falciparum as complex mixtures of genetically distinct clones 
requires the use of genetic markers to identify and distinguish the clones present 
within human host infections.  The choice of genetic markers to use depends on the 
study of interest.  For example, to generate P. falciparum drug resistance profiles, 
polymorphic genetic markers under selection pressure imposed by drugs located at 
genes of interest are used (reviewed by Wongsrichanalai et al., 2002).  On the other 
hand, in studies of population genetic structure, neutral genetic markers are 
recommended to ensure that the observed population structure is due to gene flow 
patterns and not by natural selection or immune processes (Anderson et al., 1999; 
Arez & Rosário, 2008). 
This study entailed an attempt to determine population divergence and gene flow 
patterns of malaria parasites within small geographic settings, the genetic markers of 
choice were therefore SNPs and, microsatellites were included in the analysis as 
additional markers for the identification of mixed clone infections.   
 
5.1.1. SNPs 
The use of SNPs as genetic markers has garnered tremendous interest (Morin et al., 




http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml).  The success 
of this project in identification of geographically distinct human populations using 
SNPs has paved the way for advances in sequencing technology (França, et al., 2002; 
Metzker, 2005; Metzker, 2010; Zhou et al., 2010; Shen et al., 2010).  The existence 
of these technologies has led to the extensive use of SNPs across different species 
(Kumar et al., 2012). 
SNPs are numerous across genomes e.g. genome-wide comparisons of cattle (The 
bovine hapmap consortium, 2009) or in chicken (Groenen et al., 2011) breeds 
rendering them highly informative.  In addition, genome wide SNP analysis enables 
the detection of low genetic diversity occurring within and between organisms. For 
example, in P. falciparum studies, SNPs are of significant use in identifying 
genetically distinct clones present in mixed infections (Anderson et al., 1999; 
Campino et al., 2011; Juliano et al., 2010).  In high malaria transmission areas where 
extensive genetic recombination takes place, parasites are highly diverse and a 
handful of genetic markers are sufficient to decipher the genetically distinct clones.  
However, in regions of low malaria transmission where parasite infections are 
sporadic and widespread such that parasites are almost genetically identical 
discrimination among clonal genotypes is difficult (Bendixen et al., 2001) without 
numerous genetic markers.  
 
5.1.2. Microsatellites 
Microsatellites comprise highly variable repetitive motifs occurring predominantly in 




noncoding regions (Wilder & Hollocher, 2001).  Microsatellites initially gained 
interest due to their role in the occurrence of some human neurological disorders 
such as fragile X syndrome (reviewed by O’Donnell & Warren, 2002).  This paved 
way for their use in the generation of genetic maps in other organisms such as in 
Zebra fish (Knapik et al., 1998), Soybeans (Cregan et al., 1999) and even in P. 
falciparum (Su & Wellems, 1996).  They have also been used in genetic parentage 
analysis and population genetic studies (Oliveira et al., 2006).   
In population genetic studies, microsatellites are favoured as they are abundant 
across the genome enabling the analysis of multiple loci (Li et al., 2002).  This is 
essential especially in the detection of population structure as different loci exhibit 
different levels of genetic diversity.  Different loci experience random fluctuations in 
allele frequencies as a result of genetic drift and variation in coalescent history, 
necessitating the need for multilocus analysis in the determination of population 
structure between and among subpopulations (Nei, 1973).  Microsatellites are also 
highly polymorphic due to their high rate of mutation (Jarne & Lagoda, 1996; 
Ellegren, 2004).  In addition they have been observed to be selectively neutral 
(Goldstein & Schlötterer, 1999; Schlötterer, 2000) which is important when studying 
demographic patterns in populations as selection may confound the interpretation of 
gene flow patterns between them. 
12 microsatellites assumed to be neutral were identified and validated for use in the 
study of P. falciparum populations (Anderson et al., 1999). In addition, numerous 
microsatellites have been identified across the P. falciparum genome (Mu et al., 




In this study a total of 8 microsatellites obtained from different chromosomes across 
the P. falciparum genome were analysed. 5 were adapted from Anderson et al., 
(1999) namely:  Poly , TA81, TA40, PFPK2, TA60 and, 3 from (Tsumori et al., 
2011) i.e. TA17, TA53, TA43.  These were used as additional genetic markers to the 
available SNPs described in previous chapters.  The laboratory analysis was carried 
out by collaborators at Nagasaki University, Japan.   
 
5.1.3. Synopsis of chapter 
In this chapter, I determine the informativeness of SNPs and microsatellites in terms 
of levels of between-clone genetic diversity detected and quantify the genetic 
variation observed within malaria parasite populations for both genetic markers. For 
microsatellites, I test the assumption of selective neutrality to identify whether the 
observed divergence is due to neutral mutations or selection.  This is important the 
observed alleles may have evolved under different forces, ranging from natural 
selection to genetic drift.  Since the purpose of this study is to determine how closely 
related are parasites transmitted within small spatial settings, the expected variation 
or lack thereof is highly dependent on gene flow patterns.  Any influence of 
evolutionary forces such as natural selection and gene flow should be deduced prior 
to interpreting observed patterns of genetic diversity (Jensen et al., 2005; Ramírez-
Soriano et al., 2008).   
The variation within and between populations (at a country or village level) will be 
determined.  This is a measure of the level of population structure observed and 




malaria parasites will be partitioned geographically with distances generated 
randomly.  Comparison of these randomly generated subpopulations giving non-
significant FST values will imply that there is extensive gene flow between individual 
malaria parasites.  Geographic partitions with significant FST values will be 
indicative of genetic differentiation between the subpopulations. 
 
5.1.4. Aims of this chapter 
1.  To determine if the genetic markers used are under any form of selection.  
This is performed in the form of a neutrality test or by detection of linkage 
disequilibrium (LD) (statistical association of alleles).  Loci that are found to 
be in LD comprise of allelic combinations that occur at frequencies greater 
than expected under random mating.   
2. To determine the degree of genetic markers informativeness following 
analysis of the field isolates.  This will be done by computation of allele 
frequencies and gene diversity (heterozygosity). 
3. Test for significant levels of population genetic structure in parasites to reveal 
how closely related genetically are the malaria parasites within small 
geographic settings (geographic distances of <1km).  
 
5.1.5. Null Hypotheses 
1. Parasite populations conform to random mating patterns and are not under 




2. The genetic markers are in linkage equilibrium i.e. constituting alleles that are 
assorted independently and are therefore not statistically associated. 
3. The parasite populations are isolated with no migration between them, are not 
partitioned into small subpopulations or genetically structured in space. 
5.2. Materials and methods 
5.2.1.1. Identification of clonal genotypes  
The SNPs validated in Chapter 4 were used to analyse field isolates.  Only two 
clones could be clearly identified in isolates having more than one clone.  This is 
because the proportions assigned by the Pyrosequencer were too close in value to 
enable the discrimination of 3 or more clones.  Further to this, although in Chapter 4 
clones could be identified from laboratory prepared clone mixtures when the major 
clones proportions were >60% and the minor clones <40%, when dealing with field 
isolates, the major clone was confirmed only if it occurred at proportions >70% and a 
minor clone at proportions <30% per isolate.  This is because the cut-off point in 
Chapter 4 was observed under controlled experimental conditions where only two 
clones were present per sample analysed whereas in field isolates it is possible to 
encounter more than two clones.  Because of this high stringency in the identification 
of parasite clones, more sample losses were experienced.  In some other cases, two 
clones observed to occur at proportions close to 50% were also discarded as it was 
difficult to assemble individual clonal genotypes.   
Both SNPs and microsatellites were used to identify clonal genotypes.  SNPs and 




under different mutation models.  SNPs are analysed using the infinite alleles model 
(IAM) (Kimura & Crow, 1964), which makes the assumption that each allele 
generated in a population by mutation arises independently of a previous one that 
may have occurred at the same site.  Microsatellites on the other hand, are analysed 
using the stepwise mutation model (SMM).  Since microsatellites constitute alleles of 
different sizes due to their tandem repetitive nature, the SMM assumes that each 
allele generated by mutation is dependent on the state of the previous allele (Kimura 
& Ohta, 1978). It follows that alleles showing the least difference in size have close 
genetic relatedness while those that are highly variable between clones are more 
distantly related.   
However, in this study, the mutation rate can be ignored as it involves the 
determination of parasite genetic relatedness within short time spans such that 
genetic divergence due to mutations between parasite generations is negligible.  
Nonetheless, Balloux & Lugon-Moulin, (2002) in their review article suggest that 
microsatellites have a high mutation rate and the underlying mutation mechanism 
should not be ignored especially in the determination of genetic differentiation of 
populations. 
5.2.1.2. Test of informativeness 
Using the software FSTAT vs 2.9.3 (Goudet, 2001), the SNPs and microsatellites 
were tested for their level of informativeness by scoring allele frequencies per locus.  
The number of alleles and the allelic richness were also reported.  Allelic richness is 
a measure of genetic diversity, constitutes the mean number of alleles per sample and 




than small samples.  To circumvent the problem of unequal sampling, a rarefaction 
method is used to allow the comparison of genetic diversity across different samples 
sizes.  Rarefaction involves randomly resampling alleles from the whole data set and 
deriving the expected number of alleles from a given small sample set (in this case 
fixed for the country with the smallest number of genotypes) (see review by Leberg, 
2002).  In FSTAT, from a diploid set (P. falciparum is haploid, diploid genotypes 
were obtained by coding the same allele twice) the sample size is fixed for the 
population with the smallest number of individuals typed (in this case Cameroon 
with 12 genotypes).   
 
5.2.1.3. Genetic diversity 
The overall genetic diversity (heterozygosity) in each of the geographic locations 
was computed.  FSTAT calculates gene diversity or the expected heterozygosity 
(Hexp) (under HW random mating expectations as the null hypothesis, H0).  See 
formula in Appendix G. 
F statistics were developed to determine reductions of heterozygosity within 
subpopulations due to non-random mating and among subpopulations due to 
structuring.  In haploid populations, FST is the mean reduction of expected 
heterozygosity among subpopulations relative to the total expected heterozygosity of 
the population due to structuring [Hexp (t) – Hexp (s) / Hexp (t)].   
Given that different loci are under different forces (e.g. natural selection or genetic 




statistics values as this reduces the bias occurring on individual loci due to other 
forces acting on them.  Thus, the value Hsk or Hexp (see Appendix G) is an unbiased 
estimate across different loci and across different individuals and is then used in the 
determination of F statistics values. 
FSTAT computes an estimate of FST based on multilocus averages of the expected 
heterozygosities known as GST or Nei’s F statistics (Nei, 1973).  The formulae for 
this statistic are given in Appendix G. 
FSTAT also computes Weir and Cockerham (1984) F statistics also known as 
Unlike the Nei’s estimate which weights all samples equally irrespective of the 
sample size differences,   weights allele frequencies according to the sizes of the 
analysed samples. In addition, the test provides standard error estimates and 
confidence intervals by the randomisation and resampling method.  This test is 
therefore considered to be more robust than Nei’s estimate. 
FSTAT tests for significance of FST values by the randomisation of genotypes 
between pairs of samples.  1000 permutations were performed and the log likelihood 
G-statistic (Goudet, et al., 1996; Petit et al., 2001) used as an overall test statistic to 
validate the P values.  The tests performed in FSTAT are usually designed for one 
locus therefore the G-statistic is used to obtain a P value based on the overall 
estimate of the combined loci in the data set.  The G-statistic performs a 
randomisation test on the genotypes among subpopulations and not alleles.  This 
statistic is considered powerful as there is a possibility that individual alleles are 
correlated within individuals hence the use of genotypes for randomisation (Goudet 




Since microsatellites are believed to undergo a step-wise mutation model (Slatkin, 
1995), the genetic differentiation parameter under this model RST, was estimated.  
This parameter takes into consideration the variation of microsatellites’ allele sizes.  
FSTAT estimates RST for each locus following Rousset (1996).  This estimator does 
not depend on the number of samples.  It also outputs the different components of 
variance of allele size:  Va for among samples, Vb for among individuals within 
samples and Vw for within individuals. Vt = Va + Vb + Vw is thus an unbiased 
estimate of the total overall variance in allele size.  The RST estimates recommended 
by Goodman (1997) whereby the variance of allele sizes is standardised by using the 
centred normalised allele size are reported here. 
5.2.1.4. Linkage disequilibrium 
Microsatellites only were analysed for linkage disequilibrium.  Linkage 
disequilibrium is the non-random association of alleles across loci and can occur as a 
result of a range of processes including population sub-structure and selection.  To 
test for LD, the clonal genotypes that were identical at all loci were first omitted 
from the data set and then included in a second analysis and the results compared.  
The software LIAN vs 3.5 (Haubold & Hudson, 2000) available as a web interface, 
was used for the LD analysis.  LIAN detects this by first determining the number of 
loci at which the genotypes or haplotypes are different generating a variance value 
(VD). This is then compared with the expected variance value (Ve) when loci 
conform to linkage equilibrium (occurs when alleles assort independently) (Haubold 




significance, resampling of the alleles without replacement is performed by Monte 
Carlo simulation.   
The microsatellites used in this study have been ascertained and validated for use in 
previous studies (Anderson et al., 1999; Anderson et al., 2000; Greenhouse, et al., 
2006; Tsumori et al., 2011).  The test of linkage disequilibrium was still performed 
in this study to determine whether the alleles are independently assorted or not.  Only 
the genotypes obtained from the major clones were used.  This is because including 
the minor clones would skew the data toward a high observed LD as a result of high 
genetic relatedness between the clonal genotypes.  For this test, clonal genotypes 
obtained from Cameroon were not included as they comprised few samples. 
 
5.3. Results 
5.3.1. Identification of genotypes 
A total of 13 SNPs were used and a mixed clone infection confirmed using the 
criteria described in Chapter 4 and in Section 5.2.1.1 to detect the clones 
represented at different proportions in a multiclonal infection.   
All isolates were also analysed using microsatellites (Culleton R, Nagasaki 
University) which allowed the identification of additional mixed clone infections that 
were not otherwise detected by the SNPs.  Of the 54 analysed isolates, 6 were 
identified as polyclonal by microsatellites only, 7 by Pyrosequencing
TM
 only, while 
17 isolates were identified as polyclonal by both, the remaining 24 isolates were 




identification of major and minor clones, 84 clonal genotypes were recovered and 
subsequently analysed using the methods already described in Chapter 4 (Table 5.1). 
Table 5.1  Summary of the clonal genotypes that could be identified from the 54 
isolates by Pyrosequencing
TM
 and microsatellites shown for either single clones or 
mixed clones 
 
SNPs and Microsatellites loci having missing data were removed as FSTAT would 
not compute the required statistics.  Therefore of the complete set of 8 microsatellite 
loci, the results discussed in this chapter comprise data obtained from 5 microsatellite 
loci.  In Cameroon, the loci TA40 and TA43 did not amplify by PCR and had 
missing data.  In Kenya, the loci TA40 and TA60 did not also amplify by PCR and 
had missing data.  Since these loci amplified successfully in Mali, this could have 
been due to these assays being sensitive to low DNA quality or yield obtained from 
the Cameroon and Kenya isolates.    
12 SNPs were used in the analysis as the assay at the Pf-01-393153 locus failed to 
amplify the Kenyan isolates.  This is perhaps due to the degradation of primers.  Re-
amplification of this locus was however not done due to time constraints.    
 Single Clone infections Double Clone infections  
Country Isolates No. of  Clone 
genotypes  





Cameroon 2 2 5 10 12 
Mali 19 19 15 30 49 
Kenya 3 3 10 20 23 





5.3.2. Genetic diversity estimated by allelic diversity  
The allele frequencies were calculated per locus, per allele and per population (in this 
case, Cameroon, Mali and Kenya) by estimating the number of individuals analysed 
and determining the overall allele frequencies.   Both the weighted by sample size 
and unweighted allele frequency values were computed.  The weighting by sample 
sizes is performed to eliminate bias introduced due to different sample sizes of the 
populations being studied.  This is because allele frequency differences can be as a 
result of the sampled population not being an adequate representation of the overall 
population.  The results indicated that there was considerable observed 






 Table 5.2  (a) Summary of total number of alleles sampled and (b) the estimated 







Locus Cameroon Mali Kenya Total  Locus Cameroon Mali Kenya Total  
Pf-01-101502 2 2 1 3 Poly- 6 12 9 15 
Pf-01-205304 3 4 3 4 TA81 6 7 6 8 
Pf-01-411796 1 2 1 2 TA17 8 10 6 16 
Pf-03-138-7 2 2 3 3 TA53 3 5 3 6 
Pf-03-350224 3 4 3 4 PFPK2 6 9 5 10 
Pf-03-613146 1 1 3 3 
 
 
   
 
Pf-03-842383 1 1 1 1 
 
   
 
Pf-03-967838 1 1 1 1 
 
   
 
Pf-10-658467 1 2 3 3 
 
   
 
Pf-10-992433 2 3 2 3 
 
   
 
Pf-14-279668 2 3 3 3 
 
   
 
Pf-14-1710196 3 2 2 3 
 







The number of alleles per country and per locus was counted as shown in Table 5.2a.  
The SNPs data revealed a balanced representation of alleles across the 3 countries.  
However, the microsatellites data showed that Mali had the highest number of alleles 
compared to Kenya and Cameroon.  Further, the mean number of alleles per locus or 
the allelic diversity also known as allelic richness was also calculated (See Table 
5.2b).  
Information from the SNPs in Table 5.2b reveals that loci Pf-01-411796, Pf-03-
842383 & Pf-03-967838 were the least informative as they had an average allelic 
richness of ~1.  These SNPs are therefore not polymorphic rendering them 
inappropriate in the delineation of P. falciparum clones occurring in mixed infections 





Locus Cameroon Mali Kenya Total  Locus Cameroon Mali Kenya Total  
Pf-01-101502 2.000 1.915 1.000 1.998 Poly- 6.000 10.118 8.355 10.651 
Pf-01-205304 3.000 3.534 3.000 3.439 TA81 6.000 6.188 5.856 6.897 
Pf-01-411796 1.000 1.432 1.000 1.266 TA17 8.000 7.53 5.687 9.049 
Pf-03-138-7 2.000 2.000 2.999 2.717 TA53 3.000 3.983 2.964 4.481 
Pf-03-350224 3.000 3.418 2.992 3.24 PFPK2 6.000 7.619 4.769 7.775 
Pf-03-613146 1.000 1.000 2.992 2.405 
 
 
   
 
Pf-03-842383 1.000 1.000 1.000 1.000 
 
   
 
Pf-03-967838 1.000 1.000 1.000 1.000 
 
   
 
Pf-10-658467 1.000 1.904 2.91 2.317 
 
   
 
Pf-10-992433 2.000 2.447 2.000 2.272 
 
   
 
Pf-14-279668 2.000 2.797 2.999 2.937 
 
   
 
Pf-14-1710196 3.000 2.000 2.000 2.609 
 





The microsatellites in Tables 5.2a & b indicate that Mali had the highest level of 
genetic diversity as explained by its number of alleles and estimated levels of allelic 
richness in comparison to both Cameroon (fixed sample size) and Kenya.  This is 
demonstrated in the loci Poly-, Ta53 and PFPK2 whereas in Kenya only the Poly- 
locus had a higher allelic diversity estimate compared to the other geographic regions. 
 
5.3.3.  Unbiased estimates of overall genetic diversity  
Having shown the degree of informativeness for both SNPs and microsatellites, the 
level of genetic diversity per locus and per geographic location was estimated.  Gene 
diversity, also known as heterozygosity (H), is the probability that two alleles 
sampled from a population (to make a diploid genotype) are not identical.  Thus gene 
diversity values of 0 mean that alleles are identical (no polymorphism) whereas a 
gene diversity value of 1 means that all alleles within a sampled population are not 
identical (highly polymorphic).   
Genetic diversity values obtained from SNPs (Table 5.3) are low overall with Kenya 
having the highest estimate.  Loci Pf-01-411796, Pf-03-842383 & Pf-03-967838 had 
insignificant levels of genetic diversity observed in them concordant with their low 
levels of allelic richness as in Table 5.2b.   
Conversely, the results in Table 5.3 indicate extensive genetic heterogeneity across 
the microsatellites loci analysed among the countries and overall.  Only the locus 
TA53 had lower levels of gene diversity overall, as is clearly distinct in Table 5.3 




less informative compared to the other loci. Cameroon had the highest overall 
expected heterozygosity values indicative of high levels of polymorphism followed 
by Mali and then Kenya (Table 5.3). 
The genetic differentiation estimate obtained by averaging multiple loci, GST´ was 
estimated and is also given in Table 5.3. The GST´ estimates obtained per locus in 
Table 5.3 demonstrate the need to carry out a multilocus average estimation of 
genetic differentiation as different loci exhibit different values.  The SNPs locus Pf-
03-613146 had the highest GST´ (0.0228) value relative to the other loci.  Pf-14-
279668 and Pf-14-1710196 also had relatively high GST´ values i.e. 0.117 & 0.1 
respectively.  In this analysis, the microsatellites locus TA81 had the highest GST´ 
value whereas Poly- had the lowest.   
Wright, 1978 (cited in http://www.library.auckland.ac.nz/subject-
guides/bio/pdfs/733Pop-g-stats2.pdf) suggests the following qualitative guidelines 
for the interpretation of overall FST or GST´ in this case (estimated from allozyme 
data) 
- 0.0 to 0.05 may be considered as indicating little genetic differentiation  
- 0.05 to 0.15 indicates moderate genetic differentiation  
- 0.15 to 0.25 indicates great genetic differentiation  
-above 0.25 indicate very great genetic differentiation 
Given the guideline above, very little genetic differentiation was observed between 





Table 5.3  Gene diversity (unbiased estimates) or expected heterozygosity (Hexp) per locus, per subpopulation (in this case the countries: Cameroon, 
Mali and Kenya) and overall for both the SNPs and microsatellites data.  The summary of Nei’s estimation of heterozygosity as expected heterozygosity 












 Genetic Diversity     Genetic Diversity    
Locus Cameroon Mali Kenya Hexp (s) Hexp (t´) GST´ Locus Cameroon Mali Kenya Hexp (s) Hexp (t´) GST´ 
Pf-01-101502 0.167 0.159 0 0.108 0.11 0.016 Poly- 0.848 0.921 0.887 0.886 0.908 0.024 
Pf-01-205304 0.667 0.388 0.664 0.57 0.592 0.037 TA81 0.879 0.791 0.775 0.814 0.871 0.066 
Pf-01-411796 0 0.041 0 0.014 0.014 0 TA17 0.939 0.833 0.802 0.857 0.903 0.051 
Pf-03-138-7 0.303 0.463 0.648 0.474 0.503 0.058 TA53 0.545 0.481 0.567 0.53 0.554 0.043 
Pf-03-350224 0.53 0.64 0.632 0.602 0.608 0.01 PFPK2 0.894 0.856 0.779 0.842 0.87 0.032 
Pf-03-613146 0 0 0.534 0.179 0.232 0.228 
 
 
   
   
Pf-03-842383 0 0 0 0 0 0 
 
   
   
Pf-03-967838 0 0 0 0 0 0 
 
   
   
Pf-10-658467 0 0.153 0.316 0.159 0.163 0.029 
 
   
   
Pf-10-992433 0.409 0.509 0.522 0.481 0.484 0.006 
 
   
   
Pf-14-279668 0.167 0.321 0.632 0.376 0.426 0.117 
 
   
   
Pf-14-1710196 0.621 0.493 0.514 0.541 0.601 0.1 
 
   
   




Following calculations by FSTAT using microsatellites data only, the RST value 
obtained was 0.0318. This RST value consistent with the step-wise mutation model 
(SMM) is less than, but not significantly different from the estimated FST value 
(GST´or  value) obtained using the Infinite alleles model (IAM) in Table 5.3.  
(Conway et al., 2001) also observed non-significant differences between FST and RST 
values in a study conducted in isolates obtained within Africa although significant 
differences were observed between intercontinental estimates.  In addition, FST 
estimates obtained from SNPs only (using IAM) had a value of 0.061 (Table 5.3) 
which is also not different from that observed with the microsatellites data.  This 
indicates that the SMM model can be ignored especially when studying short-term 
parasite generations where mutations have little influence on their genetic diversity. 
 
5.3.4. Population structure 
To test for population structure between the countries, the clonal genotypes were 
uploaded to the software FSTAT in separate files i.e. either for SNPs or 
microsatellites.  The results of the statistics are summarised in Table 5.4.  
Microsatellites analyses had statistically significant levels of genetic differentiation 
between Cameroon & Mali, Mali & Kenya and Cameroon & Kenya.  However, only 
the Mali & Kenya country comparisons were significant with the SNPs analysis 
(Table 5.4).  Based on the microsatellites data, the null hypothesis stating that the 






Table 5.4  Summary statistics from the SNPs and microsatellites analysis for the 
computed genetic differentiation obtained by pairwise comparisons of sequences 
between: Countries (Cameroon, Mali & Kenya), Mali clusters (1, 2 & 3) and Mali 
aureoles (1, 2 & 3) comparisons.  The clusters from the Mali study site are obtained 
from the partitioning described in Figure 5.1.  The aureoles comprise the boundaries 
defined in the map provided also in Figure 5.1.  Statistically significant values at P 
<0.05 are given in red font colour. 
 
    
SNPS Microsatellites 
Country comparison 
  Mali Kenya   Mali Kenya 
Cameroon 0.0563  0.0734  Cameroon  0.0355 0.058 
Mali    0.0485  Mali   0.037 
Clusters comparison 
  Cluster 2 Cluster 3   Cluster 2 Cluster 3 
Cluster 1 0.0695  -0.0422  Cluster 1  0.0641  0.0581 
Cluster 2   -0.0065  Cluster 2    0.0055 
Aureoles comparison 
  Aureole 2 Aureole 3   Aureole 2 Aureole 3 
Aureole 1 -0.0363  0.0139  Aureole 1  0.0311  0.0876 
Aureole 2   0.0083  Aureole 2    0.0527 
 
The clonal genotypes obtained from Mali were subjected to further geographic 
partitioning and the genetic differentiation estimates shown in the clusters 
comparisons section of Table 5.4 computed.  This was done to investigate whether 
genetically related malaria parasites occur within small spatial scales and hence test 
the hypothesis that parasites occurring within small spatial settings are highly 
structured and comprise closely mating parasite subpopulations. 
Mali was chosen as it had the highest sample representation and also because the 
exact geographic locations of its samples are known.  In this study site the clonal 




The identified clusters 1, 2 & 3 in Figure 5.1 were defined in an attempt to 
encompass as many homesteads as possible for adequate sample representation in the 
intended analysis.  The distances obtained between the houses and described in 
Table 5.5 were determined manually using the scale provided aided by the use of a 
30cm ruler. 
Table 5.5  Information on the partitioning performed on the Kolle region, Mali.  The 
geographic distance shown is between the two farthest sampled households per 
cluster.  The number of clonal genotypes analysed per cluster is also shown.  
 
The results in Table 5.4 indicate that no statistically significant level of genetic 
differentiation was detected with these partitions (P <0.05).   
Further investigation of population structure was performed using the already 
defined boundaries in the form of aureoles within the Mali study site.  This 
demarcation was established by the principal investigators in charge of the project at 
this study site for easy sampling of individuals in the households (see Figure 5.1).  
Only aureoles 1, 2 & 3 were included in this analysis as they had adequate sample 
representation.  Thus, 10 clonal genotypes from aureole 1, 28 from aureole 2 and, 10 
from aureole 3 giving a total of 48 clonal genotypes were included in this analysis.  
With this analysis, there was genetic differentiation between the clonal genotypes 
obtained from Aureoles 1 & 3 (Table 5.4).   
Partitioning 
(Cluster) 
Maximum geographic distance 
(based on largest separation 
distance of households) 
No. of analysed 
clonal genotypes 
1 300m 10 
2 250m 16 




















Figure 5.1 Map of Kolle, Mali showing the households partitioned into aureoles (each 200m) and also the further partitioning performed in an attempt to determine 
genetic differentiation within small geographic settings.  River Kolle, the breeding site, is the brown line cutting across the aureoles.  The coloured sections i.e. blue, 
pink, green or purple comprise the households or families.  The partitions (clusters 1-3) shown by the rectangles are as described in Table 5.5. The red stars 
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Additional analysis of clonal genotypes obtained from Rusinga Island, Kenya (see 
map in Chapter 2) was carried out to determine levels of genetic differentiation.  
The locations included in the analysis are Kaswanga and Kamasengre. This is 
because they had adequate sample representation. However, the actual households or 
physical locations from which the samples were obtained are unknown as collections 
were made in the local health centres.  These two regions are separated by 
approximately 5 km.  11 clonal genotypes from Kaswanga and 10 clonal genotypes 
were included in the analysis.  Interestingly, this analysis detected statistically 
significant genetic differentiation with the SNPs (FST = 0.0472) and microsatellites 
(FST = 0.15). 
 
5.3.5. Linkage disequlibrium (LD) 
The parameter IA
S
 is used to determine the magnitude of the observed LD. The 
results (Table 5.6) obtained indicate that no significant levels of LD were observed.  
The low values of IA
S
 are an obvious indication of this and the insignificant P values 
also corroborate the results.  
Table 5.6  Analysis of LD at a country level given as the overall value across the loci 
analysed.   









Mali 14 -0.015 0.7 
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5.4. Discussion 
It is important to note that the purpose of this study is not to review the performance 
of genetic markers in population genetic studies but to establish appropriate markers 
for the study of the interaction of malaria parasites within small geographic settings.  
However since both SNPs and microsatellites were used in this study, it is pertinent 
to review the findings obtained in this study and their implications for future planned 
studies of this nature.  
 
5.4.1. Genetic diversity 
Measurements of genetic diversity involve the estimation of divergence in DNA 
sequences.  Malaria parasite lineages over time are under various forces at a genome 
level such as genetic recombination, mutations or natural selection which are 
responsible for the generation of nucleotide divergence.  In addition, their interaction 
at a population level (their gene flow patterns) predisposes them to genetic drift or 
inbreeding due to mating constraints imposed by the natural phenomenon of isolation 
by distance leading to population structuring.  Since it is costly to analyse whole 
genomes for extrapolation of genetic diversity, markers obtained from multiple loci 
are used.  It is pertinent that sufficient genetic markers are utilized to ensure they 
adequately represent the existing genome wide information.  
SNPs are considered less informative in the estimation of genetic diversity as they 
are biallelic and have low mutation rate compared to the highly variable 
microsatellites (Liu et al., 2005).  This is evidenced by the differences in number of 
alleles and allelic richness observed with either the SNPs or microsatellites (Table 
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5.2 a&b).  Even though only a few microsatellites were used in this study, they were 
indeed more informative compared to the SNPs as they displayed greater allelic 
diversity and richness (Table 5.2 a&b).  This means that for accurate estimation of 
nucleotide sequence diversity, numerous SNPs would be required.  This setback is 
however mitigated by the relative abundance of SNPs in the genome easing their 
identification and use in genetic studies (Morin et al., 2004).  On the other hand, 
although abundant too, the development of microsatellites’ assays is more time 
consuming and laborious (Haasl & Payseur, 2011). 
The SNPs analysis revealed that Kenya had the highest levels of genetic diversity 
followed by Mali and Cameroon had the lowest (Table 5.3). In contrast, the 
microsatellites estimate of heterozygosity (Table 5.3) revealed that Cameroon was 
the most genetically diverse, then Mali and finally Kenya.  The disparity in estimates 
of genetic diversity observed in Cameroon, Kenya and Mali using either 
microsatellites or SNPs is not a new phenomenon and has been observed and 
investigated previously by the comparison of AFLPs and microsatellites (Mariette et 
al., 2001; Mariette et al., 2002) or microsatellites and SNPs (Väli et al., 2008).  The 
explanation for this is either the use of few genetic markers that fail to capture the 
heterogeneity of genomes or the analysis of a recently created population (Mariette et 
al., 2002).  In this study, it is possible that the few genetic markers used failed to 
clearly capture the overall genetic diversity present in malaria parasites for each of 
the study sites analysed.  Additionally, in a recently created population, such 
disparities are expected.  This is because SNPs take longer to mutate and capture the 
existing genetic divergence within populations. Thus, the low within genomic 
heterogeneity fails to capture the within population genetic diversity. On the other 
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hand the high within genomic diversity demonstrated by microsatellites 
overestimates the within population heterogeneity.   
In the estimation of allele frequencies, studies recommend the use of the predominant 
clone only to minimise ascertainment bias (see Anderson et al., 2000 using 
microsatellites; Anderson et al., 2005 using SNPs).  Ascertainment bias in the 
estimation of genetic diversity arises from the overestimation of rare allele 
frequencies or underestimation of common allele frequencies (Ellegren, 2004).  
However, in this study, all the identified clonal genotypes were used in the 
estimation of allele frequencies as use of the major clone only would lead to data 
losses.  Since the software FSTAT uses allele frequencies to estimate FST values, the 
existence of bias in the obtained results cannot be negated. 
The high levels of gene diversity or expected heterozygosity [Hexp (s)] observed per 
locus and per geographic location (Table 5.3) using microsatellites represent a 
typical scenario in areas of high malaria transmission such as in Africa.  Similar 
findings were observed using microsatellites by Anderson et al., (2000) in Uganda, 
Congo and Zimbabwe; by Tsumori et al., (2011) in Congo and Mobegi et al., (2012) 
across West Africa.  On the other hand, the low values of genetic diversity observed 
with the SNPs data (Table 5.3) are because a few of them were used in this study 
rendering it difficult for the SNPs to effectively estimate the genetic divergence 
between the countries.  In their review, Haysl & Payseur (2011) suggest that 
increasing the number of SNPs in the detection of population divergence may give 
estimates comparable to microsatellites. 
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The results obtained in this study indicate that the choice of genetic markers is very 
important in the interpretation of genetic diversity estimates.  Microsatellites are 
recommended for the estimation of genetic diversity in recent populations (Avise, 
2004).  In addition, a few of them are able to detect levels of population divergence 
as observed in this study.  Since this study is concerned with recent genetic events, 
microsatellites should suffice.  However, the enormous prospects of using the highly 
abundant SNPs in the P. falciparum genome coupled with the increased progress in 
sequencing technology (Mardis, 2008) for the detection of within genomic or within 
population diversity is not to be downplayed.  For example, Manske et al., 2012 has 
used the newly developed Illumina genetic analyser to identify about 86,000 SNPs 
appropriate for population diversity measures.  Nonetheless, it is pertinent that 
sufficient genetic markers are used to provide accurate measures of existing 
population divergence. 
 
5.4.2. Linkage disequilibrium 
It is noteworthy that LD can occur at the genomic level either due to natural selection 
or in regions of low recombination rate or if alleles are in close proximity in the 
genome such that they are linked.  It can also occur at the population level as a result 
of inbreeding or genetic drift.  In P. falciparum, significant levels of LD have been 
observed in regions of low malaria transmission such as Bolivia (Anderson et al., 
2000), Malaysia (Anthony et al., 2005), Thailand (Pumpaibool et al., 2009) and 
Phillipines (Iwagami et al., 2009) but not in high transmission intensity regions such 
as is observed in Uganda and Congo (Anderson et al., 2000 and in West Africa 
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(Mobegi et al., 2012).  Thus the lack of LD observed in this study (Table 5.6) 
signifies that indeed the microsatellites are neutral and represent independent loci 
within the P. falciparum genome.  In addition, these observations corroborate with 
the existing evidence of no LD when dealing with isolates obtained from regions of 
high malaria transmission (Anderson et al., 2000; Mobegi et al., 2012). 
 
5.4.3. Genetic differentiation  
This study was devised to infer the gene flow patterns of malaria parasites within 
small geographic settings (<1km) and thereby determine the size (in terms of 
geographic distance) of a closely mating population having high levels of genetic 
relatedness.  According to the isolation by distance theory, closely mating parasites 
are indeed expected to be genetically related.  However in P. falciparum, within a 
focus of malaria transmission, the geographic size of a cluster of closely mating 
populations (constituting a deme) is unknown.   
Closely mating malaria parasites are highly inbred as they are isolated geographically 
with limited migration between subpopulations.  This leads to reductions in 
heterozygosity (genetic diversity) due to non-random mating.  The parameter genetic 
differentiation (FST) is used to measure this.  If the geographic locations of the 
parasite isolates are known, then FST values can be determined and the points at 
which no statistically significant FST values are detected indicate the limit of 
migration of the parasites and offer an estimate of how widespread a single 
subpopulation is.   
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5.4.3.1. Overall FST values 
The overall GST´ (FST) value of 0.061 using SNPs and 0.043 with microsatellites 
(Table 5.3) obtained by pairwise comparison of genotypes across the different 
countries in Africa is low and consistent with what was detected by Anderson et al., 
(2000) in Uganda and Congo and recently by Mobegi et al., (2012) within and 
among West African countries.  These low values of FST are typically observed in 
African countries separated by geographic distances >1000km.  Higher FST values (> 
0.05) have been observed in regions separated by the same geographic distances in 
South America and Asia (Anderson et al., 2000), in the Brazillian Amazon region 
(Machado et al., 2004), and in Papua New Guinea (Schultz et al., 2010).  This makes 
the detection of genetic structure in regions of smaller geographic distances within 
Africa difficult as very low genetic differentiation is in existence across regions 
separated by very large geographic distances.  For example Tsumori et al., (2011) in 
regions separated by approximately 8km detected an FST value of 0.004 indicative of 
panmixia. 
At a continental level, low gene flow is expected between malaria parasites hence the 
observed statistically significant levels of population structure in the between country 
comparisons.  However, in Africa low values of genetic differentiation such as was 
observed here have been previously recorded (Anderson et al., 2000).  These low 
values indicate that most of the genetic variation in Africa is distributed within 
subpopulations as opposed to among subpopulations. It is pertinent to note that in 
Africa, a spectrum of genetic differentiation values is observed due to the varying 
malaria transmission patterns across the continent. For example in a study conducted 
in low malaria transmission urban and rural sites of West Africa i.e. Djibouti, 
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Niamey, Senegal & Dakar, high FST values were reported  (>0.1) not indicative of 
panmixia (Bogreau et al., 2006).  In another study conducted across West African 
countries of varying malaria prevalence detected low levels of FST (~0.03) (Mobegi 
et al., 2012) concordant with what was observed by Anderson et al., 2000 in Africa.  
These studies show that although Africa is considered to be a high malaria 
transmission zone, determining the population genetic profiles within sites of interest 
is important. 
 
5.4.3.2. Between country comparisons  
The results indicated low but significant levels of structuring with the data obtained 
from microsatellites (Table 5.4).  Such low levels of genetic differentiation were also 
observed between Mali and Burkina Faso (both West African countries) (Campino et 
al., 2011).  The SNPs data indicted that only between country comparison of Mali & 
Kenya yielded statistically significant FST values (Table 5.4).  Comparable levels of 
genetic differentiation across Africa were also observed with SNP analysis of the 
highly polymorphic Plasmodium falciparum sarco/endoplasmic reticulum calcium-
ATPase (pfSERCA) gene, implicated but not yet proven to play a role in the 
development of parasite drug resistance to the antimalarial, artemisinin (Jambou et 
al., 2010).   
In Mali, partitioning by aureoles revealed that individuals residing in tightly clutered 
households (see Figure 5.1) harboured parasites that were closely related genetically.  
This was demonstrated by the statistically significant levels of genetic differentiation 
obtained from the comparisons between aureoles 1 & 3 and not between aureoles 1 
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& 2 (Table 5.4).  A close inspection of the study site in Figure 5.1 reveals that the 
breeding site cuts across the households in these aureoles such that most individuals 
reside in close proximity to the river Kolle. 
These results are not surprising as the existing literature on the transmission patterns 
of P. falciparum indicate that regions closest to mosquito breeding grounds 
experience the highest levels of malaria transmission (Ghebreyesus et al., 1999; 
(Thomas & Lindsay, 2000; Staedke et al., 2003; van der Hoek et al., 2003; Midega et 
al., 2012).  This is because of high mosquito abundance around breeding sites such 
that individuals residing in the vicinity of these areas experience the highest 
mosquito bites accompanied by parasite inoculations.  Since the mosquitoes or the 
people (harbouring the parasites) exhibit limited migration, the parasite population 
around these sites is expected to be highly inbred with low genetic variation.  
However, it is noteworthy that intepration of these results should be taken with 
caution as only a small data set was used in this analysis.  Also, few genetic markers 
were used in this study and it is possible that they lacked the power to accurately 
detect the levels of genetic variation within the Mali study site. 
It is noteworthy that the demarcation by aureoles used in the analysis of the Mali 
study site is not ideal for this kind of study.  This is because households at the border 
of the aureoles are within close geographic distance obscuring patterns of genetic 
diversity in relation to physical distance.  The Study site in Mali offers good 
prospects in the study of malaria parasites’ transmission patterns within short 
geographic distances.  However, adequate sampling is required for accurate 
estimations to be obtained.   
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Even though the statistically significant FST value obtained by the comparison of 
isolates obtained from Kaswanga and Kamasengre in Rusinga Island, Kenya from 
the SNPs data (0.0472) seems reasonable and accurate compared to the one obtained 
using microsatellites (0.15), since only a few isolates were analysed.  However, there 
is also a high probability that these values are artifactual as only a small sample set 
was included in this analysis.   
In conclusion, the hypothesis that parasites occurring within small spatial settings are 
highly structured and comprise closely mating parasite subpopulations cannot be 
fully validated.  In the next chapter, the complete data set obtained from the SNPs 
and microsatellites will be combined for genetic distance based analyses to elucidate 
patterns of malaria parasites distribution in space as explained by their genotypes.  
 
5.4.4. Conclusion 
It is noteworthy that the SNP and microsatellites data analysis in this chapter reveals 
that within a distance of approximately 400m from the breeding site, there is 
significant genetic structuring of the malaria parasites.  This means that in this study 
site, based on the results obtained, successful malaria transmission is maintained 
within a radius of approximately 400m from the breeding site.  This however, does 
not offer conclusive evidence on population structuring within the Mali study site.  
The low number of SNPs used in this study did not have the detection power to 
reveal further genetic differentiation if it exists in the Mali region.  Additional 
genetic markers particularly in the Mali study site are therefore required to provide a 
clearer picture.   
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The information obtained from Kenya was also inadequate as the actual geographic 
location of the samples is unknown.  A proper study design to investigate the 
transmission patterns in Rusinga Island is required to trace the genetic relatedness of 
malaria parasites in this study site. 
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An important question population geneticists ask addresses how individuals interact 
in space and how this affects their degree of genetic relatedness or diversity.  Genetic 
diversity is relevant for maintenance of fitness in natural populations.  For example 
in captive breeding programs for either production of salmon (reviewed by Naylor et 
al., 2005; Hindar et al., 2006; Fraser, 2008) or protection of endangered species 
(reviewed by (Matocq & Villablanca, 2001; Williams & Hoffman, 2009) there is 
danger of inbreeding and loss of genetic variability.  In the wake of advanced 
Agricultural technology, there is concern over the consequences imparted by genetic 
introgression i.e. the transfer of genes from a genetically modified crop to their free 
living wild counterparts (reviewed by Stewart et al., 2003).  It has been implied that 
this may lead to fitness loss or extinction of wild plants brought about by competitive 
advantage of novel genes that may homogenize the existing genotypes (Mooney & 
Cleland, 2001).   
In health research, understanding the interactions of disease causing pathogens is 
essential to monitor their transmission patterns including the emergence and spread 
of genes responsible for increasing their virulence or drug resistance. For example a 
recent review on opportunistic bacterial pathogens i.e. bacteria that are otherwise 
harmless but cause disease in immune-compromised humans, appreciates that these 
bacteria develop virulence or antibiotic drug resistance in their primary hosts such as 
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plants.  Their development of adaptive mechanisms in these environments renders 
them capable of evading the human hosts’ immune response and perhaps introducing 
novel virulence factors to the pre-existing mutualistic or pathogenic bacteria 
(Aujoulat et al., 2012). 
In the vector-borne disease, P. falciparum malaria, transmission of these parasites 
from person to person by the female Anopheles mosquito is vital to understanding 
their interaction in space.  It is in the mosquito that genetically distinct malaria 
parasites undergo genetic recombination giving rise to novel genotypes.  However, 
the probability for the mosquito to pick up two genetically distinct parasite clones 
depends on parasite genetic diversity within infected human hosts.  Thus in localities, 
the cycle of repeated parasite inoculations by the mosquito from one individual to 
another is constantly replayed.  The assumption would be that malaria parasites 
obtained from people located in close neighbourhoods bear parasites that are closely 
related genetically in comparison to individuals that are far apart. 
To understand the concept of gene flow patterns in malaria parasite populations, the 
impending question is: are the parasites within a population randomly mating or do 
they constitute discrete subpopulations with limited gene flow between them?  To 
address this, Sewall Wright in 1943 developed the isolation by distance model which 
states that the genetic relatedness of individuals reduces with increase in geographic 
distance between them.  It is on this premise that genetic distance based analyses are 
founded.   
In this final chapter, the complete data set combining the SNP and microsatellite 
genetic loci will be analysed.  The gene flow patterns of these parasites will then be 
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elucidated to identify if they comprise discrete clusters of closely mating parasites 
and at what geographic distances, or if they comprise randomly mating parasites that 
are not genetically structured. Using genetic distance based methods the isolation by 
distance model will be tested on P. falciparum isolates collected from the different 
geographic regions. 
 
6.1.1. Synopsis of chapter 
This chapter highlights the main theme of this thesis – the genetic relatedness of 
malaria parasites in space.  The data obtained from both SNPs and microsatellites 
were combined to perform genetic distance based analyses in contrast to the 
frequency based analyses.  The difference between the two is that the latter 
comprises extrapolation of genetic variation from differences in allele frequencies 
whereas the former utilizes genetic distance matrices obtained from pairwise 
comparison of DNA sequences to infer genetic variation or similarity in space 
(Peakall and Smouse, 2006; 2012). In addition, these tests do not conform to 
mutation based models allowing data obtained from both SNPs and microsatellites to 
be combined for analysis.   
In this chapter, pairwise comparisons of the obtained genotypes were obtained and 
genetic distances (GD) computed.  A GD matrix was obtained and used for 
subsequent analysis to determine the relationship between GD and geographic 
distances of the P. falciparum populations in question.   
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The overall genetic variation among and between the parasite populations obtained 
from different geographic settings were determined.  Further to this, the correlation 
between GD and geographic distance over distances >1km and beyond was 
investigated.  Finally, a spatial autocorrelation analysis was performed to investigate 
the existence of discrete clusters of malaria parasites within small spatial scales 
(<1km). 
Since the geographic coordinates of the isolates obtained from Mali are known, a 
separate analysis was also carried out with these isolates obtained from shorter 
geographic distances (<1km).  
 
6.1.2. Objective of chapter 
As already stated in Chapter 1, this thesis constitutes a feasibility study to 
investigate whether the genetic relatedness of malaria parasites can be used to trace 
their transmission in space.   In Chapter 5, the identified parasite genotypes obtained 
using both SNPs and microsatellites were analysed for evidence of population 
structure within predefined geographic boundaries.  The results seemed to indicate 
that there are clusters of malaria parasites occuring within a distance of ~400m.  In 
this chapter, further exploration of these study sites to reveal distinct clusters of 
closely mating parasites and perhaps reveal how malaria parasites are transmitted 
from person to person will be carried out. 
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6.1.3. Hypotheses of study 
The null hypothesis (H0) is that malaria parasites are randomly mating in space and 
are not genetically structured.  The alternative hypothesis (H1) is the isolation by 
distance hypothesis which states that closely related parasites occur within short 
separation distances of each other in space and that their level of genetic relatedness 
dissipates with increasing geographic distance. 
 
6.2. Materials and methods 
All the clonal genotypes obtained using SNPs and microsatellites were analysed in 
this chapter (Appendix F).  The genetic based analyses were perfomed using the 
Microsoft Excel, add-in software GenAlEx 6.5 (Peakall and Smouse 2006; 2012).  
The following tests were performed: Analysis of molecular variance (AMOVA) to 
determine the genetic variation within and among the parasite populations.  Mantel 
test, a statistical tool used to define population structure of the parasites over large 
geographic distances (>1km). It provides measurements of statistical significance to 
the correlation of matrices and in this study it will be used on genetic distance (as a 
measure of genetic variation) and geographic distance matrices.  Finally, the spatial 
autocorrelation test in the identification of closely mating malaria parasite clusters 
within short geographic distances (<1km). 
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6.2.1. Genotyping isolates 
All the P. falciparum clonal genotypes obtained per isolate were included in the 
analysis.  Thus, the numerically coded data comprised a total of 84 clonal genotypes 
(12 from Cameroon, 49 from Mali and 23 from Kenya).  In addition, 17 loci (5 
microsatellites and 12 SNPs) were uploaded to the software.  The alleles per locus 
for the SNPs data were assigned the numerals 1 =A, 2 = C, 3 = G and 4 = T.  For the 
microsatellites, the alleles per locus were assigned the numbers between 1 for the 
lowest size allele observed across all loci and 15 for the highest observed allele size.  
Loci containing missing data were excluded.  The latitude and longitude co-ordinates 
for each of the clonal genotypes were uploaded in separate columns labeled ‘x’ and 
‘y’ on the same sheet containing the data set. Since the actual geographic coordinates 
of the parasite isolates obtained from Cameroon and Kenya were unknown, the 
coordinates given comprised rough estimates of the villages from where the isolates 
were collected.   
49 P. falciparum clonal genotypes obtained from Mali only were also uploaded in a 
separate GenAlEx worksheet as the geographic coordinates were known.  The data 
were partitioned into parasite populations from each of the aureoles (1, 2 & 3) 
described in the map of Mali (Figure 5.1). Thus 12 were from Aureole 1, 26 from 
Aureole 2 and 11 from Aureole 3. 
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6.2.2. Calculating distance matrices between individuals 
A haploid genetic distance matrix was first generated in GenAlEx (both for the 
whole data set and the data set obtained from Mali) by performing an individual by 
individual pairwise comparison.  Genotypes that are identical generate a GD of 0 
whereas completely different genotypes generate a GD of 1.  The sum of GDs across 
all loci was computed so that for a given pair of genotypes, the GD was equal to the 
tally of differences between the two.  In addition, two separate geographic distance 
matrices were generated using the actual geographic distances and the log 
transformed geographic distances (log 1+x). 
 
6.2.3. AMOVA analysis 
The hierarchical partitioning of genetic variation among and within populations is 
typically investigated in population genetic studies.  The parameters used include FST 
(Wright, 1931; 1951 cited in Hamilton, 2009) and its analogues: GST (Nei, 1987),  
(Weir & Cockerham, 1984), RST (Slatkin, 1995), ST (Excoffier et al., 1992).  The 
problem with these measures is their dependency on within population genetic 
variation which confounds observed levels of genetic differentiation such that high 
levels of this variation lead to low FST values (Hendrick, 2005).  It is on this premise 
that modifications of the ST parameter (Excoffier et al., 1992) have been developed 
to allow the analysis of genetic markers having different mutation rates such as SNPs 
and microsatellites.  The AMOVA framework (Meirmans, 2006; Peakall and Smouse, 
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2006; 2012) allows the direct measure of population differentiation on any form of 
genetic data and precludes the need for determining allele frequencies. 
Using the generated GD matrix, an AMOVA was performed which tests the degree 
of genetic variation within and among subpopulations (genetic differentiation) as 
given by the parameter PT (Excoffier, 1992) which is analogous to FST (Wright, 
1931; 1951 cited in Hamilton, 2009). The formulae used in this analysis are 
summarised in Appendix G. 
The parameter PT falls within the range of 0-1 and its tendency to 1 is indicative of 
increasing genetic differentiation.  This parameter gives an estimate of the proportion 
of variance present within populations relative to the total variance. 
The AMOVA test is performed under the H0 that there is no genetic differentiation 
among subpopulations (PT = 0) such that the data set comprises randomly mating 
subpopulations with little genetic differences between them unless those generated 
by chance due to sampling effects. Statistical testing was performed using 1000 
permutations where the data was reshuffled or randomized multiple times to 
determine if the observed estimate is greater than that expected by chance with a P 
value of 0.05. 
 
6.2.4. Mantel test 
In natural populations, individuals that are separated by short geographic distances 
have a higher chance of mating than those separated by large distances.  This is 
known as the isolation by distance phenomenon originally postulated by Wright, 
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(1943).  The model operates under the assumption that there is a positive correlation 
between genetic distance and geographic distance.   
The Mantel test (Mantel, 1967) enables the statistical comparison of the GD and 
geographic distance matrices. Thus for the two matrices (denoted by X & Y in 
Appendix G), a correlation coefficient value, Rxy is computed and its level of 
statistical significance defined using the H0 that no relationship exists between the 
two matrices (Rxy = 0).  Rxy spans within a range of +1 and -1.  A null distribution is 
generated by holding the components of one matrix constant while randomizing the 
other one.  The generated observed value is then compared with the permuted value 
and is considered significant if it is greater than is expected by chance to the 
permuted value.  The Mantel test is used to examine patterns of population 
distribution over large geographic distances (>1km and beyond).  Statistical 
significance was determined following 1000 randomisations at a P value of 0.05. 
The geographic co-ordinates uploaded to GenAlEx were in the form of latitude and 
longitude in decimal degrees.  The distance (D) was then computed in kilometres 
(km) (Appendix G). 
 
6.2.5. Spatial autocorrelation analysis 
The spatial autocorrelation analysis determines patterns of distribution in individual 
genotypes within short geographic distances (<1km).  This test is ideal for detecting 
clusters of population structure within small study sites.   
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GenAlEx performs this test by a multivariate spatial autocorrelation approach 
(Smouse & Peakall (1999); Peakall et al., (2003); Double et al., (2005); Smouse et 
al., (2008) circumventing the classical allele-allele and locus-locus analyses which is 
subject to stochastic noise.  Genetic and geographic distance matrices already 
generated for the Mantel test analysis will be used.  The genetic distance matrix is 
converted to a covariance matrix which is compared to the geographic distance 
matrix.  The correlation coefficient obtained (r) provides an estimate of the genetic 
relatedness of individuals falling within specified geographic distance classes with 
results output in the form of a correlogram.  The value of r falls within a range of +1 
and -1. 
This test is performed with the null hypothesis (H0) that genotypes are randomly 
distributed in space irrespective of their geographic separation (r = 0).  The test for 
statistical significance is determined by random permutations and bootstrap estimates 
of r.  The permutation test randomly shuffles individuals multiple times (performed 
1000 times) among the geographic locations and generates an r permutation value 
(rp) value under the H0 (random distribution of individuals in space with no spatial 
structure).  The rp value is bound by upper and lower limits defined within a 95% 
confidence interval (two tailed t-test).  If the calculated r value falls outside the 
bounds of this confidence limit, H0 is rejected meaning there is spatial structuring. 
Testing by bootstrapping allows confidence intervals to be estimated from pairwise 
comparisons within the predefined distance classes.  The upper and lower limits of 
the observed r estimate are obtained by drawing with replacement at each distance 
class.  1000 bootstraps were performed and the bootstrap autocorrelation coefficient 
(rbs) calculated for each distance class.  Within a 95% confidence interval, if the 
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bootstrap confidence interval falls out of r = 0, the H0 is rejected with significant 
spatial structure detected. 
The distance classes were defined depending on the geographic distances of 
separation for each of the analysed data sets.  Each distance class is represented by 
its own x matrix.  If the samples represented in the pair wise comparison fall within 
the distance class, the elements have a value of 1 otherwise all other elements falling 
beyond this distance class are not represented and have a value of 0.  The threshold 
of the distance classes is therefore set by adding one class above the maximum 
geographic distance of the data set. 
 
6.3. Results 
The analyses performed in this section aim to address the main question of this thesis 
– are malaria parasites occurring within short geographic distances (<1km) highly 
genetically related in contrast to those far apart (within distance of separation 
>1km)?  To address this, the clonal genotypes obtained by SNP and microsatellites 
analysis were combined as the tests performed here are genetic/geographic distance 
based irrespective of the underlying evolutionary processes such as mutations 
occurring within the genetic markers of choice (Peakall & Smouse, 2012).   
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6.3.1. Analysis of molecular variance (AMOVA) 
6.3.1.1. Overall AMOVA analysis  
AMOVA was performed in the overall data set to determine the degree of genetic 
variation explained within or among sampled P. falciparum isolates.  The combined 
P.falciparum genotypes were uploaded to GenAlEx and individual by individual 
pairwise comparisons performed.  A genetic distance matrix was generated and used 
to compute the genetic variation observed within and among the populations as 
summarised in Table 6.1 below. 







squares (SS)  









2 16.877 8.439 0.195 5% 
Within 
Populations 






The results displayed in Table 6.1 indicate that the majority of genetic variation in 
the overall P. falciparum isolates obtained from Cameroon, Kenya and Mali is 
explained within the populations (95% variance) as opposed to among the 
populations (5%).   
In this analysis, the overall mean observedPT was 0.049 and it was statistically 
significant with a P (rand >= data) of 0.001 i.e. the P value obtained following 
randomisations.  Further evidence to this, the frequency distribution of the observed 
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PT compared to the frequency of the random PT value obtained following 1000 
random permutations was also higher and therefore statistically significant as shown 
in Figure 6.1.  The H0 stating that the data comprises randomly mating individuals 
that are not genetically differentiated was therefore rejected. 
 
Figure 6.1  Frequency distribution of random PT (depicted in black) vs. observed 
(in red) following randomisation as a test for statistical significance in the overall 
analysis of clonal genotypes 
 
Finally, country comparisons of the parasite populations were performed and the PT 
values obtained from the analysis are shown in Table 6.2.  The results indicate that 
significant genetic differentiation was observed by comparisons between countries as 
shown by P (rand >= data).   
Table 6.2  Country comparison of P. falciparum genotypes with the corresponding 
observed and permuted PT values shown.   
Country comparison Distance (km) Observed PT P (rand >= data) 
Cameroon - Mali 2300 0.046 0.019 
Cameroon - Kenya 2800 0.065 0.028 
Mali - Kenya 5100 0.046 0.006 
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6.3.1.2. AMOVA test – Mali clonal genotypes 
The AMOVA test was also performed in P. falciparum isolates obtained from Mali 
to evaluate the hierarchical partitioning of genetic variation among and between the 
aureoles.  The results are shown in Table 6.3. 





squares (SS)  








2 9.858 4.929 0.087 2% 
Within 
aureoles 
46 167.183 3.634 3.634 98% 
Total 
48 177.041  3.721 100% 
 
The results once again show that majority of the genetic variation is explained within 
aureoles (98%) compared to among aureoles (2%).  The overall PT in Mali was 
0.023 and slightly statistically significant P (rand >= data) of 0.01 and also as given 
by the frequency distribution or the randomised PT value versus the observed 
(Figure 6.2).  However, the between aureoles comparisons did not yield statistically 
significant levels of genetic differentiation (Table 6.4). 
Table 6.4  Between aureoles comparison of P. falciparum genotypes with the 
corresponding observed and permuted PT values shown.   
Region comparison Distance (km) Observed PT P (rand >= data) 
Aureole 1 – Aureole 2 0.2 0.08 0.279 
Aureole 1 – Aureole 3 0.2 0.044 0.084 
Aureole 2 – Aureole 3 0.2 0.03 0.088 
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Figure 6.2  Frequency distribution of random PT (depicted in black) vs observed (in 
red) following randomisation as a test for statistical significance for the clonal 
genotypes obtained from Mali. 
 
6.3.2. Mantel test 
6.3.2.1. Overall data Mantel test 
The Mantel test analysis of the overall data set yielded a correlation coefficient (Rxy) 
= 0.153, P < 0.05 for the actual geographic distances and 0.135, P<0.05 with the log 
transformed (Figure 6.3 a&b).  A slightly significant relationship by regression 
analysis (R
2
 = 0.0234) was observed between the genetic and actual geographic 
distances of the parasite isolates.  The analysis performed with the log transformed 
geographic distances as is recommended by Peakall and Smouse, (2006; 2012) 
showed an even less statistical significance by regression analysis (R
2
 = 0.0183).   
Based on these observations, the H0 was rejected but not strongly indicative of a 
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slightly significant relationship between the geographic distances and the genetic 







Figure 6.3  Frequency distribution of the correlation coefficient (Rxy) (depicted in 
black) vs observed (in red) following randomisation as a test for statistical 
significance for the clonal genotypes obtained over all the countries. The analyses 
performed using the actual geographic distances are given in (a) and the log 
transformed geographic distances in (b).  
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6.3.2.2. Mali study site Mantel test 
The clonal genotypes obtained from Mali were also separately analysed for isolation 
by distance as the geographic co-ordinates were known.  The results are shown in 
Figure 6.4a & b.  No statistically significant relationship was observed between the 
genetic distance and the geographic distances with either the actual geographic 
distance analysis R
2
 value = 0.0028 or with the log transformed R
2
 = 0.0028.  The 
obtained Rxy values = 0.053 for both the actual and log transformed geographic 
distances were also not statistically significant (P < 0.05) as shown in Figure 6.4 








Figure 6.4  Frequency distribution of the correlation coefficient (Rxy) (depicted in 
black) vs observed (in red) following randomisation as a test for statistical 
significance for the clonal genotypes obtained from Mali. The analyses performed 
using the actual geographic distances are given in (a) and the log transformed 
geographic distances in (b). 
 
6.3.3. Spatial autocorrelation analysis 
6.3.3.1. Spatial autocorrelation analysis of the overall data set 
The correlogram (Figure 6.5) obtained from the overall analysis of malaria parasite 
populations indicates that significant levels of spatial autocorrelation were detected 
within the first distance class (geographic distance between 0-0.1km).  This is 
supported by the observed r value which exceeds the upper limit (upper red dashed 
line) and the mean bootstrap which exceeds 0 within this distance class.  Thus, 
within geographic distance 0-0.1km, there seems to be an indication that parasites are 
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not randomly mating but are genetically structured.  This might have been due to the 
sampling two genotypes from the same individuals that may be highly related 
genetically.  This was investigated later and depicted in Figure 6.7. 
 
n 179 125 994 197 0 864 0 1127 
Distance 
Class (km) 0 - 0.1 0.1 - 1 1 - 1000 1000 - 2000 2000- 3000 3000 - 4000 4000 - 5000 5000 - 6000 
r 0.088 0.030 0.005 0.020 0.012 -0.011 0.012 -0.017 
U 0.035 0.037 0.009 0.029 0.012 0.005 0.012 0.006 
L -0.029 -0.034 -0.007 -0.029 0.012 -0.010 0.012 -0.012 
P(r-rand >= 
r-data) 0.001 0.049 0.121 0.084 1.000 0.981 1.000 0.994 
P(r-rand <= 
r-data) 1.000 0.952 0.880 0.917 1.000 0.020 1.000 0.007 
Mean 
Bootstrap r 0.087 0.030 0.005 0.019 0.000 -0.010 0.000 -0.017 
Ur error 0.048 0.042 0.013 0.034 -0.012 0.015 -0.012 0.013 
Lr error 0.050 0.041 0.013 0.036 0.012 0.013 0.012 0.013 
Figure 6.5  Spatial autocorrelation analysis from the overall data.  The correlogram 
depicts distance classes set in km as:  0-0.1, 0.1-1, 1-1000, 1000-2000, 2000-3000, 
3000-4000, 4000-5,000 & 5000-6000.  Although the distance classes are set up to 
6000km (a total of 8 distance classes), the autocorrelation is performed for the 7 
distance classes and any class beyond that is ignored.  It is therefore pertinent to set 
the distance classes exceeding the maximum distance of separation of the isolates to 
ensure the whole data set is included in the analysis. The blue line represents the 
spatial autocorrelation coefficients computed within each distance class.  The red 
dashed lines indicate the upper (U) 25
th
 and lower (L) 975
th
 confidence limits bound 
by the 95% confidence interval about the null hypothesis of no spatial structure for 
the combined data set as determined by permutation.  When the blue line (r) exceeds 
the upper and lower confidence limits (red dashed lines), significant genetic structure 
is inferred. 1000 bootstrap trials give a mean bootstrap r bound by the 95% 
confidence limit.  The upper (U) 25
th
 and lower (L) 975
th
 confidence limits are given 
by the error bars.  When the mean bootstrap r is close to 0, the null hypothesis of no 
spatial structure is accepted.  The table below this figure show the values obtained by 
both randomisation and bootstrapping analyses as tests for statistical significance. 
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6.3.3.2. Spatial autocorrelation analysis in Mali 
Finally, a spatial autocorrelation analysis was performed for the isolates obtained 
from Kolle region, Mali (Figure 6.6) in an attempt to identify spatial genetic 
structure within short geographic distances.  
 
n 57 125 378 322 170 83 33 
Distance Class (km) 0 – 0.1 0.1 – 0.2 0.2 – 0.3 0.3 – 0.4 0.4 – 0.5 0.5 – 0.6 0.6 – 0.7 
r 0.083 0.019 -0.013 -0.002 -0.004 -0.011 0.009 
U 0.067 0.043 0.018 0.021 0.032 0.047 0.075 
L -0.049 -0.035 -0.021 -0.026 -0.036 -0.050 -0.079 
P(r-rand >= r-data) 0.012 0.159 0.906 0.572 0.626 0.694 0.433 
P(r-rand <= r-data) 0.989 0.842 0.095 0.429 0.375 0.307 0.568 
Mean Bootstrap r 0.084 0.018 -0.012 -0.002 -0.004 -0.011 0.009 
Ur error 0.120 0.045 0.022 0.026 0.036 0.038 0.065 
Lr error 0.113 0.043 0.022 0.026 0.037 0.040 0.060 
Figure 6.6  A correlogram of spatial autocorrelation analysis for Kolle region, Mali 
data.  This illustration shows distance classes set in km as:  0-0.1, 0.1-0.2, 0.2-0.3, 
0.3-0.4, 0.4-0.5, 0.5-0.6 & 0.7-0.8.  Once again, the spatial autocorrelation is 
performed up to the distance class (0.5-0.6) and the last one is ignored.  The blue line 
represents the spatial autocorrelation coefficients computed within each distance 
class.  The red dashed lines indicate the upper (U) 25
th
 and lower (L) 975
th
 
confidence limits bound by the 95% confidence interval about the null hypothesis of 
no spatial structure for the combined data set as determined by permutation.  When 
the blue line (r) exceeds the upper and lower confidence limits (red dashed lines), 
significant genetic structure is inferred. 1000 bootstrap trials give a mean bootstrap r 
bound by the 95% confidence limit.  The upper (U) 25
th
 and lower (L) 975
th
 
confidence limits are given by the error bars.  When the mean bootstrap r is close to 
0, the null hypothesis of no spatial structure is accepted.  The table below shows the r 
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values obtained by both randomisation and bootstrapping analyses as tests for 
statistical significance. 
The combined SNP and microsatellites data set of P. falciparum clonal genotypes 
obtained from Mali showed statistically significant spatial structuring within the 1
st
 
class (0-0.1km) (Figure 6.6).  Within this class, the H0 was rejected as there was 
clear indication of genetic structuring as revealed by the r value (blue line) exceeding 
the upper limit (upper red dashed line) in addition, the mean bootstrap r was above 0.   
However, the analysis performed in Figure 6.6 included within individual clonal 
genotypes which are usually highly related genetically compared to infections 
obtained between individuals.  To ascertain whether these results reflect actual 
genetic structuring of malaria parasites within the observed geographic distance, 
analysis comprising the major clones only in Mali was carried out.  The results are 
shown in Figure 6.7.  These results are a clear indication that the observed genetic 
relatedness in Figure 6.6 was due to the existence of within individuals parasite 
infections in the analysis since analysis with the major clones only did not give any 
evidence of genetic structuring within short geographic distances. 
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n 16 64 176 146 82 
Distance Class (End Point) 0-0.1 0.1-0.2 0.2-0.3 0.3-0.4 0.4-0.5 
r -0.101 0.005 -0.007 0.014 0.010 
U 0.150 0.057 0.024 0.032 0.045 
L -0.099 -0.044 -0.030 -0.033 -0.044 
P(r-rand >= r-data) 0.977 0.386 0.733 0.198 0.320 
P(r-rand <= r-data) 0.024 0.615 0.268 0.803 0.681 
Mean Bootstrap r -0.089 -0.001 -0.007 0.014 0.012 
Ur error 0.136 0.069 0.034 0.035 0.058 
Lr error 0.133 0.081 0.032 0.038 0.052 
Figure 6.7  A correlogram of spatial autocorrelation analysis for Kolle region, Mali 
comprising data from the major clones only.  This illustration shows distance classes 
set in km as:  0-0.1, 0.1-0.2, 0.2-0.3, 0.3-0.4, 0.4-0.5 & 0.5-0.6.  Once again, the 
spatial autocorrelation is performed up to the distance class (0.4-0.5) and the last one 
is ignored.  The blue line represents the spatial autocorrelation coefficients computed 





 confidence limits bound by the 95% confidence interval about the 
null hypothesis of no spatial structure for the combined data set as determined by 
permutation.  When the blue line (r) exceeds the upper and lower confidence limits 
(red dashed lines), significant genetic structure is inferred. 1000 bootstrap trials give 
a mean bootstrap r bound by the 95% confidence limit.  The upper (U) 25
th
 and lower 
(L) 975
th
 confidence limits are given by the error bars.  When the mean bootstrap r is 
close to 0, the null hypothesis of no spatial structure is accepted.  The table below 
shows the r values obtained by both randomisation and bootstrapping analyses as 
tests for statistical significance. 
 
6.4. Discussion 
In this concluding chapter of the thesis, genetic distance based analyses were 
performed.  With reference to the concept forming the basis of this project outlined 
in Chapter 1, Section 1.6, the analyses described in this chapter attempted to 
address the distribution of malaria parasites in space.  It is already known that 
malaria parasite transmission is heterogeneous.  Elucidation of parasite transmission 
patterns in space would aid in determining discrete clusters of parasite populations in 
 
  206 
different geographic regions.  These clusters can then be identified and targeted for 
stratified malaria elimination programs.   
Spatial distribution of malaria parasites has been investigated prior to establishment 
of malaria elimination programs previously.  Geographical reconnaissance using 
GPS to determine high malaria risk areas (hotspots) was used to develop malaria risk 
maps in a baseline survey conducted at the Solomon islands and Vanuatu islands 
(Reid et al., 2010; Kelly et al., 2010).  Other studies have attempted to establish 
clusters of malaria transmission using sero-conversion rates of antibodies (Bousema 
et al., 2010; Bejon et al., 2011).   
The use of neutral genetic markers to detect clusters of closely mating parasites has 
been attempted in few studies.  These have been conducted using microsatellites in 
Brazil (Machado et al., 2004), Malaysia (Anthony et al., 2011); and recently in West 
Africa (Mobegi et al., 2012).  SNP assays have also been developed and tested for P. 
falciparum population genetic studies (Campino et al., 2011; Manske et al., 2012).  
So far, detection of the genetic relatedness of malaria parasites to trace parasite 
transmission patterns in space has not been attempted.  It is on this basis that this 
study was developed, to: 1. Identify suitable genetic markers that can isolate malaria 
parasite clones present in mixed clone infections, 2. Use the identified clonal 
genotypes to unravel the spatial patterns of P. falciparum within short geographic 
settings (<1km) and across different African countries.  The information obtained in 
this study can subsequently be used in future studies to trace transmission of these 
parasites from one individual to another.  This would aid in the identification of 
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discrete clusters of malaria transmission in space that can be targeted in malaria 
intervention programs. 
 
6.4.1. AMOVA analysis 
The results obtained in this study reveal that across the 3 African countries namely, 
Cameroon, Kenya and Mali majority of the genetic variation is explained among 
parasites within populations rather than between the 3 countries (Table 6.1).  Similar 
findings were observed in a study comparing P. falciparum populations between a 
lowland and highland region using microsatellites estimation of allele frequencies in 
Western Kenya.  This study observed that between the two regions, 92.2% of the 
variation was explained within P. falciparum populations and 6.9% among 
populations (Zhong et al., 2007). 
The results in Table 6.1 give further evidence to the pre-existing knowledge of 
observed significant parasite genetic diversity levels in Africa’s high malaria 
transmission areas (Anderson et al., 2000).  The overall PT value observed was low 
and in concordance with FST values observed between parasite populations across 
Africa (Anderson et al., 2000; Mobegi et al., 2012).  The overall observed PT 
(0.049) is also comparable to the overall value obtained using microsatellites only 
(0.043).   
The low PT value obtained in this study, in addition to the low FST values obtained 
in other studies, give an impression of randomly mating parasite populations across 
distances >1000km.  This is indeed not possible considering that the greatest distance 
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of dispersal for the mosquito is approximately 1km (Trape et al., 1992; Takken et al., 
1998) (not considering mosquitos implicated for spread of ‘airport malaria’).  Human 
movement between sites has also been implicated in facilitating mixing of malaria 
parasites leading to low observed FST values (Zhong et al., 2007).  The most 
plausible reason for the low observed values of genetic differentiation is the presence 
of highly genetically diverse parasite clones within multiply infected human hosts 
such that the effective population size (number of parasites that are mating and 
contributing to the gene pool) is increased.  Thus, low levels of genetic 
differentiation are maintained because with such large effective population sizes the 
effects of genetic drift are minimal.  In addition, migration of infected individuals 
even to within short geographic distances constributes substantially to the existing 
parasite gene pool as a result of the high rate of recombination between genetically 
distinct clones.  Although there could be existing clusters of closely mating parasites 
they might be overlapping within short geographic distances diminishing the genetic 
structuring of these parasites. 
 
6.4.2. Mantel test 
A low but statistically significant positive correlation of genetic and geographic 
distances was observed in the P. falciparum clonal genotypes from the 3 African 
countries (Figure 6.3).  This is in conformity with the isolation by distance theory 
stating that the genetic relatedness of malaria parasites reduces with increasing 
geographic distance.  This is what is typically expected in nature and has been widely 
studied in plants (reviewed by Vekemans & Hardy, 2004). This was however not 
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observed in Mali giving the impression of a randomly mating parasite population 
within the study site (Figure 6.4).  
Isolation by distance phenomenon has been observed in P. falciparum in a region 
experiencing reductions of malaria incidences in Borneo, Malaysia (Anthony et al., 
2005).  However, in West Africa no correlation was observed between geographic 
distances and genetic distances (Mobegi et al., 2012).  The failure to detect isolation 
by distance in Mali could be indicative of no genetic structuring or existence of 
discrete clusters of closely mating parasites that could not be elucidated with the set 
of genetic markers used in this study.   
 
6.4.3. The spatial autocorrelation test 
This analysis was performed to examine at finer geographic spatial scales the 
distribution of malaria parasites.  The spatial autocorrelation analysis performed over 
all the P. falciparum clonal genotypes (Figure 6.5) and in the Malian genotypes, 
revealed no spatial autocorrelation except within a region spanning 0-0.043km 
(Figure 6.6).  This observation is not surprising due to the existence of closely 
related parasite genotypes obtained within a single isolate.  A recent study by 
Nkhoma et al., 2012 observed that comparison between P. falciparum haplotypes 
recovered within infections were closely related genetically than those between 
infections.  Since genotypes obtained within and between infections were included in 
this analysis, within infection clonal genotypes obtained from a single isolate are 
more genetically related compared to between infection clonal genotypes.  This was 
 
  210 
further evidenced in the analysis using major clones only in Mali (Figure 6.7) 
whereby no genetic structuring was observed. 
Although in Chapter 5 significant levels of spatial structuring were observed in 
Kolle, Mali within geographic distances ~0.4km, the results obtained in this chapter 
indicate that there is no population structure in this region meaning it comprises 
randomly mating parasites.  Perhaps there is considerable human or mosquito 
migration facilitating mixing of malaria parasites. 
It is noteworthy that the findings obtained in the Kolle region, Mali only pertain to 
this study site and is not a reflection of the overall P. falciparum spatial patterns 
across all African sites.  The dynamics of malaria transmission are varied and 
specific to each study site. Indeed this study recognizes the lack of actual geographic 
co-ordinates for the isolates collected from Rusinga Island, Kenya or in Cameroon.   
This information would have provided alternative spectra in defining patterns of 
malaria parasites’ distribution within small spatial scales.  Even so, performing a 
combinatorial analysis using both genetic markers has given a snapshot view of the 
spatial distribution of malaria parasites within a region separated by distances 
(<1km), and across Africa. 
 
6.4.4. Conclusion 
This chapter culminates the analyses planned for this thesis.  The genetic distance 
based analyses outlined in this chapter have revealed how malaria parasites are 
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dispersed in space.  No significant spatial autocorrelation has been observed within 
and between the studied sites in Africa  
 
 
  212 
7. FINAL DISCUSSION 
7.1. Synopsis of thesis 
This thesis entailed a feasibility study to investigate the transmission patterns of P. 
falciparum malaria parasites in short geographic distance (~1km).  The steps 
involved in achieving this are outlined below. 
1. This study intended to use genotyping methods for the identification of 
infecting malaria parasites present in human blood.  The first step was 
therefore, to find polymorphic genetic markers in this case, SNPs.  The 
process involved in the identification and ascertainment of these SNPs is 
covered in Chapters 3 & 4. 
2. The next step was to establish a method for SNP detection that enabled the 
identification of parasite genotypes.  Considering that malaria parasites exist 
as mixed clone infections, a technique facilitating the differentiation of clonal 
genotypes from these infections was required.  Pyrosequencing
TM
, a 
technique that identifies SNPs and quantifies them assigning proportions 
relative to their amounts e.g. in a mixed clone infection, was used.  Parasite 
clonal genotypes could then be determined on the basis that SNPs occurring 
in the same proportion comprised genotypes representing a single clone.  The 
use of the identified SNPs and technique validation is discussed in Chapters 
3 & 4. 
3. Having identified the SNPs and validated the technique, analysis of P. 
falciparum field isolates was carried out.  Malaria positive blood samples 
obtained from Kenya, Cameroon and Mali were analysed.  Initially, sample 
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collections were done in Kenya, the major criterion in this site being that they 
should be obtained from inhabitants of Rusinga Island.  However, in the 
course of the study we realised that parasite isolates obtained from within 
short geographic distances of each other (~1km) and furnished with 
geographic co-ordinates would be more informative for the purposes of this 
thesis.  Thus, further collections were carried out in Mali within a region of 
<1km and geographic coordinates were available.  In addition, through 
collaboration between the University of Edinburgh and the University of 
Cameroon, further collections were carried out in Cameroon to investigate the 
feasibility of using Illumina - Solexa sequencing for parasite clonal genotypes 
identification.  Use of this technique was later rejected due to financial 
constraints and the amount of post-sequencing in silico work required. This 
aspect was however not covered in this thesis.  Nevertheless, the Cameroon 
samples were also analysed in this thesis even though information on their 
geographic coordinates was missing.   
In addition to the SNPs, microsatellites were also used to increase the 
genotypic information obtained using SNPs only, which facilitated the 
identification of more clonal genotypes.  However, since both sets of genetic 
markers have different mutation rates, they were analysed separately in the 
model based analyses outlined in Chapter 5.  
Using the identified parasite clonal genotypes, informative tests were 
performed to reveal the usefulness of the SNPs and microsatellites in the 
detection of genetic variation in field isolates.  Also, this study intended to 
reveal the gene flow patterns of these parasites in different geographic 
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settings.  For this purpose, neutral genetic markers are preferred over use of 
markers that could be under selection.  This is because selection alters 
patterns of allelic diversity obscuring the effects of gene flow patterns in the 
distribution of allelic diversity in space.  The microsatellites were tested for 
presence of LD which, if present, is indicative of the non-random association 
of alleles due to selection.  They were found not to be in LD (see Chapter 5).   
Evidence of population structure in the regions studied was investigated.  
This was performed to reveal patterns of P. falciparum transmission whereby 
partitioning of parasites in a population into smaller subpopulations with 
limited gene flow between them would reveal that majority of the genetic 
diversity is explained between the subpopulations as opposed to within them.  
In addition, the partitioning of individual parasites into small isolated 
subpopulations leads to their being independently acted upon by genetic drift 
altering their allele frequencies and further increasing the genetic divergence 
between them. 
At a continental level, statistically significant levels of population structuring 
were observed by comparing clonal genotypes obtained from Kenya, Mali 
and Cameroon.  This is expected as at this level, parasites are separated by 
large geographic distances with limited gene flow between them.  Further 
partitioning of the clonal genotypes obtained from the Mali study site whose: 
(i) geographic coordinates were known and (ii) isolates were obtained from 
within a distance of <1km was performed and genetic differentiation 
determined.  Both sets of markers of markers seemed to indicate theat there 
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was evidence of genetic differentiation within a distance of 400m (Chapter 
5).   
4. Finally, a spatial autocorrelation analysis was performed in an attempt 
to reveal distinct clusters of closely mating parasites in space.  For these 
analyses, the SNPs and microsatellites loci were combined.  At a continental 
level, a slightly significant positive correlation between genetic and 
geographic distances was observed.  However, a similar test in Mali (region 
<1km) revealed no correlation.  Further to this, the spatial autocorrelation test 
revealed no spatial structuring in Mali (Chapter 6).  
 
7.2. Key findings and their implications in malaria management  
This study was an attempt to detect levels of genetic relatedness in malaria parasite 
isolates occurring within short geographic distances.  The findings in this study 
indicate that no closely mating parasites within tightly clustered regions were 
observed.  So, what does this mean? 
Currently, there is a renewed commitment globally to reduce or even eradicate 
malaria incidences.  To achieve this, we need to borrow lessons from the 
management and successful eradication of other infectious diseases.   
To date, the only disease to be successfully eliminated is small pox although other 
concerted efforts have led to reductions but not eradication of polio and measles.  
Firstly, these programs are evidence-based. For example in the management of 
measles; genotyping identified the genetic relatedness of the virus in different 
geographic settings allowing the monitoring of vaccine failures, disease resurgences 
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and its transmission patterns e.g. the occurrence of  imported cases (Mulders et al., 
2001; Tischer et al., 2004)  The role of research in the active surveillance of disease 
management programs is therefore relevant.  Malaria intervention studies currently 
appreciate this which is one of the reasons why the study described in this thesis was 
formulated.  This project has helped me appreciate the importance of evidence-based 
malaria intervention strategies.  It has also served as a good foundation as I take up 
my post-doctoral fellowship position on a project involving malaria elimination in 
the Lake Victoria Islands, Kenya.  My roles include determining the gene flow 
patterns of the malaria patterns due to migration of either people or mosquitos within 
and between the islands.  In addition, the P. falciparum multiplicity of infection will 
be determined before and after intervention to monitor the effectiveness of the 
control strategy.  Successful interventions leading to malaria elimination in these 
high malaria transmission islands will hopefully inform planned malaria studies in 
the mainland. 
Secondly, successful eradication of small pox and type 2 polio was possible 
following the development of vaccines for immunization (Andre et al., 2008).  
Current malaria research is focussing on the development of transmission blocking 
vaccines that would curtail transmission of the infective stages of malaria parasites 
by the mosquito.  Unlike an asexual stage vaccine which protects an individual from 
the development of clinical disease, the transmission blocking vaccine has the added 
advantage of protecting the community by reducing parasite progression which is the 
basis of vaccine development.  The focality of malaria transmission further enhances 
its efficacy because the immunisation of one susceptible individual not only 
effectively reduces the efficiency of parasite transmission within his/her house but 
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also in the neighbouring houses a phenomenon referred to as ‘herd immunity.’  This 
is the “reduction of infection or disease in the unimmunised segment as a result of 
immunising a segment of the population” (John & Samuel, 2000).  This in turn leads 
to the reduction of R0 within a household and subsequently in the community. 
In this study however, the existence of tightly clustered malaria parasites was not 
observed.  This means that either the paucity of the genetic markers used led to 
failure in the detection of malaria parasites’ divergence occurring within the studied 
regions or perhaps the level of genetic diversity in these parasites is so high (due to 
their high effective population size) that it is difficult to observe population structure.  
Based on the findings of other studies carried out in Africa e.g. Anderson et al., 2000, 
the latter explanation seems highly plausible.  It is also possible that the current 
malaria control efforts in Africa have still not managed to reduce malaria endemicity 
to levels enabling the fragmentation of parasites to small closely mating 
subpopulations. 
 
7.3. Lessons learnt 
The overall objective of this study i.e. the exploration of malaria parasites’ 
distribution within small geographic settings was achieved.  However, important 
issues that arose in the course of the study are outlined below. 
1. Proper project design – The sampling strategy whereby samples were initially 
collected from Kenya with no geographic coordinates which necessitated 
further collections in a different study site highlights the need for ample 
planning in the design of the project.  This would have saved time and costs.  
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In addition, the Kenyan samples were not informative in the intended study 
objective.   
2. Few genetic markers – Although the identified SNPs for use in this study 
were observed to be informative, higher genome coverage of P. falciparum 
genetic markers is required.  I appreciate that other studies have identified 
suitable SNPs for population genetics studies using high density genome-wide 
SNP coverage e.g. Manske et al., 2012.  To publish this work, only 
microsatellites data will be considered. 
3. Although ample information was obtained using both SNPs and 
microsatellites for the identification of clonal genotypes for future studies it is 
better to use one set of genetic markers not both of them combined especially 
to make inferences in population genetic studies.  As already stated in Chapter 
5, the fact that they have different mutation rates necessitates their separate 
analysis.   
It is noteworthy that a study can be designed to accommodate both sets of 
genetic markers. For example Nkhoma et al., (2012) used microsatellites to 
identify mixed clone infections in field isolates.  From this, they isolated single 
clones by a semi-cloning step and subsequently used SNPs to identify 
haplotypes for the determination of parasite genetic relatedness.   
 
7.4. Future prospects of study 
This feasibility study has ascertained that this work can be done successfully with 
proper design, well thought out sampling strategy and with adequate number of 
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genetic markers.  However, it is noteworthy that with the current malaria 
transmission patterns in Africa, it is not possible to detect patterns of genetic 
differentiation yet.  With the ongoing persistent malaria control efforts, regional 
fragmentation into patches of varying transmission intensities is expected to emerge.  
It is at this point that a study of this nature will be highly applicable.   
This section therefore highlights future considerations in the design of a project 
entailing tracing of malaria parasites in space as outlined in the project concept 
(Chapter 1, Section 1.6). 
1. Study site  
A suitable study site would include human habitation and proximity to a 
mosquito breeding site within the estimated average distance of travel for a 
mosquito to and from a breeding site (~1km).  The closeness of the houses 
also needs to be factored in and also the number of individuals per house.  
This is to reveal patterns of malaria parasites transmission from person to 
person (e.g. within a single household) or between houses in close proximity 
of each other. 
2. Sampling strategy 
Once an appropriate study site has been established, the households have 
been properly mapped and the geographic coordinates are known, it is 
important to consider the number of times sampling will be done to ensure 
adequate representation of infecting parasites for population genetic 
inferences.  
To begin with, the transmission intensity of an area needs to be factored in.  
For example in a high malaria transmission area, it can be assumed that 
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individuals are continuously bitten by the mosquito and inoculated with 
parasites.  On the other hand in a low malaria transmission region, the rate of 
parasite inoculations is scanty.  
Secondly, since sampling precedures may miss out sequestered parasite 
clones, repeated sampling is relevant. The issue of how often this needs to be 
done arises.  Considering the P. falciparum parasite lifecycle (see Chapter 1, 
Figure 1.1) and assuming that malaria transmission is continuous as in a high 





















Figure 7.1  Time to maturation of malaria parasites in the human host and in the 
mosquito.  In the human host, it takes ~6 days from the time malaria parasites are 
inoculated to the human host to their appearance in peripheral blood (schizogony to 
erythrocytic stage) at which point they can be collected for analysis.  For gametocyte 
maturation, it takes several 48 hour proliferative asexual cycles for the peak 
parasitaemias in the human host to be achieved triggering a stress response that 
initiates gametocyte formation.  This has been factored in the gametocyte maturation 
period to their ingestion by the mosquito but it may take longer than this (12-14 
days).  It then takes another 8-15 days in the mosquito for the infective sporozoites to 
mature and be reintroduced to the human host (sporogonic cycle).  It then takes 
another ~6 days before these parasites can be detected in peripheral blood for 
sampling. 
 
Sporogonic cycle (Maturation 
stage in the mosquito) 




12 - 14 days 
8 -15 days 
 
  221 
According to Figure 7.1, it takes ~32 days for a complete cycle from the first 
infective bite to the next reinfection.  This is assuming that the mosquito lives long 
enough to infect and re-infect a person.  This is important because, if sampling is 
done at time 0 and clonal genotypes obtained, ~32 days later novel genotypes can be 
produced following genetic recombination in the mosquito.  Thus parasite genotypes 
that may have been missed out due to sequestration can possibly be detected as 
products of recombination.  With repeated sampling, a clearer picture will emerge 
between parental genotypes and the progeny.  The question of the number of times 
this needs to be done will be covered in the next section. 
3.  Genetic markers 
Although both SNPs and microsatellites were used in this thesis for the identification 
of parasite clonal genotypes, SNPs were the choice genetic markers for analysis as 
outlined in Chapter 3 and will be discussed in this section.  In order to trace how 
malaria parasites are being transmitted in space, it is important to use high density 
SNPs per chromosome for haplotype (blocks of adjacent nucleotides that are 
inherited together) detection.  Using these haplotypes, closely related parasites can 
therefore be identified.  However, these blocks are usually broken down by 
recombination since P. falciparum has a high recombination rate i.e. ~15-20kb/cM 
per generation such that haplotype blocks have a high rate of being broken down.  
This is further complicated by the high rates of multiple infections in regions of high 
malaria transmission intensity leading to increased numbers of novel clone genotypes.  
How dense then should the SNPs coverage be per chromosome?   
A study by Mu et al., (2005) revealed that different rates of recombination occurred 
on the P. falciparum chromosome 3 (size ~1MB) with the highest rates observed in 
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the sub-telomeric regions. In this study, a haplotype block of 11.2kb was obtained in 
African P. falciparum populations.  It is therefore recommended that high SNP 
coverage from short and longer chromosomes be used. This is because in longer 
chromosomes, the rates of recombination relative to the chromosomal sizes have 
been observed to be lower than in shorter chromosomes (Mu et al, 2007) increasing 
the chances of haplotype detection. 
4. Detection method 
The Pyrosequencing
TM
 technique developed and used in this thesis is appropriate for 
this analysis more so because it allows the inference of relative proportions of 
genetically distinct clones per infection.  However, the process of generating assays 
is long and time consuming including its limits of accuracy as outlined in Chapter 4.  
The advances on next generation sequencing offer alternative methods in the analysis 
of genome-wide SNPs.  However, as already stated, when dealing with mixed clone 
infections the identification of genotypes is still a challenge.  Although it is time 
consuming, a semi-cloning step such as that used by Nkhoma et al., (2012) can be 
incorporated in the analysis to ensure that only a single parasite clone per isolate is 
sequenced.  This eases the subsequent in silico post-sequencing identification of 
clonal genotypes.   
5. Interpretation of results 
Once the haplotypes have been identified, one of the challenges in the interpretation 
of results is defining alleles that are identical by state (IBS) or identical by descent 
(IBD).  To understand this concept, see Figure 7.2 below.  
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Figure 7.2  Depiction of IBD and IBS.  The current population can be traced back to 
its original ancestor by coalescence.  The ancestral chromosome has a polymorphic 
G/T region i.e. the ‘G’ allele mutates to a ‘T’.  The base population when performing 
coalescence simulations comprises individuals assumed to be unrelated hence the 
multi-coloured chromosomes.  In the current population the G alleles in the C1, C2 
and C3 chromosomes are IBD as they are inherited from the same ancestor (B1).  On 
the other hand, the T allele carried by C4 and C5 are IBS, but not IBD, as they 
descend from different alleles in the base population (B3 and B4, respectively). 
(Figure adapted from Powell et al., 2010). 
 
Figure 7.2 reveals the complexities involved in the interpretation of data involved in 
a pedigree analysis (involving mating patterns of closely related individuals) which is 
appropriate for the project concept outlined in Chapter 1, Section 1.6.  It is expected 
that mating among relatives (inbreeding) is concordant with high observed GR 
values.  However, in this analysis, the current population (the first sampled 
population) is usually assumed to constitute the parental clones and probabilistic 
inferences made on their ancestral population (base population in Figure 7.2).  It is 
at this point that erroneous interpretation can be made if IBS alleles are not IBD.   
This problem can be circumvented by using highly dense continuous genetic markers 
per chromosome for accurate detection of haplotypes that are IBD (Browning, 2008).  
Base population 
Mutation event from G to T 
Current population 
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Ths is because highly dense SNPs per chromosome have a high chance of being IBD 
due to linkage obscuring the effects of IBS alleles.  The use of high density SNPs 
coupled with sampling at more than one time point would ensure accurate detection 
of haplotypes from which inferences on the local mating patterns of parasites can be 
made. 
In conclusion, the findings and the lessons learnt in this study offer tremendous 
prospects to the tracing of malaria parasites within short geographic distances 




  225 
8. REFERENCES 
 
Adjei O, May J (2008). Spatial variation of malaria incidence in young children from 
a geographically homogeneous area with high endemicity. The Journal of Infectious 
Diseases 197(1): 85–93 
 
Albrechtsen A Nielsen FC, Nielsen R (2010). Ascertainment biases in SNP chips 
affect measures of population divergence. Molecular Biology and Evolution 27(11): 
2534–47 
 
Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo 
OK, Greenwood B, Hall FM, Levine MM, Mendis K, Newman DR, Plowe CV, 
Rodriguez MH, Sinden R, Slutsker L, Tanner M (2011).  A research agenda to 
underpin malaria eradication.  PLoS Medicine 8(1):1-8 
 
Anderson TJ, Su XZ, Bockarie M, Lagog M, Day, KP (1999). Twelve microsatellite 
markers for characterization of Plasmodium falciparum from finger-prick blood 
samples. Parasitology 119 (2): 113–25  
 
Anderson TJ, Haubold B, Williams JT, Estrada-Franco GJ, Richardson L, Mollinedo 
R, Bockarie M, Mokili J, Mharakurwa S, French N, Whitworth J, Velez DI, 
Brockman AH, Nosten F, Ferreira MU, Day KP(2000). Microsatellite markers reveal 
a spectrum of population structures in the malaria parasite Plasmodium falciparum. 
Molecular Biology and Evolution 17(10): 1467–82  
 
Anderson, TJC, Nair S, Sudimack D, Williams JT, Mayxay M, Newton PN, 
Guthmann JP, Smithuis FM, Tran TH, van den Broek IVF, White NJ, Nosten F 
(2005). Geographical distribution of selected and putatively neutral SNPs in 
Southeast Asian malaria parasites. Molecular Biology and Evolution 22(12): 2362–
74  
 
Andre FE, Booy R, Bock H, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, 
Peltola H, Ruff TA, Santosham M, Schmitt HJ (2008).  Vaccination greatly reduces 
disease, disability, death and inequity worldwide.  Bulletin of the World Health 
Organization 86(2): e1000405 
 
Ansell J, Hamilton KA, Pinder M, Walraven GEL, Lindsay S (2002). Short-range 
attractiveness of pregnant women to Anopheles gambiae mosquitoes. Transactions of 
the Royal Society of Tropical Medicine and Hygiene 96(2):113–6 
 
Anthony TG, Conway DJ, Cox-Singh J, Matusop A, Ratnam S, Shamsul S, Singh B. 
(2005). Fragmented population structure of Plasmodium falciparum in a region of 
declining endemicity. The Journal of Infectious Diseases 191(9): 1558–64  
 
 
  226 
Arez AP, do Rosário, VE (2008). The relevance of molecular markers in the analysis 
of malaria parasite populations. Transboundary and Emerging Diseases 55(5-6): 
226–32  
 
Arnot DE, Roper C, Bayoumi R.AL (1993). Digital codes from hypervariable 
tandemly repeated DNA sequences in the Plasmodium falciparum circumsporozoite 
gene can genetically barcode isolates. Molecular and Biochemical Parasitology 
61(1): 15–24  
 
Arnot DE (2002). The influence of the genetic complexity of Plasmodium 
falciparum infections on the epidemiology of malaria. Transactions of the Royal 
Society of Tropical Medicine and Hygiene 96(1): S1/131–S1/136 
 
Auburn S, Campino S, Clark TG, Djimde AA, Zongo I, Pinches R, Manske M, 
Mangano V, Alcock D, Anastasi E, Maslen G, MacInnis B, Rockett K, Modiano D, 
Newbold CI, Doumbo OK, Ouédraogo JB, Kwiatkowski DP (2011).  An Effective 
Method to Purify Plasmodium falciparum DNA Directly from Clinical Blood 
Samples for Whole Genome High-Throughput Sequencing.  PLoS ONE 6(7): e22213 
 
Aujoulat F, Roger F, Bourdier A, Lotthé A, Lamy B,  Marchandin H, Jumas-Bilak 
(2012). From Environment to Man: Genome Evolution and Adaptation of Human 
Opportunistic Bacterial Pathogens. Genes 3: 191–232 
 
Avise CJ (2004). Short tandem repeat loci (STRs) (microsatellites).  In Molecular 
markers, natural history and evolution (2nd eds), pp 92-93.  Sinauer Associates, 
Sunderland, Massachussets  
 
Ayala FJ, Escalante AA, Lal AA, Rich SM (1998) in Malaria:Parasite Biology, 
Pathogenesis, and Protection, ed. Sherman, I. W. (American Society of 
Microbiology, Washington, DC), pp. 285–300. 
 
Babiker HA, Ranford-Cartwright LC, Currie D, Charlwood JD, Billingsley P, 
Teuscher T, Walliker D (1994). Random mating in a natural population of the 
malaria parasite Plasmodium falciparum. Parasitology 109(4): 413–21  
 
Babiker HA, Walliker D (1997). Current views on the population structure of 
Plasmodium falciparum: Implications for control. Parasitology Today 13(7): 262–7  
 
Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G,Walliker D (1998). 
Characteristics of Plasmodium falciparum parasites that survive the lengthy dry 
season in eastern Sudan where malaria transmission is markedly seasonal. The 
American Journal of Tropical Medicine and Hygiene 59(4): 582–90  
 
Babiker HA, Ranford-Cartwright LC, Walliker D (1999). Genetic structure and 
dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. 
Transactions of the  Royal Society of Tropical Medicine and  Hygiene 93: S11–S14 
 
 
  227 
Baird JK, Jones TR, Danudirgo EW, Annis BA, Bangs MJ, Basri H, Purnomo 
Masbar S (1991). Age-dependent acquired protection against Plasmodium 
falciparum in people having two years exposure to hyperendemic malaria. The 
American Journal of Tropical Medicine and Hygiene 45(1): 65–76  
 
Balloux F, Lugon-Moulin N. (2002). The estimation of population differentiation 
with microsatellite markers. Molecular Ecology 11(2): 155–65  
 
Beier JC (1998). Malaria parasite development in mosquitoes. Annual Review of 
Entomology 43: 519–43  
 
Bejon P, Williams TN, Liljander A, Noor AM,  Wambua, J, Ogada E, Olotu A, Osier 
F HA, Hay SI, Färnert A, Marsh, K (2010). Stable and unstable malaria hotspots in 
longitudinal cohort studies in Kenya. PLoS medicine 7(7): p.e1000304 
 
Bejon P, Turner L, Lavstsen T, Cham G, Olotu A, Drakeley C J, Lievens M, 
Vekemans J, Savarese G, Lusingu J, Seidlein L, Bull P, Marsh K, Theander GT 
(2011). Serological Evidence of Discrete Spatial Clusters of Plasmodium falciparum 
Parasites. PloS one 6(6): e21711. doi:10.1371/journal.pone.0021711 
 
Bendixen M, Msangeni HA, Pedersen BV, Shayo D, Bødker R (2001). Diversity of 
Plasmodium falciparum populations and complexity of infections in relation to 
transmission intensity and host age: a study from the Usambara Mountains, Tanzania. 
Transactions of the Royal Society of Tropical Medicine and Hygiene 95(2): 143–8  
 
Berendt AR, Ferguson DJP, Gardner J, Turner GT, Rowe A, McCormick C, Roberts 
D, Graig A, Pinches R, Elford BC, Newbold CI (1994). Molecular mechanisms of 
sequestration in malaria. Parasitology 108:S19-S28  
Bhattarai, A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khatib R, Al-mafazy A-
W, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, 
Kaneko A, Björkman A (2007). Impact of artemisinin-based combination therapy 
and insecticide-treated nets on malaria burden in Zanzibar. PLoS Medicine 
4(11):e309  
 
Bockarie MJ, Davies JB, Thomson MC, Morgan HG (1990). The transmission of 
onchocerciasis at a forest village in Sierra Leone. I. Simulium damnosum s.l. biting 
densities and infection with Onchocerca volvulus at five representative sites. Annals 
of Tropical Medicine and Parasitology 84(6): 587–97  
 
Bogreau H, Renaud F, Bouchiba H, Durand P, Ass, S-B, Henry M-C, Garnotel E, 
Pradines B, Fusai T,  Wade B, Adehossi E, Parola P, Kamil AM, Puijalon O, Rogier 
C (2006). Genetic diversity and structure of African Plasmodium falciparum 
populations in urban and rural areas. The American Journal of Tropical Medicine 
and Hygiene 74(6): 953–9  
 
Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, Otieno S, 
Carneiro I, Cox J, Msuya E, Kleinschmidt I, Maxwell C, Greenwood B, Riley E, 
 
  228 
Sauerwein R, Chandramohan D, Gosling R (2010). Identification of hot spots of 
malaria transmission for targeted malaria control. The Journal of Infectious Diseases 
201(11): 1764–74 
 
Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, Ghani 
A, Drakeley C, Gosling R (2012). Hitting Hotspots: Spatial Targeting of Malaria for 
Control and Elimination. PLoS Medicine 9(1):e1001165 
 
Breman JG, de Quadros CA, Dowdle WR, Foege WH, Henderson DA, John TJ, 
Levine MM (2011).  Laboratory investigations are indispensable to monitor the 
progress of measles elimination - results of the German Measles Sentinel 1999-2003.  
PLoS Medicine 8(1): e1000405 
 
Browning S (2008).  Estimation of pairwise identity by descent from dense genetic 
marker data in a population sample of haplotypes.  Genetics 178(4): 2123-32 
 
Bruce-Chwatt LJ (1981).  Alphonse Laveran’s discovery 100 years ago and today’s 
global fight against malaria.  Journal of the Royal Society of Medicine 74:531-36 
 
Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, 
Walliker D, Day KP  (2000a). Genetic diversity and dynamics of Plasmodium 
falciparum and P. vivax populations in multiply infected children with asymptomatic 
malaria infections in Papua New Guinea. Parasitology 121 (3): 257–72 
 
Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day, 
KP (2000b) Cross-species interactions between malaria parasites in humans. Science 
287: 845–848 
 
Bruce MC, Macheso A, Galinski MR, Barnwell JW (2007). Characterization and 
application of multiple genetic markers for Plasmodium malariae. Parasitology 134: 
637–50 
 
Campino S, Auburn S, Kivinen K, Zongo I, Ouedraogo, J.-B, Mangano V., Djimde 
A, Doumbo KO, Kiara MS, Nzila A, Borrman S, Marsh K, Michon P, Meller I, Siba 
P, Jiang H, Su XZ, Amaratunga C, Socheat D, Fairhurst MR, Imwong M, Anderson 
T, Nosten F, White JN, Gwilliam R, Deloukas P, MacInnis B, Newbold CI, Rockett, 
Clarke GT, Kwiatkowski DP (2011). Population Genetic Analysis of Plasmodium 
falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay. 
PloS One 6(6): e20251  
 
Cappana E (2006).  Grassi versus Ross: who solved the riddle of malaria? 
International Microbiology 9(1):69-74 
 
Carlton JM. Toward a malaria haplotype map (2007). Nature and Genetics 39:5-6 
 
Carter R, McGregor IA (1973). Enzyme variation in Plasmodium falciparum in the 
Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene 67(6): 
830–837 
 
  229 
 
Carter R, Voller A (1975). The distribution of enzyme variation in populations of 
Falciparum in Africa. Transactions of the Royal Society of Tropical Medicine and 
Hygiene 69(4): 371–376 
 
Carter R, Graves PM (1988).  Gametocytes.  In Malaria Principles and Practice of 
Malariology. (ed . W. H. Wernsdorfer & I. McGregor), pp. 253-305. Edinburgh. 
Churchill Livingstone  
 
Carter R, Mendis KN, Roberts D (2000). Spatial targeting of interventions against 
malaria. Bulletin of the World Health Organization 78(12): 1401–11  
Carter R (2001).  Transmission blocking malaria vaccines.  Vaccine 19:2309-2314 
Carter R & Mendis KN (2002). Evolutionary and Historical Aspects of the Burden of 
Malaria. Clinical Microbiology Reviews 15(4):564-594  
Castelli F, Odolini S, Autino B, Foca E, Russo R (2010). Malaria Prophylaxis: A 
Comprehensive Review. Pharmaceuticals 3(10): 3212–3239 
 
Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJC, Sesay 
SSS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, 
Whittle HC, Greenwood BM, Conway DJ (2008). Changes in malaria indices 
between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 372(9649): 
1545–54 
 
Centers for Disease Control and Prevention (CDC). Malaria: Larval Control and 
Other Vector Control Interventions:  
http://www.cdc.gov/malaria/malaria_worldwide/reduction/vector_control.html 
 
Chandiwana SK,Woolhouse ME (1991). Heterogeneities in water contact patterns 
and the epidemiology of Schistosoma haematobium. Parasitology 103(3): 363–70  
 
Charlwood JD, Alecrim WA (1989). Capture-recapture studies with the South 
American malaria vector Anopheles darlingi, Root. Annals of Tropical Medicine and 
Parasitology 83(6): 569–76 
 
Cheesman S, Creasey A, Degnan K, Kooij T (2007).  Validation of 
PyrosequencingTM for accurate and high throughput estimation of allele frequencies 
in malaria parasites. Molecular and Biochemical Parasitology 152:213-219  
 
Cheesman S, Tanabe K, Sawai H, O'Mahony E, Carter R (2009). Strain-specific 
immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the 
rodent malaria parasite Plasmodium chabaudi. Journal of Molecular Epidemiology 
and Evolutionary Genetics in Infectious Diseases 9(2): 248–55  
 
Cheesman S, O'Mahony E, Pattaradilokrat S, Degnan K, Knott S, Carter R (2010). A 
single parasite gene determines strain-specific protective immunity against malaria: 
 
  230 
the role of the merozoite surface protein I. International journal for parasitology 
40(8): 951–61 
 
Clarke SE, Bøgh C, Brown RC, Pinder M, Walraven GE, Lindsay SW (2000).  Do 
untreated bed nets protect against malaria? Transactions of the Royal Society of 
Tropical Medicine and Hygiene 95(5):457-62 
 
Coatney GR, Collins WE, Warren McW, Contacos PG (1971). The Primate Malarias, 
2nd Edn. U.S. Department of Health, Education and Welfare, NIH, Bethesda, 
Maryland, USA. Cited in Singh et al., 2004 
 
Cole-Tobian JL, Biasor M, King CL (2005). High complexity of Plasmodium vivax 
infections in Papua New Guinean children. The American Journal of Tropical 
Medicine and Hygiene 73(3): 626–33  
 
Collins WJ, Greenhouse B, Rosenthal P, Dorsey G (2006). The use of genotyping in 
antimalarial clinical trials: a systematic review of published studies from 1995-2005. 
Malaria journal 5 (122) doi:10.1186/1475-2875-5-122 
 
Contamin H, Fandeur T, Bonnefoy S, Skouri F, Ntoumi F, Mercereau-Puijalon O, 
(1995). PCR typing of field isolates of Plasmodium falciparum. Journal of clinical 
microbiology 33(4): 944–51  
 
Conway DJ, Greenwood BM, McBride JS (1991). The epidemiology of multiple-
clone Plasmodium falciparum infections in Gambian patients. Parasitology 
103(1):1–6 
 
Conway DJ, McBride JS (1991). Population genetics of Plasmodium falciparum 
within a malaria hyperendemic area. Parasitology 103(1): 7–16  
 
Conway DJ, Roper C, Oduola AM, Arnot DE, Kremsner PG, Grobusch MP, Curtis 
CF, Greenwood BM (1999).  High recombination rate in natural populations of 
Plasmodium falciparum.  Proceedings of the National Academy of Sciences of the 
United States of America 96(8):  4506-11 
 
Conway DJ, Machado RL, Singh B, Dessert P, Mikes ZS, Povoa MM, Oduola AM, 
Roper C (2001). Extreme geographical fixation of variation in the Plasmodium 
falciparum gamete surface protein gene Pfs48/45 compared with microsatellite loci. 
Molecular and Biochemical Parasitology 115(2): 145–56  
 
Cowan GJM, Creasey, AM, Dhanasarnsombut K, Thomas AW, Remarque EJ, 
Cavanagh DR, (2011). A malaria vaccine based on the polymorphic block 2 region 
of MSP-1 that elicits a broad serotype-spanning immune response. PloS One 6(10): 
p.e26616  
 
Cox-Singh J, Davis, TME, Lee K-S, Shamsul SSG, Matusop A, Ratnam S, Rahman 
HA, Conway DJ, Singh B (2008a).  Plasmodium knowlesi malaria in humans is 
 
  231 
widely distributed and potentially life threatening.  Clinical Infectious Diseases 
46(2): 165-71 
 
Cox-Singh J, Singh B (2008b). Knowlesi malaria: newly emergent and of public 
health importance? Trends in Parasitology 24(9): 406–10  
 
Craig MH, Snow RW, le Sueur D (1999). A climate-based distribution model of 
malaria transmission in sub-Saharan Africa. Parasitology Today 15(3): 105–11  
 
Creasey A, Fenton B, Walker A, Thaithong S, Oliveira S, Mutambu S, Walliker, D 
(1990). Genetic diversity of Plasmodium falciparum shows geographical variation. 
The American Journal of Tropical Medicine and Hygiene 42(5): 403–13 
 
Cregan B, Mudge J, Fickus EW, Marek LF, Danesh D, Denny R, Shoemaker RC, 
Matthews BF, Jarvik T, Young ND (1999) Targeted isolation of simple sequence 
repeat markers through the use of bacterial artificial chromosomes. Theoretical and 
Applied Genetics 98: 919-928 
 
Daubersies P, Sallenave-Sales S, Magne S, Trape JF, Contamin H, Fandeur T, 
Rogier C, Mercereau-Puijalon O, Druilhe P (1996).  Rapid turnover of Plasmodium 
falciparum populations in asymptomatic individuals living in a high transmission 
area. The American Journal of Tropical Medicine and Hygiene 54(1): 18–26 
 
Day KP, Koella JC, Nee S, Gupta S, Read AF (1992). Population genetics and 
dynamics of Plasmodium falciparum: an ecological view. Parasitology 104: 
Suppl(1987):S35–52  
 
de Meeûs T, McCoy KD, Prugnolle F, Chevillon C, Durand P, Hurtrez-Boussès S, 
Renaud F (2007). Population genetics and molecular epidemiology or how to 
“débusquer la bête”.  Journal of molecular Epidemiology and Evolutionary Genetics 
in Infectious Diseases 7(2): 308–32 
 
Dondorp MA, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F 
Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim 
P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat 
D, White NJ (2009).  Artemisinin Resistance in Plasmodium falciparum Malaria.  
New England Journal of Medicine 361(5):455-467 
 
Doolan DL, Dobaño C, Baird JK (2009). Acquired immunity to malaria. Clinical 
Microbiology Reviews 22(1):13–36 
 
Double MC, Peakall R, Beck NR and Cockburn A (2005). Dispersal, philopatry and 
infidelity: dissecting local genetic structure in superb fairy-wrens (Malurus cyaneus). 
Evolution 59: 625-635 
 
Drakeley C, Schellenberg D, Kihonda J, Sousa CA, Arez AP, Lopes D, Lines J, 
Mshinda H, Lengeler C, Schellenberg JA, Tanner M, Alonso P (2003). An estimation 
of the entomological inoculation rate for Ifakara: a semi-urban area in a region of 
 
  232 
intense malaria transmission in Tanzania. Tropical Medicine and International 
Health 8(9):767–774 
 
Druilhe P, Daubersies P, Patarapotikul J, Gentil C, Chene L, Chongsuphajaisiddhi T, 
Duffy PE (2007). Plasmodium in the placenta: parasites, parity, protection, 
prevention and possibly preeclampsia. Parasitology 134(13):1877–81  
 
Dyer M, Day KP (2000). Commitment to gametocytogenesis in Plasmodium 
falciparum. Parasitology today 16(3):102–7  
 
Edvinsson B, Dardé M-L, Pelloux H, Evengård B (2007).  Rapid genotyping of 
Toxoplasma gondii by pyrosequencing.  Clinical Microbiology and Infection 
13(4):424-9 
 
Eichner M, Diebner HH, Molineaux L, Collins WE, Jeffery GM, Dietz K (2001). 
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: 
parameter estimates from fitting a model to malaria therapy data. Transactions of the 
Royal Society of Tropical Medicine and Hygiene 95(5):497–501  
 
Ellegren H (2004). Microsatellites: simple sequences with complex evolution. Nature 
reviews. Genetics 5(6): 435–45 
 
Engelbrecht F, Togel E, Beck HP, Enwezor F, Oettli A, Felger I (2000).  Analysis of 
Plasmodim falciparum infections in a village in Northern Nigeria: determination of 
msp2 genotypes and parasite-specific IgG responses.  Acta Tropica 74:63-71 
 
England R, Pettersson M (2005).  Pyro Q-CpGTM:  Quantitative analysis of 
methylation in multiple CpG sites by Pyrosequencing®.  Nature methods: 
10.1038/NMETH800 
 
Excoffier L, Smouse PE and Quattro JM (1992) Analysis of molecular variance 
inferred from metric distances among DNA haplotypes: Application to human 
mitocondrial DNA restriction sites. Genetics 131: 479-491 
 
Färnert A, Snounou G, Rooth I, Bjorkman A (1997). Daily dynamics of Plasmodium 
falciparum subpopulations in a holoendemic area.  The American Journal of Tropical 
Medicine and Hygiene 56(5):538–547 
 
Färnert A, Arez AP, Babiker HA, Beck HP, Benito A, Bjiirkman A, Rubio JM 
(2001). Genotyping of Plasmodium falciparum infections by PCR : a comparative 
multicentre study Transactions of the Royal Society of Tropical Medicine and 
Hygiene 95: 225–232 
 
Färnert A, Lebbad M, Faraja L, Rooth I (2008). Extensive dynamics of Plasmodium 




  233 
Färnert A, Williams TN, Mwangi TW, Ehlin A, Fegan G, Macharia A, Lowe BS, 
Montgomery SM, Marsh K (2009). Transmission-dependent tolerance to multiclonal 
Plasmodium falciparum infection. The Journal of Infectious Diseases 200(7): 1166–
75. 
 
Fegan GW, Noor AM, Akhwale WS, Cousens S, Snow RW (2007). Effect of 
expanded insecticide-treated bednet coverage on child survival in rural Kenya: a 
longitudinal study. Lancet 370(9592):1035–9 
 
Felger I, Smith T, Edoh D, Kitua A, Alonso P, Tanner M, Beck HP (1999). Multiple 
Plasmodium falciparum infections in Tanzanian infants. Transactions of the Royal 
Society of Tropical Medicine and Hygiene 93 (Suppl 1): 29–34  
 
Felger I, Tavul L, Kabintik S, Marshall V, Genton B, Alpers M, Beck HP (1994). 
Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 
alleles in an area with endemic malaria in Papua New Guinea. Experimental 
Parasitology 79(2):106–16  
 
Felsenstein J (2007).  Theoretical evolutionary genetics.  Department of Genome 
Sciences, University of Washington, Seattle Washington  
 
Fillinger U, Sonye G, Killeen GF, Knols BGJ, Becker N (2004).  The practical 
importance of permanent and semipermanent habitats for controlling aquatic stages 
of Anopheles gambiae sensu lato mosquitoes: operational observations from a rural 
town in western Kenya.  Tropical Medicine and International Health 9(12): 1274-89 
 
França LTC, Carrilho E, Kist TBL (2002). A review of DNA sequencing techniques. 
Quarterly reviews of biophysics 35(2): 169–200  
 
Fraser DJ (2008). How well can captive breeding programs conserve biodiversity? A 
review of salmonids. Evolutionary Applications: doi:10.1111/j.1752-
4571.2008.00036.x 
 
Fried M, Duffy PE (1996).  Adherence of Plasmodium falciparum to chondroitin 
sulphate A in the human placenta.  Science 272:1502-1504 
 
Frischknecht F, Baldacci P, Martin B, Zimmer C, Thiberge S, Olivo-Marin J-C 
Shorte SL, Ménard R (2004). Imaging movement of malaria parasites during 
transmission by Anopheles mosquitoes. Cellular Microbiology 6(7):687–94  
 
Gadsby NJ, Carter R (2008).  A Genetic Analysis of Two Strains of Plasmodium 
chabaudi adami that Differ in Growth and Pathogenicity.  University of Edinburgh 
Research Archives:  http://www.era.lib.ed.ac.uk/handle/1842/2760 
 
Gamage-Mendis AC, Carter R, Mendis C, De Zoysa AP, Herath PR, Mendis KN 
(1991). Clustering of malaria infections within an endemic population: risk of 
malaria associated with the type of housing construction. The American Journal of 
Tropical Medicine and Hygiene 45(1):77-85  
 
  234 
 
Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain 
A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA., Rutherford K, Salzberg 
SL., Craig A, Kyes S, Chan M-S, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, 
Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DMA, 
Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, 
Subramanian G M, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, 
Davis RW, Fraser CM, Barrell B (2002).   Genome sequence of the human malaria 
parasite Plasmodium falciparum.  Nature 419:498-511 
 
Ghebreyesus TA, Haile M, Witten KH, Getachew A, Yohannes AM, Yohannes M, 
Teklehaimanot HD (1999). Incidence of malaria among children living near dams in 
northern Ethiopia: community based incidence survey. BMJ (Clinical research 
edition.) 319(7211): 663–6  
 
Ghebreyesus TA, Haile M, Witten KH, Getachew A, Yohannes M, Lindsay SW, 
Byass P (2000). Household risk factors for malaria among children in the Ethiopian 
highlands. Transactions of the Royal Society of Tropical Medicine and Hygiene 
94(1):17-21  
 
Gilles HM (1993). Epidemiology of malaria. In: Bruce-Chwatt’s Essential 
Malariology (H.M. Gilles and D.A. Warrell, eds), 3rd ed. pp. 124–163. London: 
 
Goldstein DB, Clark AG (1995) Microsatellite variation in North American 
populations of Drosophila melanogaster. Nucleic Acids Research 23:3882–3886 
 
Goldstein DB, Schlötterer (eds) (1999) Microsatellites: evolution and applications. 
Oxford University Press, Oxford 
 
Goodman SJ (1997). Rst Calc: a collection of computer programs for calculating 
estimates of genetic differentition from microsatellite data and a determining their 
significance. Molecular Ecology 6: 881-885 
 
Gorgas CW (1918).  Sanitation in Panama. New York:D. Appleton and Company, 
1918.  182-205 
 
Gouagna LC, Bancone G, Yao F, Yameogo B, Dabiré KR, Costantini C, Simporé J, 
Ouedraogo JB, Modiano D (2010). Genetic variation in human HBB is associated 
with Plasmodium falciparum transmission. Nature Genetics 42(4): 328–31  
 
Goudet J, Raymond M, Demeeus T, Rousset F (1996).  Testing differentiation in 
diploid populations. Genetics 144: 1933-1940 
 
Goudet J (2001). FSTAT, a program to estimate and test gene diversities and fixation 
indices (version 2.9.3).  Available from http://www.unil.ch/izea/softwares/fstat.html.   
 
 
  235 
Government of Kenya (GoK): Poverty Reduction Strategy Paper for the period 2001-
2004. Nairobi, Government of the Republic of Kenya, Ministry of Finance and 
Planning; 2001   
 
Greenhouse B, Myrick A, Dokomajilar C, Woo JM, Carlson EJ, Rosenthal PJ, 
Dorsey G (2006).  Validation of microsatellite markers for use in genotyping 
polyclonal Plasmodium falciparum infections.  The American Journal of Tropical 
Medicine and Hygiene 75(5): 836-42 
 
Greenwood BM, Fidoc, DA, Kyle DE, Kappe SHI, Alonso PL, Collins FH, Duffy PE 
(2008). Malaria : progress, perils, and prospects for eradication. The Journal of 
Clinical Investigation 118(4): 1266–1276 
 
Groenen MAM, Megens HJ, Zare Y, Warren WC, Hillier LW, Crooijmans RPM, 
Vereijken A, Okimoto R, Muir WM, Cheng HH (2011).  The development and 
characterization of a 60K SNP chip for chicken.  BMC Genomics 12(1): 274 
 
Gunawardena DM, Wickremasinghe AR, Muthuwatta L, Weerasingha S, Rajakaruna 
J, Senanayaka T, Kotta PK, Attanayake N, Carter R, Mendis KN (1998). Malaria risk 
factors in an endemic region of Sri Lanka, and the impact and cost implications of 
risk factor-based interventions. The American Journal of Tropical Medicine and 
Hygiene 58(5):533-542  
 
Haasl RJ, Payseur BA (2011). Multi-locus inference of population structure: a 
comparison between single nucleotide polymorphisms and microsatellites. Heredity 
106(1): 158–71  
 
Hall N (2007). Advanced sequencing technologies and their wider impact in 
microbiology. The Journal of experimental biology 210(9):1518–25  
Hamad AA, El Hassan IM, El Khalifa AA, Ahmed GI, Abdelrahim SA, Theander 
TG, Arnot DE (2000). Chronic Plasmodium falciparum infections in an area of low 
intensity malaria transmission in the Sudan. Parasitology 120 (Pt 5):447–56  
 
Hamilton BM (2009). DNA polymorphism (Chapter 8 – Molecular evolution).  In 
Population Genetics (1
st
 ed). Pp 235-282.  Hoboken, New Jersey. Wiley-Blackwell 
 
Haubold H, Hudson RR (2000). LIAN 3.0: detecting linkage disequilibrium in 
multilocus data. Bioinformatics 16: 847-848 
 
Hay SI, Omumbo JA, Craig MH, Snow RW (2000a). Earth observation, geographic 
information systems and Plasmodium falciparum malaria in sub-Saharan Africa. 
Advances in Parasitology 47:173–215 
 
Hay SI, Rogers DJ, Toomer JF, Snow RW (2000b). Annual Plasmodium falciparum 
entomological inoculation rates (EIR) across Africa: literature survey, internet access 




  236 
Hay SI, Snow RW (2006).  The malaria atlas project:  Developing global maps of 
malaria risk.  PLoS Medicine 3(12):2204-2208 
 
Hendrick PW (2005).  A standardized genetic differentiation measure.  Evolution 59 
(8): 1633-38 
 
Hill WG, Babiker HA (1995). Estimation of numbers of malaria clones in blood 
samples. Proceedings of the Royal Society of Biological Sciences 262(1365): 249–57  
 
Hindar K, Fleming I, Mcginnity P, Diserud O (2006). Genetic and ecological effects 
of salmon farming on wild salmon: modelling from experimental results. ICES 
Journal of Marine Science 63(7): 1234–1247 
 
Hughes AL (1992). Positive selection and interallelic recombination at the merozoite 
surface antigen-1 (MSA-1) locus of Plasmodium falciparum. Molecular Biology and 
Evolution 9: 381–393 
 
Hughes MK,  Hughes AL (1995). Natural selection on Plasmodium surface proteins. 
Molecular and Biochemical Parasitology 71: 99–113 
 
Hughes AL, Vierra F (2001). Very large long-term effective population size in the 
virulent human malaria parasite Plasmodium falciparum. Proceedings of the Royal 
Society of Biological science 268(1478):1855–60  
 
Hurwitz, ES, Johnson D, Campbell, CC (1981). Resistance of Plasmodium 
falciparum malaria to sulfadoxine-pyrimethamine (Fansidar) in a refugee camp in 
Thailand. Lancet 1068-107 
 
Iwagami M, Rivera PT, Villacorte EA, Escueta AD, Hatabu T, Kawazu S, Hayakawa 
T, Tanabe K, Kano S (2009). Genetic diversity and population structure of 
Plasmodium falciparum in the Philippines. Malaria journal 8: 96. doi:10.1186/1475-
2875-8-96 
 
Jambou R, Martinelli A, Pinto J, Gribaldo S, Legrand E, Niang M, Kim N, Pharath L, 
Volnay B, Ekala MT, Bouchier T, Fandeur B, Berzosa F, Benito A, Ferreira DI, 
Vieira PP, Alecrim MG, Mercereau-Puijalon O, Cravo P (2010). Geographic 
structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ 
ATPase (PfSERCA) gene diversity. PloS One 5(2): e9424. 
doi:10.1371/journal.pone.0009424 
 
Jarne P, Lagoda PJ (1996). Microsatellites, from molecules to populations and back. 
Trends in Ecology & Evolution 11(10): 424–9  
 
Jensen JD, Kim Y, DuMont VB, Aquadro CF, Bustamante CD (2005).  
Distinguishing between selective sweeps and demography using DNA polymorphism 
data.  Genetics 170(3): 1401-10 
 
 
  237 
Jongwutiwes S, Putaporntip C, Iwasaki T, Sata T, Kanbara H (2004).  Naturally 
acquired Plasmodium knowlesi malaria in human, Thailand.  Emerging Infectious 
Diseases 10(12) 2211-3 
 
Jiang H, Yi M, Mu J, Zhang L, Ivens A, Klimczak LJ, Huyen Y, Stephens RM, Su X 
(2008).  Detection of genome-wide polymorphisms in the AT-rich Plasmodium 
falciparum genome using a high-density microarray.  BioMed Central Genomics 
9:398-412 
 
Jiang H, Li N, Gopalan V, Zilversmit MM, Varma S, Nagarajan V, Li J, Mu J, 
Hayton K, Henschen, B, Yi M, Stephens R, McVean G, Awadalla P, Wellems TE, 
Su X (2011).  High recombination rates and hotspots in a Plasmodium falciparum 
genetic cross.  Genome Biology 12 (4): R33 
 
John TJ, Samuel R (2000).  Herd immunity and herd effect: new insights and 
definitions.  European Journal of Epidemiology 16: 601-6 
 
Jones MK, Good MF (2006). Malaria parasites up close. Nature medicine 12(2):170–
1  
 
Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White 
N, Suh E, Beerli P, Su X (2003).  Early origin and recent expansion of Plasmodium 
falciparum.  Science 300 (5617): 318-21 
 
Juliano JJ, Porter K, Mwapasa V, Sem R, Roger, WO, Ariey F, Wongsrichanala C, 
Read A, Meshnick RS (2010a). Exposing malaria in-host diversity and estimating 
population diversity by capture-recapture using massively parallel Pyrosequencing. 
PNAS doi:10.1073/pnas  
 
Juliano JJ, Gadalla N, Sutherland CJ, Meshnick SR (2010b). The perils of PCR: can 
we accurately “correct” antimalarial trials? Trends in Parasitology 26(3): 119–24  
 
Kaneko A (2010). A community-directed strategy for sustainable malaria elimination 
on islands: short-term MDA integrated with ITNs and robust surveillance. Acta 
Tropica 114(3): 177–83 
 
Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R (2003).  The 
paroxysm of Plasmodium vivax malaria.  Trends in Parasitology 19(4):188-193 
 
Kelly GC, Hii J, Batarii W, Donald W, Hale E, Nausien J, Pontifex S, Vallely A, 
Tanner M, Clements A  (2010). Modern geographical reconnaissance of target 
populations in malaria elimination zones. Malaria journal 9(1):289 
doi:10.1186/1475-2875-9-289 
 
Kimura M, Crow JF (1964).  The number of alleles that can be maintained in a finite 
population.  Genetics 49: 725-38 
 
 
  238 
Kimura M, Ohta T (1978).  Stepwise mutation model and distribution of allelic 
frequencies in a finite population.  Proceedings of the National Academy of Sciences 
USA 75: 2868-72 
 
Kimura E, Mattei D, di Santi SM, Scherf A (1990). Genetic diversity in the major 
merozoite surface antigen of Plasmodium falciparum: high prevalence of a third 
polymorphic form detected in strains derived from malaria patients. Gene 91(1): 57–
62 
 
Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, Ehmer P, 
Nchama GN (2009). Marked increase in child survival after four years of intensive 
malaria control. The American Journal of Tropical Medicine and Hygiene 80(6): 
882–8  
 
Knapik EW, Goodman A, Ekker M, Chevrette M, Delgado J, Neuhauss S, Shimoda 
N, Driever W, Fishman MC, Jacob HJ (1998) A microsatellite genetic linkage map 
for zebrafish (Danio rerio). Nature Genetics 18: 338-343 
 
Koepfli C, Schoepflin S, Bretscher M, Lin E, Kiniboro B, Zimmerman PA, Siba P, 
Smith TA, Mueller I, Felger I (2011).  How much remains undetected? Probability of 
molecular detection of human Plasmodia in the field.  PloS One 6(4): e19010 
 
Kolakovich KA, Ssengoba A, Wojcik K, Tsuboi T, al-Yaman F,  Alpers M, Adams 
JH (1996). Plasmodium vivax: favored gene frequencies of the merozoite surface 
protein-1 and the multiplicity of infection in a malaria endemic region. Experimental 
Parasitology 83: 11–18 
 
Konate L, Zwetyengal J, Christopher R, Bischoff E, Fontenile D, Tall A, Spiegelz 
A,Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, Bäter K, Klug S, Busch 
W,Kun JFJ, Missinou MA, Lell B, Sovric M, Knoop H, Bojowald B, Dangelmaier O, 
Kremsner,  Peter G (2002). New emerging Plasmodium falciparum genotypes in 
children during the transition phase from asymptomatic parasitemia to malaria. The 
American Journal of Tropical Medicine and Hygiene 66(6): 653–8  
 
Kozarewa I, Ning Z, Quail MA, Sanders MJ, Turner DJ (2009).  Amplification-free 
Illumina sequencing-library preparation facilitates improved mapping and assembly 
of GC-biased genomes.  Nature Methods 6(4): 291-295 
 
Kumar  S, Banks TW, Cloutier S (2012).  SNP Discovery through Next-Generation 
Sequencing and Its Applications.  International Journal of Plant Genomics 2012:1-
15 
 
Kyes S, Harding R, Black G, Craig A, Peshu N, Newbold C, Marsh K (1997).  
Limited spatial clustering of individual Plasmodium falciparum alleles in field 




  239 
Lacroix R, Mukabana WR, Gouagna LC, Koella JC (2005). Malaria infection 
increases attractiveness of humans to mosquitoes. PLoS Biology 3(9):.e298 
 
Langhorne J, Ndungu FM, Sponaas AM, Marsh K (2008).  Immunity to malaria: 
more questions than answers.  Nature Immunology 9(7): 725-32 
 
Leamon JH, Lee WL, Tartaro KR, Lanza JR, Sarkis GJ, DeWinter AD, Berka J, 
Weiner M, Rothberg JM, Lohman KL (2003). A massively parallel PicoTiter Plate 
based platform for discrete picoliter-scale polymerase chain reactions. 
Electrophoresis 24(21): 3769–77  
 
Leberg PL (2002). Estimating allelic richness?: Effects of sample size. Molecular 
Ecology 11: 2445–2449 
 
Levinson G, Gutman GA (1987) High frequencies of short frameshifts in poly-
CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. 
Nucleic Acids Research 15: 5323–5338 
 
Li Y-C, Korol AB, Fahima T, Beiles A, Nevo E. (2002). Microsatellites: genomic 
distribution, putative functions and mutational mechanisms: a review. Molecular 
ecology 11(12): 2453–65  
 
Lindsay SW, Armstrong Schellenberg JRM, HA Zeiler, Daly RJ, Salum FM, Wilkins 
HA (1995).  Exposure of Gambian children to Anopheles gambiae malaria vectors in 
an irrigated rice production area.  Medical and Veterinary Entomology 9:50-58 
 
Liu S, Mu J, Jiang H, Su Xin-zhuan L (2008). Effects of Plasmodium falciparum 
mixed infections on in vitro antimalarial drug tests and genotyping. The American 
journal of Tropical Medicine and Hygiene 79(2):178–84  
 
Macdonald G (1957).  The epidemiology and control of malaria. London, New York, 
Toronto, Oxford University Press` 
 
Machado RLD, Povoa MM, Calvosa VSP, Ferreira MU, Rossit ARB, dos Santos EJ 
M, Conway DJ (2004). Genetic structure of Plasmodium falciparum populations in 
the Brazilian Amazon region. The Journal of Infectious Diseases 190(9): 1547–55  
 
Magesa SM, Mdira KY, Babiker HA, Alifrangis M, Färnert A, Simonsen PE, 
Bygbjerg IC, Walliker D, Jakobsen PH (2002). Diversity of Plasmodium falciparum 
clones infecting children living in a holoendemic area in north-eastern Tanzania. 
Acta Tropica 84(2): 83–92  
 
Malaria Vaccine Technology Roadmap (2004).  (www.MalariaVaccineRoadmap.net) 
 
Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, O'Brien J, 
Djimde A, Doumbo O, Zongo I, Ouedraogo JB, Michon P, Mueller I, Siba P,Nzila A, 
Borrmann S, Kiara SM, Marsh K, Jiang H, Su XZ, Amaratunga C, Fairhurst R, 
Socheat D, Nosten F, Imwong M, White NJ, Sanders M, Anastasi E, Alcock D, 
 
  240 
Drury E, Oyola S, Quail MA, Turner DJ, Ruano-Rubio V, Jyothi D, Amenga-Etego 
L, Hubbart C, Jeffreys A, Rowlands K, Sutherland C, Roper C, Mangano V,Modiano 
D, Tan JC, Ferdig MT, Amambua-Ngwa A, Conway DJ, Takala-Harrison S, Plowe 
CV, Rayner JC, Rockett KA, Clark TG, Newbold CI, Berriman M,MacInnis B, 
Kwiatkowski DP. (2012). Analysis of Plasmodium falciparum diversity in natural 
infections by deep sequencing. Nature: 487(7407):375-9 
 
Mantel N (1967). The detection of disease clustering and a generalized regression 
approach. Cancer Research 27: 209-220 
 
Mardis ER (2008).  The impact of next-generation sequencing on genetics. Trends in 
Genetics 24(3): 133-41 
 
Mariette S, Chagné D, Lézier C, Pastuszka P, Raffin A, Plomion C, Kremer A (2001). 
Genetic diversity within and among Pinus pinaster populations: comparison between 
AFLP and microsatellite markers. Heredity 86(Pt 4): 469–79 
 
Mariette S, Le Corre V, Austerlitz, F, Kremer A (2002). Sampling within the genome 
for measuring within-population diversity: trade-offs between markers. Molecular 
Ecology 11(7): 1145–56  
 
Marshall VM, Anthony RL, Bangs MJ, Anders RF, Coppel RL (1994). Allelic 
variants of the Plasmodium falciparum merozoite surface antigen 2 (MSA-2) in a 
geographically restricted area of Irian Jaya. Molecular and Biochemical Parasitology 
63(1): 13–21 
 
Matocq MD, Villablanca FX (2001). Low genetic diversity in an endangered species: 
recent or historic pattern? Biological Conservation 98(1): 61–68 
 
Mbogo CN, Snow RW, Khamala CP, Kabiru EW, Ouma JH, Githure JI, Marsh K, 
Beier JC (1995).  Relationships between Plasmodium falciparum transmission by 
vector populations and the incidence of severe disease at nine sites on the Kenyan 
coast.  American Journal of Tropical Medicine and Hygiene 52:201-206 
 
McBride JS, Walliker D, Morgan G (1982). Antigenic diversity in the human malaria 
parasite Plasmodium falciparum. Science 217(4556): 254–7  
 
Meirmans PG. (2006). Using the AMOVA framework to estimate a standardized 
genetic differentiation measure. Evolution 60(11): 2399–2402 
 
Mellouk S, Langsley G (1998). A primary malarial infection is composed of a very 
wide range of genetically diverse but related parasites. The Journal of Clinical 
Investigation 101(9): 2008–16 
 
Mendis KN, David PH, Carter R (1991). Antigenic polymorphism in malaria: is it an 
important mechanism for immune evasion? Immunology Today 12(3): A34–7.  
 
 
  241 
Metzker ML (2005). Emerging technologies in DNA sequencing. Genome Research 
15(12): 1767–76  
 
Metzker ML (2010). Sequencing technologies - the next generation. Nature Reviews 
Genetics 11(1): 31–46  
 
Michalakis Y, Veuille M (1996) Length variation of CAG/CAA trinucleotide repeats 
in natural populations of Drosophila melanogaster and its relation to the 
recombination rate. Genetics 143: 1713–1725 
 
Midega JT, Smith DL, Olotu A, Mwangangi JM, Nzovu JG, Wambua J, Nyangweso 
G, Mbogo M, Christophides GK, Marsh K, Bejon P, (2012). Wind direction and 
proximity to larval sites determines malaria risk in Kilifi District in Kenya. Nature 
Communications 3: 674 doi:10.1038/ncomms1672 
 
Miller LH, Good MF, Millon G (1994). Malaria pathogenesis.  Science 264:1878-
1883 
Minakawa N, Mutero CM, Githure JI, Beier JC, Yan G (1999). Spatial distribution 
and habitat characterization of anopheline mosquito larvae in Western Kenya. The 
American Journal of Tropical Medicine and Hygiene 61(6):1010–6  
 
Minakawa N, Sonye G, Dida GO, Futami K, Kaneko S (2008).  Recent reduction in 
the water level of Lake Victoria has created more habitats for Anopheles funestus.  
Malaria Journal 7:119 
 
Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A (2007). 
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 
is a direct and predictable function of antibody titer. Malaria Journal 6: 107  
 
Mobegi VA, Loua KM, Ahouidi AD, Satoguina J, Nwakanma DC, Amambua-Ngwa, 
A, Conway DJ (2012). Population genetic structure of Plasmodium falciparum 
across a region of diverse endemicity in West Africa. Malaria journal 11(1): 223. 
doi:10.1186/1475-2875-11-223 
 
Mooney HA, Cleland EE (2001). The evolutionary impact of invasive species. 
Proceedings of the National Academy of Sciences of the United States of America 
98(10): 5446–51 
 
Morin PA, Luikart G, Wayne RK (2004). SNPs in ecology, evolution and 
conservation. Trends in Ecology & Evolution. doi:10.1016/j.tree.2004.01.009 
 
Mu J, Duan J, Joy DA, Su X (2002). Chromosome-wide SNPs reveal an ancient 
origin for Plasmodium falciparum. Nature 418:323–326 
 
Mu J, Awadalla P, Duan J, McGee KM, Joy DA, McVean GAT, Su X (2005). 
Recombination hotspots and population structure in Plasmodium falciparum. PLoS 
Biology 3(10):p.e335 
 
  242 
 
Mu J Awadalla, P Duan, J, McGee KM, Keebler J, Seydel K, McVean GAT, Su X 
(2007). Genome-wide variation and identification of vaccine targets in the 
Plasmodium falciparum genome. Nature Genetics 3(1) 126–30  
 
Mukabana WR, Takken W, Coe R, Knols BG (2002). Host-specific cues cause 
differential attractiveness of Kenyan men to the African malaria vector Anopheles 
gambiae. Malaria Journal 1:17 
 
Mulders MN, Truong AT, Muller CP (2001).  Monitoring of measles elimination 
using molecular epidemiology.  Vaccine 19 (17-19): 2245-9 
 
Muller DA, Charlwood JD, Felger I, Ferreira C, Smith T (2001).  Prospective risk of 
morbidity in relation to multiplicity of infection with Plasmodium falciparum in Sao 
Tome. Acta Tropica 78:155-162 
 
Mutuku FM, Alaii JA, Bayoh MN, Gimnig JE, Vulule JM, Walker ED, Kabiru E, 
Hawley WA (2006). Distribution, description, and local knowledge of larval habitats 
of Anopheles gambiae s.l. in a village in western Kenya. The American Journal of 
Tropical Medicine and Hygiene 74(1): 44–53  
 
Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh K (2008). 
Evidence for over-dispersion in the distribution of clinical malaria episodes in 
children. PloS One 3(5): p.e2196  
 
Myers SR, Griffiths RC (2003). Bounds on the minimum number of recombination 
events in a sample history. Genetics 163(1): 375–94  
 
Myrick A, Leemann E, Dokomajilar C, Hopkins H, Dorsey G, Kamya MR, 
Rosenthal PJ (2006). Short report: Dynamics of Plasmodium falciparum malaria 
after sub-optimal therapy in Uganda. The American Journal of Tropical Medicine 
and Hygiene 74(5):758–61  
 
National Vector Borne Disease Control Programme (NVBDCP). Guidelines on the 
use of larvivorous fish for vector control. Available at 
http://nvbdcp.gov.in/Doc/Guidelines-larvivorous-fish.pdf 
 
Naylor R, Hindar K, Fleming Ian A, Goldburg R, Williams S, Volpe J, Whoriskey F, 
Eagle J, Kelso D, Mangel M (2005). Fugitive Salmon?: Assessing the Risks of 
Escaped Fish from Net-Pen Aquaculture.  Bioscience 55(5): 427-37 
 
Nei M (1973).  Analysis of genetic diversity in subdivided populations.  Proceedings 
of the National Academy of Sciences USA 70: 3321-3 
 
Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, Msobo M, Peshu N, 
Marsh K (1997).  Receptor-specific adhesion and clinical disease in Plasmodium 
falciparum.  American Journal of Tropical Medicine 57:389-398 
 
 
  243 
Nkhoma SC, Nair S, Cheeseman IH, Rohr-Allegrini C, Singlam S, Nosten F, 
Anderson TJC (2012). Close kinship within multiple-genotype malaria parasite 
infections. Proceedings of the Royal Society of Biological sciences 
doi:10.1098/rspb.2012.0113 
 
Noedl H (2008).  Evidence of Artemisinin-Resistant Malaria in Western Cambodia.  
New England Journal of Medicine 359(24):2619-2620 
 
Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ(2008). Complexity of 
Plasmodium falciparum clinical samples from Uganda during short-term culture. The 
Journal of Infectious Diseases 198(10):1554–7  
 
Ntoumi F, Contamin H, Rogier C, Bonnefoy S, Trape JF, Mercereau-Puijalon O 
(1995).  Age-dependent carriage of multiple Plasmodium falciparum merozoite 
surface antigen-2 alleles in asymptomatic malaria infections.  American Journal of 
Tropical Medicine and Hygiene 52:81-88 
 
Ntoumi F, Mercereau-Puijalon O, Ossari S, Luty A, Reltien J, Georges A, Millet P 
(1997).  Plasmodium falciparum: sickle-cell trait is associated with higher prevalence 
of multiple infections in Gabonese children with asymptomatic infections. 
Experimental Parasitology 87(1):39–46 
 
O' Donell TW, Warren ST (2002).  A decade of molecular studies of fragile X 
syndrome.  Annual Review of Neuroscience 25: 315-38 
 
Olotu, A, Moris P, Mwacharo J, Vekemans J, Kimani D, Janssens M, Kai O, Jongert 
E, Lievens M, Leach A, Villafana T, Savarese B, Marsh K, Cohen J, Bejon P (2011). 
Circumsporozoite-specific T cell responses in children vaccinated with 
RTS,S/AS01E and protection against P. falciparum clinical malaria. PloS One: 
6(10): e25786  
 
O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CRJC, 
Marsh K (2008). Effect of a fall in malaria transmission on morbidity and mortality 
in Kilifi, Kenya. Lancet 372(9649): 1555–62 
 
Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, Jima D, Gausi K, 
Komatsu R, Korenromp E , Low-Beer D, Grabowsky M (2009). Initial evidence of 
reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up 
of malaria prevention and treatment. Malaria Journal 8: 14 
 
Owusu-Agyei- S, Smith T, Beck H-P, Amenga-Etego L, Felger I (2002).  Molecular 
Epidemiology of Plasmodium falciparum infections among asymptomatic 
inhabitants of a holoendemic malarious area in northern Ghana.  Tropical Medicine 
and International Health 7(5):421-428 
 
Pasternak ND, Dzikowski, R (2009).  PfEMP1: an antigen that plays a key role in the 
pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum. 
The international Journal of Biochemistry & Cell Biology 41(7): 1463-6  
 
  244 
 
Paul RE, Packer MJ, Walmsley M, Lagog M, Ranford-Cartwright LC, Paru R, Day 
KP (1995). Mating patterns in malaria parasite populations of Papua New Guinea. 
Science 269(5231): 709–11 
Paulitschke M & Nash GB (1993). Membrane rigidity of red blood cells parasitized 
by different strains of Plasmodium falciparum. The Journal of Laboratory and 
Clinical Medicine 122(5)581-589  
Peakall R, Ruibal M and Lindenmayer DB (2003) Spatial autocorrelation analysis 
offers new insights into gene flow in the Australian bush rat, Rattus fuscipes. 
Evolution 57: 1182-1195 
 
Peakall R, Smouse PE (2006). Genalex 6: genetic analysis in Excel. Population 
genetic software for teaching and research. Molecular Ecology Notes 6(1): 288–295 
 
Peakall R, Smouse PE (2012) GenAlEx 6.5: genetic analysis in Excel. Population 
genetic software for teaching and research - an update. Bioinformatics: doi:10.1093 
 
Petit E, Balloux F, Goudet J (2001). Sex biased dispersal in a migratory bat : a 
characterization using sex-specific demographic parameters. Evolution 55: 635-640 
 
Pluess B, Tanser FC, Lengeler C, Sharp BL (2010). Indoor residual spraying for 
preventing malaria. Cochrane Database of Systematic Reviews 4:.CD006657  
 
Pumpaibool T, Arnathau C, Durand P, Kanchanakhan N, Siripoon N, Suegorn A, 
Sitthi-Amorn C, Renaud F, Harnyuttanakorn P (2009). Genetic diversity and 
population structure of Plasmodium falciparum in Thailand, a low transmission 
country. Malaria Journal 8: 155. doi:10.1186/1475-2875-8-155 
 
Ramírez-Soriano A, Ramos-O SE, Rozas J, Calafell F, Navarro A (2008).  Statistical 
power analysis of neutrality tests under demographic expansions, contractions and 
bottlenecks with recombination.  Genetics 179(1): 555-67 
 
Reid H, Vallely A, Taleo G, Tatem AJ, Kelly G, Riley I, Harris I, Henri I, Iamaher S, 
Clements AC. (2010). Baseline spatial distribution of malaria prior to an elimination 
programme in Vanuatu. Malaria Journal 9: 150 doi:10.1186/1475-2875-9-150 
 
Ridley M (2004).  Random events in population genetics. In Evolution, 3
rd
 Ed., pp. 
138-140.  Blackwell Publishing company, Oxford, UK 
 
Ronaghi M, Karamohamed S, Petterson B, Uhlen M, Nyren P (1996).  Real-time 
DNA sequencing using detection of pyrophosphate release.  Analytical Biochemistry 
242:84-89 
 
Ross R (1911).  The prevention of Malaria. John Murray, London 
 
Rousset F (1996).  Equilibrium Values of Measures of Population Subdivision for 
Stepwise Mutation Processes. Genetics 142: 1357-1362 
 
  245 
 
Rozas J (2009). DNA Sequence Polymorphism Analysis using DnaSP. Pp. 337-350. 
In Posada, D. (ed.) Bioinformatics for DNA Sequence Analysis; Methods. In 
Molecular Biology Series Vol. 537. Humana Press, NJ, USA 
 
Sanderson A, Walliker D, Molez JF (1981). Enzyme typing of Plasmodium 
falciparum from African and some other Old World countries. Transactions of the 
Royal Society of Tropical Medicine and Hygiene 75(2):263–7 
 
Sanger F, Nicklen S, Coulson AR (1977).  DNA sequencing with chain-terminating 
inhibitors.  Proceedings of the  National Academy of Sciences, USA 74: 5463-5467 
 
Schellenberg JR, Abdulla S, Nathan R, Mukasa O, Marchant TJ, Kikumbih N, Mushi 
AK, Mponda H, Minja H, Mshinda H, Tanner M, Lengeler C (2001). Effect of large-
scale social marketing of insecticide-treated nets on child survival in rural Tanzania. 
Lancet 357(9264): 1241–7  
 
Schlötterer C. (2000). Evolutionary dynamics of microsatellite DNA. Chromosoma 
109(6): 365–371  
 
Schultz L, Wapling J, Mueller I, Ntsuke PO, Senn N, Nale J, Kiniboro B, Buckee CO, 
Tavul L, Siba MP, Reeder CJ, Barry AE (2010). Multilocus haplotypes reveal 
variable levels of diversity and population structure of Plasmodium falciparum in 
Papua New Guinea, a region of intense perennial transmission. Malaria Journal 9(1): 
336. doi:10.1186/1475-2875-9-336 
 
Selkoe KA, Toonen RJ (2006). Microsatellites for ecologists: a practical guide to 
using and evaluating microsatellite markers. Ecology Letters 9(5):615–29  
 
Shauka AM, Breman JG, McKenzie FE (2010). Using the entomological inoculation 
rate to assess the impact of vector control on malaria parasite transmission and 
elimination. Malaria Journal 9:122  
 
Shen Y, Wan Z, Coarfa C, Drabek R, Chen L, Ostrowski EA, Liu Y, Weinstock GM, 
Wheeler AD, Gibbs AR, Yu F (2010). A SNP discovery method to assess variant 
allele probability from next-generation resequencing data. Genome Research 20(2): 
273–80 
 
Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, Rich 
ML,Karema C, Daily JP (2008). Reduced paediatric hospitalizations for malaria and 
febrile illness patterns following implementation of community-based malaria 
control programme in rural Rwanda. Malaria Journal 7:167  
 
Singh B, Kim SL, Matusop A, Radhakrishnan A, Shamsul SSG, Cox-Singh J, 
Thomas A, Conway DJ (2004). A large focus of naturally acquired Plasmodium 
knowlesi infections in human beings. Lancet 363(9414):1017–24 
 
 
  246 
Slatkin M (1995). A measure of population subdivision based on microsatellite allele 
frequency. Genetics 139: 457-462 
 
Smith DL, Dushoff J, Snow RW, Hay SI (2005). The entomological inoculation rate 
and Plasmodium falciparum infection in African children. Nature 438(7067):492–5  
 
Smith DL, McKenzie FE, Snow RW, Hay SI (2007). Revisiting the basic 
reproductive number for malaria and its implications for malaria control. PLoS 
Biology: 5(3):.e42 
 
Smouse PE, Long JC and Sokal RR (1986). Multiple regression and correlation 
extensions of the Mantel test of matrix correspondence. Systematic Zoology 35: 627-
632 
 
Smouse PE and Long JC (1992). Matrix correlation analysis in anthropology and 
genetics. American Journal of Physical Anthropology 35: 187-213 
 
Smouse PE and Peakall R (1999). Spatial autocorrelation analysis of individual 
multiallele and multilocus genetic structure. Heredity 82: 561-573 
 
Smouse PE, Peakall R and Gonzales E (2008). A heterogeneity test for fine-scale 
genetic structure. Molecular Ecology 17: 3389-3400 
 
Sreekumar C, Hill DE, Miska KB, Vianna MCB, Yan L, Myers RL, Dubey JP 
(2005).  Genotyping and detection of multiple infections of Toxoplasma gondii using 
Pyrosequencing.  International Journal for Parasitology 35(9): 991-9 
 
Srinivas G, Edwin AR, Dhanraj B (2005). The use of personal protection measures 
against malaria in an urban population. Public Health 119(5): 415–7  
 
Staedke SG, Nottingham EW, Cox J, Kamya, MR, Rosenthal PJ, Dorsey G (2003). 
Short report: proximity to mosquito breeding sites as a risk factor for clinical malaria 
episodes in an urban cohort of Ugandan children. The American Journal of Tropical 
Medicine and Hygiene 69(3): 244–6  
 
Steketee RW (2009). Good news in malaria control... now what? The American 
Journal of Tropical Medicine and Hygiene 80(6): 879–80  
 
Stewart CN, Halfhill MD, & Warwick SI (2003). Transgene introgression from 
genetically modified crops to their wild relatives. Nature reviews Genetics 4(10): 
806–17 
 
Su X-Z, Wellems TE, (1996). Towards a high resolution Plasmodium falciparum 
linkage map: polymorphic markers from hundreds of simple sequence repeats. 
Genomics 33: 430-44 
 
 
  247 
Su, X, Ferdig MT, Huang Y, Huynh CQ, Liu A, You J, Wootton, JC, Wellems TES 
(1999) A genetic map and recombination parameters of the human malaria parasite P. 
falciparum. Science 286: 1351–1353 
 
Su, X, Jiang H, Yi M, Mu J, Stephens RM (2009).  Large-scale genotyping and 
genetic mapping in Plasmodium parasites. The Korean journal of parasitology 
47(2):83-91 
 
Suwanarusk R, Cooke BM, Dondorp AM, Silamut K, Sattabongkot J, White NJ, 
Udomsangpetch R (2011).  Blood 117(2): 381-92 
 
Takala SL, Smith DL, Stine OC, Coulibaly D, Thera MA, Doumbo OK, Plowe CV 
(2006). A high-throughput method for quantifying alleles and haplotypes of the 
malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 
kDa. Malaria Journal 5: 31  
 
Takken W, Charlwood JD, Billingsley PF GG (1998). Dispersal and survival of 
Anopheles funestus and A . gambiae s . l  ( Diptera?: Culicidae ) during the rainy 
season in southeast Tanzania. Bulletin of Entomological Research 561–566. 
 
Takken W, Knols BG (1999). Odor-mediated behavior of Afrotropical malaria 
mosquitoes. Annual Review of Entomology 44: 131–57  
 
Tanabe K, Sakihama N, Färnert A, Rooth I, Björkman A, Walliker D, Ranford-
Cartwright L (2002).  In vitro recombination during PCR of Plasmodium falciparum 
DNA: a potential pitfall in molecular population genetic analysis. Molecular and 
Biochemical Parasitology 122(2):  211–6  
 
Thaithong S, Sueblinwong T, Beale GH (1981). Enzyme typing of some isolates of 
Plasmodium falciparum from Thailand. Transactions of the Royal Society of Tropical 
Medicine and Hygiene 75(2): 268–70  
 
The Bovine HapMap Consortium (2009).  Genome-wide survey of SNP variation 
uncovers the genetic structure of cattle breeds.  Science 324: 528-532 
 
The malERA Consultative Group on Vaccines (2011) A Research Agenda for 
Malaria Eradication: Vaccines. PLoS Medicine 8(1):S1-S10 
 
Thomas CJ, Lindsay SW (2000). Local-scale variation in malaria infection amongst 
rural Gambian children estimated by satellite remote sensing. Transactions of the 
Royal Society of Tropical Medicine 94: 159– 163 
 
Tin F, Haling N, Lasserre, R (1982). Single-dose treatment of falciparum malaria 
with mefloquine: field studies with different doses in semi-immune adults and 
children in Burma. Bulletin of the World Health Organization 60: 913-917 
 
Tischer A, Santibanez S, Siedler A, Heider A, Hengel H (2004).  Laboratory 
investigations are indispensable to monitor the progress of measles elimination--
 
  248 
results of the German Measles Sentinel 1999-2003.  Journal of Clinical Virology 
31(3): 165-78 
 
Trape JF, Lefebvre-Zante E, Legros F, Ndiaye G, Bouganali H, Druilhe P, Salem G 
(1992). Vector density gradients and the epidemiology of urban malaria in Dakar, 
Senegal. The American Journal of Tropical Medicine and Hygiene 47(2):181–9  
 
Trape JF, Rogier C, Konate L et al. (1994).  The Dielmo project: al longitudinal 
study of natural malaria infection and the mechanisms of protective immunity in a 
community living in a holoendemic area of Senegal.  The American Journal of 
Tropical Medicine and Hygiene 51:123-137. 
 
Trape J-F, Mercereau-Puijalon O (1999). Variation of Plasmodium falciparum msp1 
block 2 and msp2 allele prevalence and of infection complexity in two neighbouring 
Senegalese villages with different transmission conditions. Transactions of the Royal 
Society of Tropical Medicine and Hygiene 93(1): 21–28 
 
Trape, JF, Rogier C (2002). Combating malaria in Africa. Trends in Parasitology 
18(5): 224–30  
 
Tsumori Y, Ndounga M, Sunahara T, Hayashida N, Inoue M, Nakazawa S, Casimiro, 
P, Rie I, Haruki U, Kazuyuki T, Osamu K, Culleton R (2011). Plasmodium 
falciparum: differential selection of drug resistance alleles in contiguous urban and 
peri-urban areas of Brazzaville, Republic of Congo. PloS One 6(8): e23430. 
doi:10.1371/journal.pone.0023430 
 
Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F (2008). 
Multiplicity of Plasmodium falciparum infection in asymptomatic children in 
Senegal: relation to transmission, age and erythrocyte variants. Malaria Journal 7:17 
 
Väli U, Einarsson A, Waits L, Ellegren H (2008). To what extent do microsatellite 
markers reflect genome-wide genetic diversity in natural populations? Molecular 
Ecology 17(17): 3808–17 
 
van der Hoek W, Konradsen F, Amerasinghe PH, Perera D, Piyaratne M, 
Amerasinghe FP (2003). Towards a risk map of malaria for Sri Lanka: the 
importance of house location relative to vector breeding sites. International Journal 
of Epidemiology 32(2): 280–285 
 
Vekemans X, Hardy OJ (2004). New insights from fine-scale spatial genetic 
structure analyses in plant populations. Molecular Ecology 13(4): 921–935 
 
Vignal A, Milan D, San Cristobal MEA (2002). A review on SNP and other types of 
molecular markers and their use in animal genetics. Review Literature And Arts Of 
The Americas 34: 275–305 
 
Wacher TJ, Milligan PJ, Rawlings P, Snow WF (1994). Tsetse-trypanosomiasis 
challenge to village N’Dama cattle in The Gambia: field assessments of spatial and 
 
  249 
temporal patterns of tsetse-cattle contact and the risk of trypanosomiasis infection. 
Parasitology 109 (Pt 2):149–62 
 
Wahlgren M, Barragan A, Chen Q, Fernandez V, Hagblom P, Heddini A, 
Schlichtherle M, Scholander C, Sundström A, Treutiger CJ, Euler A, Carlson J 
(1998).  Rosetting of malaria-infected erythrocytes:  Ligands, host receptors and the 
involvement of serum proteins. In, Malaria: Parasite Biology, pathogenesis and 
protection pp. 387-398. ASM Press, Washington DC  
Walliker D,  Quakyi IA, Wellems TE,  Mccutchan TF,  Szarfman A, London WT, 
Corcoran LM, Burkot TR, Carter R (1987).  Genetic analysis of the human malaria 
parasite Plasmodium falciparum.  Science 236:1661-1666 
 
Walliker D (1994). The role of molecular genetics in field studies on malaria 
parasites. International Journal for Parasitology 24(6):799–808 
 
Walliker D, Babiker H, Ranford-Cartwright L (1998).  The genetic structure of 
malaria parasite populations.  In:  Malaria: parasite biology, pathogenesis and 
protection, I. W Sherman ed. American Society for Microbiology.  Washington D.C., 
235-251 
 
Wanji S, Mafo FF, Tendongfor N, Tanga MC, Tchuente E, Bilong Bilong CE, Njine 
T (2009).  Spatial distribution, environmental and physicochemical characterization 
of Anopheles breeding sites in the Mount Cameroon region.  Journal of Vector Borne 
Diseases 46(1): 75-80 
 
Watterson GA (1975).  On the number of segregating sites in genetic models without 
recombination.  Theoretical Population Biology 7:256-76 
 
Weir BS, Cockerham CC (1984).  Estimating F-statistics for the analysis of 
population structure.  Evolution 38: 1358-70 
 
Wells TNC, Burrows JN, Baird JK (2010). Targeting the hypnozoite reservoir of 
Plasmodium vivax: the hidden obstacle to malaria elimination. Trends in 
Parasitology 26(3):145–51 
 
White NJ (2008). The role of anti-malarial drugs in eliminating malaria. Malaria 
journal 7 (Suppl 1): S8  
 
White NJ (2011). A Vaccine for Malaria. The New England Journal of Medicine 
10.1056/nejme1111777 
 
WHO (2006).  Guidelines for the Treatment of Malaria. Geneva: World Health 
Organization  
 
WHO (2007). WHO Global Malaria Programme: Position Statement on ITNs. 
Available from: http://www.who.int/malaria/publications/atoz/itnspospaperfinal.pdf  
 
 
  250 
WHO (2010).  Guidelines for the treatment of malaria. Geneva: WHO. 1-210 
 
WHO (2011): Malaria Vaccine Rainbow Tables.  
[http://www.who.int/ vaccine_research/links/Rainbow/en/index.html] 
 
WHO recommended insecticides for indoor residual spraying against malaria vectors. 
Available from:  http://www.who.int/whopes/en/  
 
Wilder JA, Hollocher H (2001). Mobile elements and the genesis of microsatellites 
in Dipterans. Molecular Biology and Evolution 18:384-392 
 
Wilkins HA, Blumenthal UJ, Hagan P, Hayes RJ, Tulloch S (1987). Resistance to 
reinfection after treatment of urinary schistosomiasis. Transactions of the Royal 
Society of Tropical Medicine and Hygiene 81(1):29–35 
 
Williams TN (2006). Human red blood cell polymorphisms and malaria. Current 
Opinion in Microbiology 9(4): 388–94 
 
Williams SE, & Hoffman EA (2009). Minimizing genetic adaptation in captive 
breeding programs: A review. Biological Conservation 142(11): 2388–2400 
 
Wirth, DF (2002). Biological revelations. Nature 419(6906): 495-496  
 
Wongsrichanalai C, Pickard AL, Wernsdorfer WH, & Meshnick SR (2002). Reviews 
Epidemiology of Drug-resistant Malaria 2: 209–218 
 
Woolhouse MEJ, Dye C, Etard JF, Smith T, Charlwood JC, Garnett GP, Hagan P, 
Hii JLK, Ndhlovu PD, Quinnel RJ, Watts CH, Chandiwana SK, Anderson RM 
(1997). Heterogeneities in the transmission of infectious agents: Implications for the 
design of control programs. Proceedings of the National Academy of Sciences 
94(1):338-342 
 
Wright S (1931).  Evolution in Mendelian populations.  Cited in Hamilton BM 
(2009). Population structure and gene flow (Chapter 4).  In Population Genetics (1
st
 
ed). Pp 135-141.  Hoboken, New Jersey. Wiley-Blackwell 
 
Wright S (1943).  Isolation by distance.  Genetics 28: 114-38 
 
Wright S (1951).  The genetic structure of populations.  Cited in Hamilton BM 
(2009). Population structure and gene flow (Chapter 4).  In Population Genetics (1
st
 
ed). Pp 135-141.  Hoboken, New Jersey. Wiley-Blackwell 
 
Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, 
Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, 
Miura K, Long C, Saul A, Miller LH, Durbin AP (2008). Phase 1 trial of malaria 
transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with 
montanide ISA 51. PloS One 3(7):.e2636  
 
 
  251 
Yang Z, Miao J, Huang Y, Li X, Putaporntip C (2006). Genetic structures of 
geographically distinct Plasmodium vivax populations assessed by PCR/RFLP 
analysis of the merozoite surface protein 3-beta gene. Acta Tropica 100: 205–12 
 
Zhong D, Afrane Y, Githeko A, Yang Z, Cui L, Menge DM, Temu E, Yan G (2007). 
Plasmodium falciparum genetic diversity in western Kenya highlands. The American 
Journal of Tropical Medicine and Hygiene 77(6): 1043–50 
 
Zhou X, Ren L, Meng Q, Li Y, Yu Y, Yu J (2010). The next-generation sequencing 
technology and application. Protein & Cell 1(6): 520–36 
 
Zhou G, Githeko AK, Minakawa N, Yan G (2010).  Community-wide benefits of 
targeted indoor residual spray for malaria control in the western Kenya highland.  










  252 
APPENDIX A:  STANDARD PCR PROTOCOL 
Date: _______________ 
 
REAGENT WORKING CONC WORKING 
VOLUME (50 µl) 
X__________ 
10 µM Forward Primer 0.4 µM 2.0 µl  
10 µM Reverse Primer 0.4 µM 2.0 µl  
5 U/µl Immolase 1 U 0.2 µl  
25 mM dNTP mix 150 µM 0.3 µl  
50 mM MgCl2 1.5 mM 1.5 µl  
10X PCR buffer 1X 5.0 µl  
10 µg/µl DNA  1.0 µl  
PCR H20  38.0 µl  




 denaturation:  95 c  7 min 
1
st
 annealing   42 c  1 min 
1
st
 extension   72 c  2 min 
2
nd
 denaturation  95 c  3 min 
2
nd
 annealing   44 c  1 min 
2
nd
 extension   72 c  2 min 
3
rd
 denaturation   95 c  1 min     
3
rd
 annealing   49 c  1 min      X  38 
3
rd
 extension   72 c  2 min          
Final extension   72 c  5 min 
    10 c                 4 ever 
Samples: 
1. 11. 21. 31. 41. 
2. 12. 22. 32. 42. 
3. 13. 23. 33. 43. 
4. 14. 24. 34. 44. 
5. 15. 25. 35. 45. 
6. 16. 26. 36. 46. 
7. 17. 27. 37. 47. 
8. 18. 28. 38. 48. 
9. 19. 29. 39. 49. 
10. 20. 30. 40. 50. 
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APPENDIX B: POISSON EXPECTATIONS FOR PARASITE 
DILUTIONS 
This illustration serves as a guideline when cloning out parasites either in mice or 
blood cultures.  As already described in Section 5.2.1, according to the Poisson 
expectation shown below 80% positive wells are expected to occur in wells 
estimated to contain 1.6 pRBCs and 99-100% positive wells in those estimated at 
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APPENDIX C:  KENYA ETHICAL REVIEW APPROVAL LETTER 
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APPENDIX F: SUMMARY OF THE P. FALCIPARUM SAMPLES 
ANALYSED FROM CAMEROON, MALI AND KENYA.   
 
The sample ID is given as C = Cameroon, H = Mali and K = Kenya.  The a and b for 
example C3a and C3b represent the major clone and minor clone respectively.  The 
columns indicated as letters A - M represent the SNP IDs with the chromosome SNP 
position as in Chapter 3:  Two SNP positions were eliminated as they had missing 
data.  The letters represent the SNPs:  A - Pf-01-101502, B - Pf-01-205304, C - Pf-
01-393153, D - Pf-01-411796, E - Pf-03-138-7, F - Pf-03-350224, G - Pf-03-613146, 
H - Pf-03-842383, I - Pf-03-967838, J - Pf-10-658467, K - Pf-10-992433, L - Pf-14-
279668 & M - Pf-14-1710196.  The numbers in the aforementioned columns 
represent 1 = A, 2 = C, 3 = G and 4 = T.  The columns indicated as Poly , TA81, 
TA17, TA53, TA40, PFPK2, TA60 & TA43 represent the 8 analysed microsatellite 
loci and the numbers in the column represent the allelic polymorphisms observed in 
each locus.  The bold alleles represent the peak alleles and are classified as major 
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No. Sample Pop Poly  TA81 TA17 TA53 TA40 PFPK2 TA60 TA43 A B C D E F G H I J K L M 
1 C2 Cameroon 177 164 213 142 0 246 257 0 1 2 2 1 3 4 2 1 1 1 1 1 4 
2 C3a Cameroon 180 182 247 159 0 237 232 0 1 2 2 1 4 4 2 1 1 1 1 1 1 
3 C3b Cameroon 180 182 247 159 0 237 232 0 1 4 1 1 4 4 2 1 1 1 1 4 4 
4 C4a Cameroon 168 164 188 139 0 267 229 0 1 2 2 1 4 4 2 1 1 1 3 1 4 
5 C4b Cameroon 168 164 212 139 0 267 229 0 1 4 2 1 4 4 2 1 1 1 1 1 4 
6 C5a Cameroon 165 161 278 142 0 243 238 0 1 4 2 1 4 4 2 1 1 1 1 1 4 
7 C5b Cameroon 165 161 258 142 0 243 238 0 1 4 2 1 4 4 2 1 1 1 1 1 4 
8 C6a Cameroon 133 170 216 142 0 249 245 0 1 4 1 1 4 4 2 1 1 1 1 1 4 
9 C6b Cameroon 165 176 216 142 0 249 245 0 1 2 1 1 4 4 2 1 1 1 1 1 4 
10 C11 Cameroon 159 173 240 142 0 261 241 0 1 2 2 1 4 4 2 1 1 1 3 1 1 
11 C14a Cameroon 180 170 243 142 0 246 232 0 1 2 2 1 4 4 2 1 1 1 1 1 4 
12 C14b Cameroon 180 170 243 142 0 237 232 0 4 4 2 1 3 2 2 1 1 1 3 1 1 
13 H1a Mali 162 0 213 150 267 240 322 243 1 2 2 1 4 4 2 1 1 1 1 1 4 
14 H1b Mali 176 0 228 139 278 240 328 243 1 2 2 1 4 4 2 1 1 1 1 1 4 
15 H2a Mali 156 176 213 139 267 0 302 213 1 4 2 1 4 4 2 1 1 1 1 1 4 
16 H2b Mali 156 176 213 139 278 0 309 213 1 2 2 1 3 4 2 1 1 1 1 1 4 
17 H3a Mali 171 161 228 142 269 246 322 238 1 2 2 1 4 4 2 1 1 1 3 1 4 
18 H3b Mali 171 161 228 142 269 246 322 222 1 2 2 1 4 4 2 1 1 1 3 1 4 
19 H4 Mali 184 170 258 146 269 240 322 232 1 2 2 1 3 1 2 1 1 1 1 1 4 
20 H5 Mali 162 170 243 136 261 237 0 244 1 2 2 1 3 4 2 1 1 1 1 1 4 
21 H6 Mali 0 176 228 142 287 243 309 213 1 2 2 1 3 4 2 1 1 1 3 1 4 
22 H8 Mali 156 173 213 142 276 261 312 226 1 2 2 1 4 4 2 1 1 1 1 1 4 
23 H12 Mali 168 176 243 139 276 240 322 213 1 2 2 1 4 4 2 1 1 1 1 1 4 
24 H13 Mali 180 164 0 142 278 237 309 244 1 2 2 1 4 4 2 1 1 1 1 1 4 
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No. Sample Pop Poly  TA81 TA17 TA53 TA40 PFPK2 TA60 TA43 A B C D E F G H I J K L M 
26 H16b Mali 165 167 0 142 269 240 312 254 1 4 2 1 4 4 2 1 1 1 1 4 4 
27 H18 Mali 184 176 198 142 287 0 322 0 2 4 2 1 4 4 2 1 1 3 1 1 4 
28 H21a Mali 168 176 198 142 249 243 306 244 0 2 2 1 4 4 2 1 1 1 3 1 4 
29 H21b Mali 168 176 198 142 249 243 306 244 0 2 2 1 4 4 2 1 1 1 3 1 4 
30 H23 Mali 190 170 233 142 269 240 325 254 1 2 2 2 3 2 2 1 1 1 3 1 4 
31 H24a Mali 165 167 243 139 230 0 318 244 1 4 2 1 4 4 2 1 1 1 1 4 4 
32 H24b Mali 165 167 243 139 230 0 318 263 1 4 2 1 4 4 2 1 1 1 1 4 4 
33 H26 Mali 208 176 228 142 267 237 0 238 1 2 2 1 4 2 2 1 1 1 1 1 4 
34 H27a Mali 162 167 204 142 252 237 315 257 1 2 2 1 4 4 2 1 1 1 1 1 4 
35 H27b Mali 0 170 183 142 261 240 328 257 1 2 2 1 4 4 2 1 1 3 3 1 4 
36 H28 Mali 174 179 236 142 269 243 318 234 1 2 2 1 4 4 2 1 1 1 3 1 4 
37 H30a Mali 171 0 228 142 263 0 318 0 1 2 2 1 4 4 2 1 1 1 3 4 4 
38 H30b Mali 165 0 243 142 263 0 322 0 1 2 2 1 4 4 2 1 1 1 3 4 4 
39 H31 Mali 0 0 243 0 267 264 315 226 1 4 2 1 4 2 2 1 1 3 3 1 4 
40 H34 Mali 171 167 233 139 273 0 322 234 1 2 2 1 3 2 2 1 1 1 1 1 4 
41 H35 Mali 159 170 213 0 269 243 309 241 1 2 2 1 4 4 2 1 1 1 1 1 4 
42 H37 Mali 190 164 243 142 267 243 315 250 1 2 2 1 4 4 2 1 1 1 1 1 4 
43 H38 Mali 190 164 243 142 267 243 315 250 1 2 2 1 4 4 2 1 1 1 1 1 4 
44 H40a Mali 162 167 201 142 269 309 0 232 1 4 2 1 4 4 2 1 1 1 3 1 4 
45 H40b Mali 162 167 201 142 269 309 0 232 1 4 2 1 4 4 2 1 1 1 2 1 4 
46 H41a Mali 190 170 213 142 230 255 318 254 1 2 2 1 4 2 2 1 1 1 1 1 4 
47 H41b Mali 190 170 213 142 230 255 318 234 1 2 2 1 4 2 2 1 1 1 1 1 4 
48 H42a Mali 159 167 213 142 246 243 312 219 1 2 2 1 3 4 2 1 1 1 1 1 4 
49 H42b Mali 159 167 198 146 273 264 315 219 1 2 2 1 4 2 2 1 1 1 3 4 4 
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No. Sample Pop Poly  TA81 TA17 TA53 TA40 PFPK2 TA60 TA43 A B C D E F G H I J K L M 
51 H44 Mali 0 170 228 0 273 246 322 232 1 2 2 1 3 4 2 1 1 1 1 1 4 
52 H45 Mali 0 170 228 0 269 246 309 247 2 2 2 1 4 4 2 1 1 3 3 1 4 
53 H46 Mali 165 164 228 142 267 237 322 257 1 2 2 1 4 4 2 1 1 1 3 1 4 
54 H47a Mali 174 167 0 0 0 243 0 0 1 4 2 1 4 4 2 1 1 1 3 4 4 
55 H47b Mali 174 167 0 0 0 243 0 0 1 1 2 1 4 4 2 1 1 1 3 4 4 
56 H48a Mali 0 167 0 142 0 249 312 0 1 2 2 1 3 4 2 1 1 1 1 1 4 
57 H48b Mali 0 167 0 142 0 249 312 0 2 2 2 1 3 4 2 1 1 1 1 1 4 
58 H50a Mali 171 179 233 142 267 0 309 257 1 2 2 1 4 4 2 1 1 1 3 4 4 
59 H50b Mali 168 176 228 136 269 0 0 0 1 2 2 1 4 4 2 1 1 1 1 1 4 
60 H51a Mali 180 167 228 142 269 246 309 210 2 2 2 1 4 4 2 1 1 1 0 1 4 
61 H51b Mali 180 167 228 142 269 246 309 210 1 1 2 1 4 4 2 1 1 1 0 1 4 
62 K64a Kenya 174 167 198 142 0 255 0 247 1 2 0 1 4 4 2 1 0 1 1 4 4 
63 K64b Kenya 174 167 198 142 0 255 0 222 1 2 0 1 1 4 2 1 0 1 3 4 4 
64 K157 Kenya 184 167 213 142 0 237 0 238 1 4 0 1 4 4 2 1 1 1 1 4 4 
65 K173 Kenya 156 164 243 146 0 243 0 244 1 2 0 1 4 4 2 1 1 1 3 1 4 
66 K193a Kenya 168 164 201 142 0 243 0 238 1 2 0 1 3 4 2 1 1 1 1 4 4 
67 K193b Kenya 168 164 201 142 0 243 0 238 1 4 0 1 4 2 2 1 1 3 3 1 4 
68 K194a Kenya 165 164 222 159 0 243 0 244 1 2 0 1 3 4 2 1 1 1 3 4 4 
69 K194b Kenya 165 164 222 159 0 243 0 225 1 2 0 1 1 4 2 1 1 1 3 1 4 
70 K195 Kenya 190 164 228 0 0 240 0 248 1 4 0 1 4 2 2 1 1 1 3 4 4 
71 K201a Kenya 145 179 198 142 0 249 0 251 1 4 0 1 4 4 2 1 1 1 3 1 4 
72 K201b Kenya 145 179 198 142 0 249 0 232 1 4 0 1 4 4 2 1 1 1 3 1 4 
73 K205 Kenya 156 164 228 142 0 255 0 222 1 4 0 1 3 4 2 1 1 1 1 1 4 
74 K207a Kenya 165 173 228 146 0 240 0 204 1 2 0 1 4 4 2 1 1 1 1 1 4 
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No. Sample Pop Poly  TA81 TA17 TA53 TA40 PFPK2 TA60 TA43 A B C D E F G H I J K L M 
76 K225 Kenya 168 164 198 142 0 240 0 244 1 4 0 1 4 4 2 1 1 1 1 1 4 
77 K226a Kenya 196 170 228 146 0 243 0 225 1 4 0 1 4 4 4 1 1 1 3 1 4 
78 K226b Kenya 196 170 243 146 0 243 0 225 1 4 0 1 4 4 4 1 1 1 1 4 4 
79 K228a Kenya 162 173 243 142 0 240 0 214 1 2 0 1 4 4 4 1 1 1 1 1 4 
80 K228b Kenya 165 173 228 142 0 240 0 214 1 2 0 1 1 4 4 1 1 1 1 4 4 
81 K230a Kenya 162 176 243 146 0 240 0 235 1 2 0 1 4 4 4 1 1 1 3 1 4 
82 K230b Kenya 162 176 243 146 0 243 0 235 1 2 0 1 4 2 4 1 1 3 3 1 4 
83 K241a Kenya 168 164 228 142 0 249 0 254 1 4 0 1 4 4 4 1 1 3 1 4 4 
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APPENDIX G:  FORMULAE 
 





Where:  Hsk or Hexp = unbiased estimator of gene diversity or 
heterozygosity (see Nei, 1987, eq 7.39 p 164) per sample k 
nk = size of sample k (sample k is the subpopulations i.e. Cameroon, Kenya 
& Mali) 
Pi = frequency of the ith allele  
 
2. FSTAT determination of Nei’s GST with the microsatellites data 
 




Where:  Ho = Observed heterozygosity but since this is a haploid, diploid genotypes 
were obtained by coding the same allele twice, thus: 
 
 (P = frequency of the ith or kth allele)  
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The sum of    =   
 is the harmonic mean of the nk (size of sample k).  Harmonic mean of the 
sample size as the sample size varies in each of the analysed regions 
 Note that these are not weighted by sample size. 
 
The value of Ht is given by the equation: 
 
Where:  np = number of samples 
 
To generate GST the formula is: 
 
Where:  Ht  is the overall gene diversity independent of sample size and Hs is as 
shown above. 
3. Analysis of molecular variance (AMOVA) by GenAlEx 
 
The formulae for AMOVA are adapted from those of the analysis of variance 
(ANOVA) except the sums of squares (SS) and mean sums of squares (MS) are 
obtained from a genetic distance matrix.   
 
Where: SSTOT = total sums of squares  
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d
2
ij = the squared genetic distance between the ith and jth of different alleles 





Where: SSWP1 = Sum of squares within population 1 
d
2
ij = the squared genetic distance between the ith and jth alleles 
n = number of samples within population 1 
 
The total sums of squares within all populations (SSWP) is given by SSWP1 + SSWP2, 
SSWP3……SSWPn 
The sums of squares among populations (SSAP) is given by:  SSTOT - SSWP 
The mean sums of squares within populations (MSWP) are computed as: 
 
Where:  SSWP = Sums of squares within populations 
dfWP = Degrees of freedom within populations N - Np; N is the 
number of populations NP is number of populations with kth 
populations explained later.    
 
The mean sums of squares among populations (MSAP) are computed as: 
 
Where:  SSAP = Sums of squares among populations 
DfAP = Degrees of freedom among populations = Np – 1; NP is 
number of samples with kth populations explained later.   
 
Variance estimates are then given by: 
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Variance within populations (VWP) = MSWP  
Variance among populations (VAP) is: 
 
 
Where:    
Where: N = Number of samples 
 Np = Number of populations with kth populations 
 Nk = Number of samples in the kth populations 
 
The estimation of the variance among populations (VAP) relative to the total variance 
(PT) is finally computed as:  
 
 
4. Mantel test analysis by GenAlEx 
 
GenAlEx performs a Mantel test using the formulae (Smouse et al. 1986; Smouse & 
Long 1992): 
 
Where: SSx = sum of squares for the x matrix 
 N = total number of samples in the x matrix 
 i & j = alleles represented in the population 
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  = The square of how much each value in the x matrix deviates 




Where: SSy = sum of squares for the y matrix 
 N = total number of samples in the y matrix 
 i & j = alleles represented in the population 
  = the square of how much each value in the y matrix deviates 
from the mean 
 
 
Where: SPxy = sum of the cross products of the deviations of the matrices x and y 
from the mean 
 
Where: Rxy = Mantel test derived from the fraction of sum of the deviations’ cross 
products and the square root product of the sum of squares for the x and y 
matrices 
The geographic co-ordinates uploaded to GenAlEx were in the form of latitude and 
longitude in decimal degrees.  The distance (D) was then computed in kilometres 
(km) 
D =  
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Where: xi and yi are the coordinates for the i-th allele and xj and yj are the 
coordinates for the j-th allele. 
 
5. Spatial autocorrelation analysis using GenAlEx 
 
The formulae for the spatial autocorrelation test are (Smouse & Peakall, 1999): 
 
 
Where:  Cij, Cii and Cjj = respective elements of the covariance matrix obtained from 
the ith and jth alleles 
   xij = respective elements of the x matrix obtained from the ith and jth alleles. 
 
The covariance matrix, Cij is computed using the formula: 
 
Where: The XijCij value is the covariance matrix value for pairwise comparisons of 
two samples – i.e. the element in the matrix with i = 1 and j = 2. XijCii is the 
covariance matrix value of the diagonal element with i = 1 and j=1.  XijCjj is 
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APPENDIX H:  ALLELE FREQUENCIES 
Allele frequency estimates computed per country and per locus including weighted 
and unweighted by sample sizes values for both SNPs and microsatellites data.  The 
numbers of samples used per country vary due to the existence of missing data in 
some of the loci.  The No. denotes the number of alleles observed in each locus in the 
case of microsatellites.  
Poly -  
  Cameroon Mali Kenya Weighted Unweighted 
     No. 12 42 23     
1 0.083 0 0 0.013 0.028 
2 0 0 0.087 0.026 0.029 
3 0 0.071 0.087 0.065 0.053 
4 0.083 0.071 0 0.052 0.052 
5 0 0.119 0.109 0.097 0.076 
6 0.25 0.143 0.239 0.188 0.211 
7 0.167 0.119 0.217 0.156 0.168 
8 0 0.119 0 0.065 0.04 
9 0 0.071 0.087 0.065 0.053 
10 0.083 0.024 0 0.026 0.036 
11 0.333 0.071 0 0.091 0.135 
12 0 0.048 0.043 0.039 0.03 
13 0 0.119 0.043 0.078 0.054 
14 0 0 0.087 0.026 0.029 
15 0 0.024 0 0.013 0.008 
 
TA81 
  Cameroon Mali Kenya Weighted Unweighted 
     No. 12 44 23     
1 0.167 0.057 0 0.057 0.074 
2 0.25 0.091 0.435 0.215 0.259 
3 0 0.364 0.13 0.241 0.165 
4 0.25 0.193 0.087 0.171 0.177 
5 0.083 0.045 0.174 0.089 0.101 
6 0.083 0.205 0.087 0.152 0.125 
7 0 0.045 0.087 0.051 0.044 
8 0.167 0 0 0.025 0.056 
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TA17 
  Cameroon Mali Kenya Weighted Unweighted 
No. 12 42 23     
1 0 0.024 0 0.013 0.008 
2 0.083 0 0 0.013 0.028 
3 0 0.095 0.217 0.117 0.104 
4 0 0.048 0.087 0.052 0.045 
5 0 0.024 0 0.013 0.008 
6 0.167 0.19 0.043 0.143 0.134 
7 0.167 0 0 0.026 0.056 
8 0 0 0.087 0.026 0.029 
9 0 0.31 0.348 0.273 0.219 
10 0 0.071 0 0.039 0.024 
11 0 0.024 0 0.013 0.008 
12 0.083 0 0 0.013 0.028 
13 0.167 0.19 0.217 0.195 0.192 
14 0.167 0 0 0.026 0.056 
15 0.083 0.024 0 0.026 0.036 
16 0.083 0 0 0.013 0.028 
 
TA53 
  Cameroon Mali Kenya Weighted Unweighted 
     No. 12 42 22     
1 0 0.048 0 0.026 0.016 
2 0.167 0.179 0 0.125 0.115 
3 0.667 0.702 0.591 0.664 0.653 
4 0 0.048 0.318 0.118 0.122 
5 0 0.024 0 0.013 0.008 
6 0.167 0 0.091 0.053 0.086 
 
PFPK2 
  Cameroon Mali Kenya Weighted Unweighted 
     No. 12 39 23     
1 0.25 0.154 0.043 0.135 0.149 
2 0 0.205 0.261 0.189 0.155 
3 0.167 0.256 0.348 0.27 0.257 
4 0.167 0.154 0 0.108 0.107 
5 0.167 0.051 0.217 0.122 0.145 
6 0 0.051 0.13 0.068 0.061 
7 0.083 0.026 0 0.027 0.036 
8 0 0.051 0 0.027 0.017 
9 0.167 0 0 0.027 0.056 
10 0 0.051 0 0.027 0.017 
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 Cameroon Mali Kenya All_W All_UW 
Pf-01-101502 
  12 47 23     
A 0.917 0.915 1 0.939 0.944 
C 0 0.085 0 0.049 0.028 
T 0.083 0 0 0.012 0.028 
Pf-01-205304 
  12 49 23     
A 0 0.041 0 0.024 0.014 
C 0.5 0.776 0.478 0.655 0.585 
G 0.333 0.102 0.261 0.179 0.232 
T 0.167 0.082 0.261 0.143 0.17 
Pf-01-411796 
  12 49 23     
A 1 0.98 1 0.988 0.993 
C 0 0.02 0 0.012 0.007 
Pf-03138-7 
  12 49 23     
A 0 0 0.174 0.048 0.058 
G 0.833 0.653 0.478 0.631 0.655 
T 0.167 0.347 0.348 0.321 0.287 
Pf-03-350224 
  12 49 23     
A 0 0.02 0 0.012 0.007 
C 0.083 0.143 0.13 0.131 0.119 
G 0.667 0.388 0.435 0.44 0.496 
T 0.25 0.449 0.435 0.417 0.378 
Pf-03-613146 
  12 49 23     
C 1 1 0.652 0.905 0.884 
G 0 0 0.217 0.06 0.072 
T 0 0 0.13 0.036 0.043 
Pf-03-842383 
  12 49 23     
A 1 1 1 1 1 
Pf-03-967838 
  12 49 21     
A 1 1 1 1 1 
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  Cameroon Mali Kenya All_W All_UW 
Pf-10658467 
  12 49 23     
A 1 0.918 0.826 0.905 0.915 
C 0 0 0.087 0.024 0.029 
G 0 0.082 0.087 0.071 0.056 
Pf-10-992433 
  12 47 23     
A 0.75 0.596 0.522 0.598 0.622 
C 0 0.021 0 0.012 0.007 
G 0.25 0.383 0.478 0.39 0.37 
Pf-14-279668 
  12 49 23     
A 0.917 0.816 0.522 0.75 0.752 
G 0.083 0.061 0.304 0.131 0.15 
T 0 0.122 0.174 0.119 0.099 
Pf-1710196 
  12 49 23     
A 0.25 0 0 0.036 0.083 
G 0.583 0.408 0.435 0.44 0.475 
T 0.167 0.592 0.565 0.524 0.441 
 
